id	sid	tid	token	lemma	pos
bjos-8642673	1	1	revista	revista	ADJ
bjos-8642673	1	2	fop	fop	ADJ
bjos-8642673	1	3	n	n	PROPN
bjos-8642673	1	4	13	13	NUM
bjos-8642673	1	5	1591	1591	NUM
bjos-8642673	1	6	appraisal	appraisal	NOUN
bjos-8642673	1	7	of	of	ADP
bjos-8642673	1	8	oral	oral	ADJ
bjos-8642673	1	9	lesions	lesion	NOUN
bjos-8642673	1	10	status	status	NOUN
bjos-8642673	1	11	of	of	ADP
bjos-8642673	1	12	hiv	hiv	PROPN
bjos-8642673	1	13	/	/	SYM
bjos-8642673	1	14	aids	aids	PROPN
bjos-8642673	1	15	patients	patient	NOUN
bjos-8642673	1	16	in	in	ADP
bjos-8642673	1	17	south	south	ADJ
bjos-8642673	1	18	western	western	ADJ
bjos-8642673	1	19	uganda	uganda	PROPN
bjos-8642673	1	20	ezera	ezera	PROPN
bjos-8642673	1	21	agwu1	agwu1	PROPN
bjos-8642673	1	22	;	;	PUNCT
bjos-8642673	1	23	john	john	PROPN
bjos-8642673	1	24	cletus	cletus	PROPN
bjos-8642673	1	25	ihongbe2	ihongbe2	PROPN
bjos-8642673	1	26	;	;	PUNCT
bjos-8642673	1	27	jackson	jackson	PROPN
bjos-8642673	1	28	francis	francis	PROPN
bjos-8642673	1	29	tirwomwe3	tirwomwe3	PROPN
bjos-8642673	1	30	;	;	PUNCT
bjos-8642673	1	31	victoria	victoria	PROPN
bjos-8642673	1	32	pazos4	pazos4	PROPN
bjos-8642673	1	33	;	;	PUNCT
bjos-8642673	1	34	michael	michael	PROPN
bjos-8642673	1	35	tirwomwe5	tirwomwe5	PROPN
bjos-8642673	1	36	;	;	PUNCT
bjos-8642673	1	37	luis	luis	PROPN
bjos-8642673	1	38	casadesus6	casadesus6	PROPN
bjos-8642673	2	1	1msc	1msc	NUM
bjos-8642673	2	2	,	,	PUNCT
bjos-8642673	2	3	phd	phd	NOUN
bjos-8642673	2	4	,	,	PUNCT
bjos-8642673	2	5	student	student	NOUN
bjos-8642673	2	6	,	,	PUNCT
bjos-8642673	2	7	lecturer	lecturer	NOUN
bjos-8642673	2	8	and	and	CCONJ
bjos-8642673	2	9	head	head	NOUN
bjos-8642673	2	10	,	,	PUNCT
bjos-8642673	2	11	department	department	NOUN
bjos-8642673	2	12	of	of	ADP
bjos-8642673	2	13	medical	medical	ADJ
bjos-8642673	2	14	microbiology	microbiology	NOUN
bjos-8642673	2	15	2bsc	2bsc	NUM
bjos-8642673	2	16	,	,	PUNCT
bjos-8642673	2	17	phd	phd	NOUN
bjos-8642673	2	18	,	,	PUNCT
bjos-8642673	2	19	associate	associate	NOUN
bjos-8642673	2	20	professor	professor	NOUN
bjos-8642673	2	21	,	,	PUNCT
bjos-8642673	2	22	department	department	NOUN
bjos-8642673	2	23	of	of	ADP
bjos-8642673	2	24	medical	medical	ADJ
bjos-8642673	2	25	laboratory	laboratory	NOUN
bjos-8642673	2	26	sciences	sciences	PROPN
bjos-8642673	2	27	,	,	PUNCT
bjos-8642673	2	28	faculty	faculty	NOUN
bjos-8642673	2	29	of	of	ADP
bjos-8642673	2	30	basic	basic	ADJ
bjos-8642673	2	31	medical	medical	ADJ
bjos-8642673	2	32	sciences	science	NOUN
bjos-8642673	2	33	,	,	PUNCT
bjos-8642673	2	34	college	college	NOUN
bjos-8642673	2	35	of	of	ADP
bjos-8642673	2	36	medicine	medicine	NOUN
bjos-8642673	2	37	,	,	PUNCT
bjos-8642673	2	38	ambrose	ambrose	PROPN
bjos-8642673	2	39	alli	alli	PROPN
bjos-8642673	2	40	university	university	PROPN
bjos-8642673	2	41	,	,	PUNCT
bjos-8642673	2	42	nigeria	nigeria	PROPN
bjos-8642673	2	43	3bds	3bds	NUM
bjos-8642673	2	44	,	,	PUNCT
bjos-8642673	2	45	dpd	dpd	PROPN
bjos-8642673	2	46	,	,	PUNCT
bjos-8642673	2	47	senior	senior	ADJ
bjos-8642673	2	48	lecturer	lecturer	NOUN
bjos-8642673	2	49	and	and	CCONJ
bjos-8642673	2	50	head	head	NOUN
bjos-8642673	2	51	,	,	PUNCT
bjos-8642673	2	52	department	department	NOUN
bjos-8642673	2	53	of	of	ADP
bjos-8642673	2	54	dentistry	dentistry	PROPN
bjos-8642673	2	55	4bsc	4bsc	PROPN
bjos-8642673	2	56	,	,	PUNCT
bjos-8642673	2	57	phd	phd	NOUN
bjos-8642673	2	58	,	,	PUNCT
bjos-8642673	2	59	professor	professor	NOUN
bjos-8642673	2	60	,	,	PUNCT
bjos-8642673	2	61	department	department	NOUN
bjos-8642673	2	62	of	of	ADP
bjos-8642673	2	63	medical	medical	ADJ
bjos-8642673	2	64	microbiology	microbiology	NOUN
bjos-8642673	2	65	5bsc	5bsc	NUM
bjos-8642673	2	66	,	,	PUNCT
bjos-8642673	2	67	teaching	teach	VERB
bjos-8642673	2	68	assistant	assistant	NOUN
bjos-8642673	2	69	,	,	PUNCT
bjos-8642673	2	70	department	department	NOUN
bjos-8642673	2	71	of	of	ADP
bjos-8642673	2	72	biochemistry	biochemistry	NOUN
bjos-8642673	2	73	6bsc	6bsc	NUM
bjos-8642673	2	74	,	,	PUNCT
bjos-8642673	2	75	msc	msc	PROPN
bjos-8642673	2	76	,	,	PUNCT
bjos-8642673	2	77	professor	professor	NOUN
bjos-8642673	2	78	,	,	PUNCT
bjos-8642673	2	79	department	department	NOUN
bjos-8642673	2	80	of	of	ADP
bjos-8642673	2	81	medical	medical	ADJ
bjos-8642673	2	82	microbiology	microbiology	NOUN
bjos-8642673	2	83	school	school	NOUN
bjos-8642673	2	84	of	of	ADP
bjos-8642673	2	85	health	health	NOUN
bjos-8642673	2	86	sciences	sciences	PROPN
bjos-8642673	2	87	,	,	PUNCT
bjos-8642673	2	88	kampala	kampala	PROPN
bjos-8642673	2	89	international	international	PROPN
bjos-8642673	2	90	university	university	PROPN
bjos-8642673	2	91	,	,	PUNCT
bjos-8642673	2	92	western	western	ADJ
bjos-8642673	2	93	campus	campus	NOUN
bjos-8642673	2	94	,	,	PUNCT
bjos-8642673	2	95	bushenyi	bushenyi	PROPN
bjos-8642673	2	96	,	,	PUNCT
bjos-8642673	2	97	uganda	uganda	PROPN
bjos-8642673	2	98	received	receive	VERB
bjos-8642673	2	99	for	for	ADP
bjos-8642673	2	100	publication	publication	NOUN
bjos-8642673	2	101	:	:	PUNCT
bjos-8642673	2	102	may	may	AUX
bjos-8642673	2	103	12	12	NUM
bjos-8642673	2	104	,	,	PUNCT
bjos-8642673	2	105	2008	2008	NUM
bjos-8642673	2	106	accepted	accept	VERB
bjos-8642673	2	107	:	:	PUNCT
bjos-8642673	2	108	september	september	PROPN
bjos-8642673	2	109	09	09	NUM
bjos-8642673	2	110	,	,	PUNCT
bjos-8642673	2	111	2008	2008	NUM
bjos-8642673	2	112	correspondence	correspondence	NOUN
bjos-8642673	2	113	to	to	ADP
bjos-8642673	2	114	:	:	PUNCT
bjos-8642673	2	115	agwu	agwu	PROPN
bjos-8642673	2	116	ezera	ezera	PROPN
bjos-8642673	2	117	,	,	PUNCT
bjos-8642673	2	118	department	department	NOUN
bjos-8642673	2	119	of	of	ADP
bjos-8642673	2	120	medical	medical	ADJ
bjos-8642673	2	121	microbiology	microbiology	NOUN
bjos-8642673	2	122	school	school	NOUN
bjos-8642673	2	123	of	of	ADP
bjos-8642673	2	124	health	health	PROPN
bjos-8642673	2	125	sciences	sciences	PROPN
bjos-8642673	2	126	kampala	kampala	PROPN
bjos-8642673	2	127	international	international	PROPN
bjos-8642673	2	128	university	university	PROPN
bjos-8642673	2	129	,	,	PUNCT
bjos-8642673	2	130	western	western	ADJ
bjos-8642673	2	131	campus	campus	NOUN
bjos-8642673	2	132	,	,	PUNCT
bjos-8642673	2	133	ishaka	ishaka	PROPN
bjos-8642673	2	134	,	,	PUNCT
bjos-8642673	2	135	box	box	PROPN
bjos-8642673	2	136	71	71	NUM
bjos-8642673	2	137	,	,	PUNCT
bjos-8642673	2	138	bushenyi	bushenyi	PROPN
bjos-8642673	2	139	,	,	PUNCT
bjos-8642673	2	140	uganda	uganda	PROPN
bjos-8642673	2	141	.	.	PUNCT
bjos-8642673	3	1	phone	phone	NOUN
bjos-8642673	3	2	:	:	PUNCT
bjos-8642673	3	3	+256782101486	+256782101486	NUM
bjos-8642673	3	4	e	e	NOUN
bjos-8642673	3	5	-	-	NOUN
bjos-8642673	3	6	mail	mail	NOUN
bjos-8642673	3	7	:	:	PUNCT
bjos-8642673	3	8	agwuezera@yahoo.com	agwuezera@yahoo.com	X
bjos-8642673	4	1	abstract	abstract	ADJ
bjos-8642673	4	2	aim	aim	NOUN
bjos-8642673	4	3	:	:	PUNCT
bjos-8642673	4	4	to	to	PART
bjos-8642673	4	5	establish	establish	VERB
bjos-8642673	4	6	a	a	DET
bjos-8642673	4	7	regional	regional	ADJ
bjos-8642673	4	8	surveillance	surveillance	NOUN
bjos-8642673	4	9	data	datum	NOUN
bjos-8642673	4	10	that	that	PRON
bjos-8642673	4	11	may	may	AUX
bjos-8642673	4	12	contribute	contribute	VERB
bjos-8642673	4	13	to	to	ADP
bjos-8642673	4	14	improvement	improvement	NOUN
bjos-8642673	4	15	of	of	ADP
bjos-8642673	4	16	oral	oral	ADJ
bjos-8642673	4	17	health	health	NOUN
bjos-8642673	4	18	prevention	prevention	NOUN
bjos-8642673	4	19	/	/	SYM
bjos-8642673	4	20	control	control	NOUN
bjos-8642673	4	21	programs	program	NOUN
bjos-8642673	4	22	in	in	ADP
bjos-8642673	4	23	south	south	ADJ
bjos-8642673	4	24	western	western	ADJ
bjos-8642673	4	25	uganda	uganda	PROPN
bjos-8642673	4	26	.	.	PUNCT
bjos-8642673	5	1	methods	method	NOUN
bjos-8642673	5	2	:	:	PUNCT
bjos-8642673	5	3	using	use	VERB
bjos-8642673	5	4	who	who	PRON
bjos-8642673	5	5	guidelines	guideline	VERB
bjos-8642673	5	6	,	,	PUNCT
bjos-8642673	5	7	hiv	hiv	PROPN
bjos-8642673	5	8	-	-	PUNCT
bjos-8642673	5	9	associated	associate	VERB
bjos-8642673	5	10	oral	oral	ADJ
bjos-8642673	5	11	lesions	lesion	NOUN
bjos-8642673	5	12	were	be	AUX
bjos-8642673	5	13	identified	identify	VERB
bjos-8642673	5	14	among	among	ADP
bjos-8642673	5	15	605	605	NUM
bjos-8642673	5	16	hiv	hiv	NOUN
bjos-8642673	5	17	/	/	SYM
bjos-8642673	5	18	aids	aids	PROPN
bjos-8642673	5	19	patients	patient	NOUN
bjos-8642673	5	20	(	(	PUNCT
bjos-8642673	5	21	469	469	NUM
bjos-8642673	5	22	females	female	NOUN
bjos-8642673	5	23	and	and	CCONJ
bjos-8642673	5	24	136	136	NUM
bjos-8642673	5	25	males	male	NOUN
bjos-8642673	5	26	)	)	PUNCT
bjos-8642673	5	27	,	,	PUNCT
bjos-8642673	5	28	selected	select	VERB
bjos-8642673	5	29	at	at	ADP
bjos-8642673	5	30	random	random	ADJ
bjos-8642673	5	31	from	from	ADP
bjos-8642673	5	32	4	4	NUM
bjos-8642673	5	33	districts	district	NOUN
bjos-8642673	5	34	of	of	ADP
bjos-8642673	5	35	south	south	ADJ
bjos-8642673	5	36	western	western	ADJ
bjos-8642673	5	37	uganda	uganda	PROPN
bjos-8642673	5	38	.	.	PUNCT
bjos-8642673	6	1	pearson	pearson	PROPN
bjos-8642673	6	2	’s	’s	PART
bjos-8642673	6	3	chi	chi	PROPN
bjos-8642673	6	4	square	square	PROPN
bjos-8642673	6	5	test	test	NOUN
bjos-8642673	6	6	of	of	ADP
bjos-8642673	6	7	independence	independence	NOUN
bjos-8642673	6	8	(	(	PUNCT
bjos-8642673	6	9	α=0.01	α=0.01	PROPN
bjos-8642673	6	10	)	)	PUNCT
bjos-8642673	6	11	,	,	PUNCT
bjos-8642673	6	12	was	be	AUX
bjos-8642673	6	13	used	use	VERB
bjos-8642673	6	14	to	to	PART
bjos-8642673	6	15	compare	compare	VERB
bjos-8642673	6	16	results	result	NOUN
bjos-8642673	6	17	.	.	PUNCT
bjos-8642673	7	1	results	result	NOUN
bjos-8642673	7	2	:	:	PUNCT
bjos-8642673	7	3	prevalence	prevalence	NOUN
bjos-8642673	7	4	of	of	ADP
bjos-8642673	7	5	oral	oral	ADJ
bjos-8642673	7	6	lesions	lesion	NOUN
bjos-8642673	7	7	was	be	AUX
bjos-8642673	7	8	73.2	73.2	NUM
bjos-8642673	7	9	%	%	NOUN
bjos-8642673	7	10	.	.	PUNCT
bjos-8642673	8	1	pseudomembranous	pseudomembranous	ADJ
bjos-8642673	8	2	candidiasis	candidiasis	NOUN
bjos-8642673	8	3	(	(	PUNCT
bjos-8642673	8	4	pc	pc	NOUN
bjos-8642673	8	5	)	)	PUNCT
bjos-8642673	8	6	showed	show	VERB
bjos-8642673	8	7	the	the	DET
bjos-8642673	8	8	highest	high	ADJ
bjos-8642673	8	9	overall	overall	ADJ
bjos-8642673	8	10	prevalence	prevalence	NOUN
bjos-8642673	8	11	of	of	ADP
bjos-8642673	8	12	71.1	71.1	NUM
bjos-8642673	8	13	%	%	NOUN
bjos-8642673	8	14	(	(	PUNCT
bjos-8642673	8	15	34.9	34.9	NUM
bjos-8642673	8	16	%	%	NOUN
bjos-8642673	8	17	single	single	ADJ
bjos-8642673	8	18	and	and	CCONJ
bjos-8642673	8	19	36.2	36.2	NUM
bjos-8642673	8	20	%	%	NOUN
bjos-8642673	8	21	mixed	mixed	ADJ
bjos-8642673	8	22	)	)	PUNCT
bjos-8642673	8	23	;	;	PUNCT
bjos-8642673	8	24	followed	follow	VERB
bjos-8642673	8	25	by	by	ADP
bjos-8642673	8	26	39.9	39.9	NUM
bjos-8642673	8	27	%	%	NOUN
bjos-8642673	8	28	prevalence	prevalence	NOUN
bjos-8642673	8	29	of	of	ADP
bjos-8642673	8	30	erythematous	erythematous	ADJ
bjos-8642673	8	31	candidiasis	candidiasis	NOUN
bjos-8642673	8	32	(	(	PUNCT
bjos-8642673	8	33	ec	ec	PROPN
bjos-8642673	8	34	)	)	PUNCT
bjos-8642673	8	35	(	(	PUNCT
bjos-8642673	8	36	13.2	13.2	NUM
bjos-8642673	8	37	%	%	NOUN
bjos-8642673	8	38	)	)	PUNCT
bjos-8642673	8	39	single	single	ADJ
bjos-8642673	8	40	;	;	PUNCT
bjos-8642673	8	41	26.7	26.7	NUM
bjos-8642673	8	42	%	%	NOUN
bjos-8642673	8	43	mixed	mixed	ADJ
bjos-8642673	8	44	)	)	PUNCT
bjos-8642673	8	45	and	and	CCONJ
bjos-8642673	8	46	18.8	18.8	NUM
bjos-8642673	8	47	%	%	NOUN
bjos-8642673	8	48	prevalence	prevalence	NOUN
bjos-8642673	8	49	of	of	ADP
bjos-8642673	8	50	angular	angular	ADJ
bjos-8642673	8	51	chelitis	chelitis	PROPN
bjos-8642673	8	52	(	(	PUNCT
bjos-8642673	8	53	ac	ac	PROPN
bjos-8642673	8	54	)	)	PUNCT
bjos-8642673	8	55	(	(	PUNCT
bjos-8642673	8	56	3.1	3.1	NUM
bjos-8642673	8	57	%	%	NOUN
bjos-8642673	8	58	single	single	ADJ
bjos-8642673	8	59	and	and	CCONJ
bjos-8642673	8	60	15.7	15.7	NUM
bjos-8642673	8	61	%	%	NOUN
bjos-8642673	8	62	mixed	mixed	ADJ
bjos-8642673	8	63	)	)	PUNCT
bjos-8642673	8	64	.	.	PUNCT
bjos-8642673	9	1	there	there	PRON
bjos-8642673	9	2	was	be	VERB
bjos-8642673	9	3	:	:	PUNCT
bjos-8642673	9	4	23.6	23.6	NUM
bjos-8642673	9	5	%	%	NOUN
bjos-8642673	9	6	co	co	NOUN
bjos-8642673	9	7	-	-	NOUN
bjos-8642673	9	8	infection	infection	NOUN
bjos-8642673	9	9	of	of	ADP
bjos-8642673	9	10	pc	pc	NOUN
bjos-8642673	9	11	and	and	CCONJ
bjos-8642673	9	12	ec	ec	PROPN
bjos-8642673	9	13	;	;	PUNCT
bjos-8642673	9	14	12.6	12.6	NUM
bjos-8642673	9	15	%	%	NOUN
bjos-8642673	9	16	pc	pc	NOUN
bjos-8642673	9	17	and	and	CCONJ
bjos-8642673	9	18	ac	ac	PROPN
bjos-8642673	9	19	,	,	PUNCT
bjos-8642673	9	20	3.1	3.1	NUM
bjos-8642673	9	21	%	%	NOUN
bjos-8642673	9	22	were	be	AUX
bjos-8642673	9	23	ec	ec	PROPN
bjos-8642673	9	24	and	and	CCONJ
bjos-8642673	9	25	ac	ac	PROPN
bjos-8642673	9	26	,	,	PUNCT
bjos-8642673	9	27	and	and	CCONJ
bjos-8642673	9	28	17.0	17.0	NUM
bjos-8642673	9	29	%	%	NOUN
bjos-8642673	9	30	intra	intra	ADJ
bjos-8642673	9	31	-	-	ADJ
bjos-8642673	9	32	oral	oral	ADJ
bjos-8642673	9	33	pigmentation	pigmentation	NOUN
bjos-8642673	9	34	.	.	PUNCT
bjos-8642673	10	1	prevalence	prevalence	NOUN
bjos-8642673	10	2	of	of	ADP
bjos-8642673	10	3	oral	oral	ADJ
bjos-8642673	10	4	lesions	lesion	NOUN
bjos-8642673	10	5	was	be	AUX
bjos-8642673	10	6	significantly	significantly	ADV
bjos-8642673	10	7	(	(	PUNCT
bjos-8642673	10	8	p<0.01	p<0.01	PROPN
bjos-8642673	10	9	)	)	PUNCT
bjos-8642673	10	10	dependent	dependent	ADJ
bjos-8642673	10	11	on	on	ADP
bjos-8642673	10	12	host	host	NOUN
bjos-8642673	10	13	pre	pre	NOUN
bjos-8642673	10	14	-	-	NOUN
bjos-8642673	10	15	exposure	exposure	ADJ
bjos-8642673	10	16	to	to	ADP
bjos-8642673	10	17	antimicrobials	antimicrobial	NOUN
bjos-8642673	10	18	.	.	PUNCT
bjos-8642673	11	1	conclusions	conclusion	NOUN
bjos-8642673	11	2	:	:	PUNCT
bjos-8642673	11	3	oral	oral	ADJ
bjos-8642673	11	4	infections	infection	NOUN
bjos-8642673	11	5	are	be	AUX
bjos-8642673	11	6	still	still	ADV
bjos-8642673	11	7	highly	highly	ADV
bjos-8642673	11	8	prevalent	prevalent	ADJ
bjos-8642673	11	9	among	among	ADP
bjos-8642673	11	10	the	the	DET
bjos-8642673	11	11	studied	study	VERB
bjos-8642673	11	12	hiv	hiv	PROPN
bjos-8642673	11	13	/	/	SYM
bjos-8642673	11	14	aids	aids	PROPN
bjos-8642673	11	15	patients	patient	NOUN
bjos-8642673	11	16	in	in	ADP
bjos-8642673	11	17	south	south	ADJ
bjos-8642673	11	18	western	western	ADJ
bjos-8642673	11	19	uganda	uganda	PROPN
bjos-8642673	11	20	.	.	PUNCT
bjos-8642673	12	1	this	this	DET
bjos-8642673	12	2	observation	observation	NOUN
bjos-8642673	12	3	may	may	AUX
bjos-8642673	12	4	be	be	AUX
bjos-8642673	12	5	due	due	ADJ
bjos-8642673	12	6	to	to	ADP
bjos-8642673	12	7	inadequate	inadequate	ADJ
bjos-8642673	12	8	antimicrobial	antimicrobial	ADJ
bjos-8642673	12	9	agents	agent	NOUN
bjos-8642673	12	10	and	and	CCONJ
bjos-8642673	12	11	oral	oral	ADJ
bjos-8642673	12	12	/	/	SYM
bjos-8642673	12	13	dental	dental	ADJ
bjos-8642673	12	14	care	care	NOUN
bjos-8642673	12	15	.	.	PUNCT
bjos-8642673	13	1	there	there	PRON
bjos-8642673	13	2	’s	’	VERB
bjos-8642673	13	3	urgent	urgent	ADJ
bjos-8642673	13	4	need	need	NOUN
bjos-8642673	13	5	to	to	PART
bjos-8642673	13	6	train	train	VERB
bjos-8642673	13	7	primary	primary	ADJ
bjos-8642673	13	8	health	health	NOUN
bjos-8642673	13	9	care	care	NOUN
bjos-8642673	13	10	workers	worker	NOUN
bjos-8642673	13	11	in	in	ADP
bjos-8642673	13	12	management	management	NOUN
bjos-8642673	13	13	of	of	ADP
bjos-8642673	13	14	oral	oral	ADJ
bjos-8642673	13	15	lesions	lesion	NOUN
bjos-8642673	13	16	associated	associate	VERB
bjos-8642673	13	17	with	with	ADP
bjos-8642673	13	18	hiv	hiv	PROPN
bjos-8642673	13	19	/	/	SYM
bjos-8642673	13	20	aids	aids	PROPN
bjos-8642673	13	21	.	.	PUNCT
bjos-8642673	14	1	more	more	ADJ
bjos-8642673	14	2	studies	study	NOUN
bjos-8642673	14	3	are	be	AUX
bjos-8642673	14	4	needed	need	VERB
bjos-8642673	14	5	to	to	PART
bjos-8642673	14	6	evaluate	evaluate	VERB
bjos-8642673	14	7	hiv	hiv	PROPN
bjos-8642673	14	8	/	/	SYM
bjos-8642673	14	9	aids	aids	PROPN
bjos-8642673	14	10	oral	oral	ADJ
bjos-8642673	14	11	lesions	lesion	NOUN
bjos-8642673	14	12	in	in	ADP
bjos-8642673	14	13	the	the	DET
bjos-8642673	14	14	populace	populace	NOUN
bjos-8642673	14	15	.	.	PUNCT
bjos-8642673	15	1	key	key	ADJ
bjos-8642673	15	2	words	word	NOUN
bjos-8642673	15	3	:	:	PUNCT
bjos-8642673	15	4	oral	oral	ADJ
bjos-8642673	15	5	lesions	lesion	NOUN
bjos-8642673	15	6	,	,	PUNCT
bjos-8642673	15	7	hiv	hiv	PROPN
bjos-8642673	15	8	/	/	SYM
bjos-8642673	15	9	aids	aids	PROPN
bjos-8642673	15	10	,	,	PUNCT
bjos-8642673	15	11	uganda	uganda	PROPN
bjos-8642673	15	12	in	in	ADP
bjos-8642673	15	13	t	t	PROPN
bjos-8642673	15	14	roduc	roduc	PROPN
bjos-8642673	15	15	t	t	PROPN
bjos-8642673	15	16	ion	ion	NOUN
bjos-8642673	15	17	once	once	ADV
bjos-8642673	15	18	infected	infect	VERB
bjos-8642673	15	19	with	with	ADP
bjos-8642673	15	20	human	human	ADJ
bjos-8642673	15	21	immunodeficiency	immunodeficiency	NOUN
bjos-8642673	15	22	virus	virus	NOUN
bjos-8642673	15	23	(	(	PUNCT
bjos-8642673	15	24	hiv	hiv	PROPN
bjos-8642673	15	25	)	)	PUNCT
bjos-8642673	15	26	,	,	PUNCT
bjos-8642673	15	27	progression	progression	NOUN
bjos-8642673	15	28	to	to	PART
bjos-8642673	15	29	acquired	acquire	VERB
bjos-8642673	15	30	immunodeficiency	immunodeficiency	NOUN
bjos-8642673	15	31	syndrome	syndrome	NOUN
bjos-8642673	15	32	(	(	PUNCT
bjos-8642673	15	33	aids	aids	PROPN
bjos-8642673	15	34	)	)	PUNCT
bjos-8642673	15	35	and	and	CCONJ
bjos-8642673	15	36	death	death	NOUN
bjos-8642673	15	37	is	be	AUX
bjos-8642673	15	38	the	the	DET
bjos-8642673	15	39	reality	reality	NOUN
bjos-8642673	15	40	for	for	ADP
bjos-8642673	15	41	most	most	ADJ
bjos-8642673	15	42	people	people	NOUN
bjos-8642673	15	43	in	in	ADP
bjos-8642673	15	44	resource	resource	NOUN
bjos-8642673	15	45	poor	poor	ADJ
bjos-8642673	15	46	countries1	countries1	PROPN
bjos-8642673	15	47	.	.	PUNCT
bjos-8642673	16	1	the	the	DET
bjos-8642673	16	2	impact	impact	NOUN
bjos-8642673	16	3	of	of	ADP
bjos-8642673	16	4	hiv	hiv	PROPN
bjos-8642673	16	5	on	on	ADP
bjos-8642673	16	6	individuals	individual	NOUN
bjos-8642673	16	7	and	and	CCONJ
bjos-8642673	16	8	families	family	NOUN
bjos-8642673	16	9	in	in	ADP
bjos-8642673	16	10	sub	sub	ADJ
bjos-8642673	16	11	-	-	ADJ
bjos-8642673	16	12	saharan	saharan	ADJ
bjos-8642673	16	13	africa	africa	PROPN
bjos-8642673	16	14	is	be	AUX
bjos-8642673	16	15	still	still	ADV
bjos-8642673	16	16	very	very	ADV
bjos-8642673	16	17	great2	great2	NOUN
bjos-8642673	16	18	and	and	CCONJ
bjos-8642673	16	19	therefore	therefore	ADV
bjos-8642673	16	20	increasing	increase	VERB
bjos-8642673	16	21	research	research	NOUN
bjos-8642673	16	22	attention	attention	NOUN
bjos-8642673	16	23	is	be	AUX
bjos-8642673	16	24	being	be	AUX
bjos-8642673	16	25	given	give	VERB
bjos-8642673	16	26	to	to	ADP
bjos-8642673	16	27	prevention	prevention	NOUN
bjos-8642673	16	28	,	,	PUNCT
bjos-8642673	16	29	control	control	NOUN
bjos-8642673	16	30	and	and	CCONJ
bjos-8642673	16	31	management	management	NOUN
bjos-8642673	16	32	hiv	hiv	PROPN
bjos-8642673	16	33	/	/	SYM
bjos-8642673	16	34	aids	aids	PROPN
bjos-8642673	16	35	victims3	victims3	NOUN
bjos-8642673	16	36	.	.	PUNCT
bjos-8642673	17	1	in	in	ADP
bjos-8642673	17	2	uganda	uganda	PROPN
bjos-8642673	17	3	,	,	PUNCT
bjos-8642673	17	4	and	and	CCONJ
bjos-8642673	17	5	most	most	ADJ
bjos-8642673	17	6	lowincome	lowincome	NOUN
bjos-8642673	17	7	settings	setting	NOUN
bjos-8642673	17	8	,	,	PUNCT
bjos-8642673	17	9	the	the	DET
bjos-8642673	17	10	relationships	relationship	NOUN
bjos-8642673	17	11	of	of	ADP
bjos-8642673	17	12	these	these	DET
bjos-8642673	17	13	parameters	parameter	NOUN
bjos-8642673	17	14	are	be	AUX
bjos-8642673	17	15	far	far	ADV
bjos-8642673	17	16	less	less	ADV
bjos-8642673	17	17	clear	clear	ADJ
bjos-8642673	17	18	,	,	PUNCT
bjos-8642673	17	19	partly	partly	ADV
bjos-8642673	17	20	because	because	SCONJ
bjos-8642673	17	21	of	of	ADP
bjos-8642673	17	22	the	the	DET
bjos-8642673	17	23	scarcity	scarcity	NOUN
bjos-8642673	17	24	of	of	ADP
bjos-8642673	17	25	cohorts	cohort	NOUN
bjos-8642673	17	26	with	with	ADP
bjos-8642673	17	27	complete	complete	ADJ
bjos-8642673	17	28	laboratory	laboratory	NOUN
bjos-8642673	17	29	testing	testing	NOUN
bjos-8642673	17	30	and	and	CCONJ
bjos-8642673	17	31	diagnostic	diagnostic	ADJ
bjos-8642673	17	32	capabilities4	capabilities4	PROPN
bjos-8642673	17	33	.	.	PUNCT
bjos-8642673	18	1	the	the	DET
bjos-8642673	18	2	oral	oral	ADJ
bjos-8642673	18	3	cavity	cavity	NOUN
bjos-8642673	18	4	is	be	AUX
bjos-8642673	18	5	an	an	DET
bjos-8642673	18	6	essential	essential	ADJ
bjos-8642673	18	7	part	part	NOUN
bjos-8642673	18	8	of	of	ADP
bjos-8642673	18	9	the	the	DET
bjos-8642673	18	10	body	body	NOUN
bjos-8642673	18	11	and	and	CCONJ
bjos-8642673	18	12	contributes	contribute	VERB
bjos-8642673	18	13	to	to	ADP
bjos-8642673	18	14	total	total	ADJ
bjos-8642673	18	15	health	health	NOUN
bjos-8642673	18	16	and	and	CCONJ
bjos-8642673	18	17	well	well	ADV
bjos-8642673	18	18	-	-	PUNCT
bjos-8642673	18	19	being	being	NOUN
bjos-8642673	18	20	.	.	PUNCT
bjos-8642673	19	1	it	it	PRON
bjos-8642673	19	2	is	be	AUX
bjos-8642673	19	3	evident	evident	ADJ
bjos-8642673	19	4	that	that	SCONJ
bjos-8642673	19	5	poor	poor	ADJ
bjos-8642673	19	6	oral	oral	ADJ
bjos-8642673	19	7	health	health	NOUN
bjos-8642673	19	8	affects	affect	VERB
bjos-8642673	19	9	general	general	ADJ
bjos-8642673	19	10	health	health	NOUN
bjos-8642673	19	11	and	and	CCONJ
bjos-8642673	19	12	that	that	SCONJ
bjos-8642673	19	13	some	some	DET
bjos-8642673	19	14	systemic	systemic	ADJ
bjos-8642673	19	15	diseases	disease	NOUN
bjos-8642673	19	16	can	can	AUX
bjos-8642673	19	17	affect	affect	VERB
bjos-8642673	19	18	oral	oral	ADJ
bjos-8642673	19	19	health	health	NOUN
bjos-8642673	19	20	.	.	PUNCT
bjos-8642673	20	1	since	since	SCONJ
bjos-8642673	20	2	hiv	hiv	PROPN
bjos-8642673	20	3	infection	infection	NOUN
bjos-8642673	20	4	was	be	AUX
bjos-8642673	20	5	first	first	ADV
bjos-8642673	20	6	described	describe	VERB
bjos-8642673	20	7	in	in	ADP
bjos-8642673	20	8	1981	1981	NUM
bjos-8642673	20	9	,	,	PUNCT
bjos-8642673	20	10	a	a	DET
bjos-8642673	20	11	variety	variety	NOUN
bjos-8642673	20	12	of	of	ADP
bjos-8642673	20	13	oral	oral	ADJ
bjos-8642673	20	14	conditions	condition	NOUN
bjos-8642673	20	15	associated	associate	VERB
bjos-8642673	20	16	with	with	ADP
bjos-8642673	20	17	hiv	hiv	PROPN
bjos-8642673	20	18	disease	disease	NOUN
bjos-8642673	20	19	have	have	AUX
bjos-8642673	20	20	been	be	AUX
bjos-8642673	20	21	documented	document	VERB
bjos-8642673	20	22	.	.	PUNCT
bjos-8642673	21	1	studies	study	NOUN
bjos-8642673	21	2	have	have	AUX
bjos-8642673	21	3	shown	show	VERB
bjos-8642673	21	4	that	that	SCONJ
bjos-8642673	21	5	70	70	NUM
bjos-8642673	21	6	to	to	PART
bjos-8642673	21	7	90	90	NUM
bjos-8642673	21	8	percent	percent	NOUN
bjos-8642673	21	9	of	of	ADP
bjos-8642673	21	10	people	people	NOUN
bjos-8642673	21	11	infected	infect	VERB
bjos-8642673	21	12	with	with	ADP
bjos-8642673	21	13	hiv	hiv	PROPN
bjos-8642673	21	14	will	will	AUX
bjos-8642673	21	15	develop	develop	VERB
bjos-8642673	21	16	at	at	ADP
bjos-8642673	21	17	least	least	ADV
bjos-8642673	21	18	one	one	NUM
bjos-8642673	21	19	oral	oral	ADJ
bjos-8642673	21	20	manifestation	manifestation	NOUN
bjos-8642673	21	21	during	during	ADP
bjos-8642673	21	22	the	the	DET
bjos-8642673	21	23	course	course	NOUN
bjos-8642673	21	24	of	of	ADP
bjos-8642673	21	25	the	the	DET
bjos-8642673	21	26	disease5	disease5	NOUN
bjos-8642673	21	27	-	-	PUNCT
bjos-8642673	21	28	6	6	NUM
bjos-8642673	21	29	.	.	PUNCT
bjos-8642673	22	1	oral	oral	ADJ
bjos-8642673	22	2	lesions	lesion	NOUN
bjos-8642673	22	3	correspond	correspond	VERB
bjos-8642673	22	4	to	to	ADP
bjos-8642673	22	5	the	the	DET
bjos-8642673	22	6	decline	decline	NOUN
bjos-8642673	22	7	in	in	ADP
bjos-8642673	22	8	numbers	number	NOUN
bjos-8642673	22	9	of	of	ADP
bjos-8642673	22	10	cd4	cd4	PROPN
bjos-8642673	22	11	+	+	NOUN
bjos-8642673	22	12	cells	cell	NOUN
bjos-8642673	22	13	and	and	CCONJ
bjos-8642673	22	14	an	an	DET
bjos-8642673	22	15	increase	increase	NOUN
bjos-8642673	22	16	in	in	ADP
bjos-8642673	22	17	viral	viral	ADJ
bjos-8642673	22	18	load	load	NOUN
bjos-8642673	22	19	and	and	CCONJ
bjos-8642673	22	20	are	be	AUX
bjos-8642673	22	21	also	also	ADV
bjos-8642673	22	22	independent	independent	ADJ
bjos-8642673	22	23	indicators	indicator	NOUN
bjos-8642673	22	24	of	of	ADP
bjos-8642673	22	25	disease	disease	NOUN
bjos-8642673	22	26	progression7	progression7	NOUN
bjos-8642673	22	27	-	-	PUNCT
bjos-8642673	22	28	8	8	NUM
bjos-8642673	22	29	.	.	PUNCT
bjos-8642673	23	1	bacteria	bacteria	NOUN
bjos-8642673	23	2	are	be	AUX
bjos-8642673	23	3	the	the	DET
bjos-8642673	23	4	predominant	predominant	ADJ
bjos-8642673	23	5	component	component	NOUN
bjos-8642673	23	6	of	of	ADP
bjos-8642673	23	7	resident	resident	ADJ
bjos-8642673	23	8	oral	oral	ADJ
bjos-8642673	23	9	flora	flora	NOUN
bjos-8642673	23	10	and	and	CCONJ
bjos-8642673	23	11	its	its	PRON
bjos-8642673	23	12	high	high	ADJ
bjos-8642673	23	13	species	species	NOUN
bjos-8642673	23	14	diversity	diversity	NOUN
bjos-8642673	23	15	reflects	reflect	VERB
bjos-8642673	23	16	many	many	ADJ
bjos-8642673	23	17	endogenous	endogenous	ADJ
bjos-8642673	23	18	derived	derived	ADJ
bjos-8642673	23	19	nutrients	nutrient	NOUN
bjos-8642673	23	20	and	and	CCONJ
bjos-8642673	23	21	the	the	DET
bjos-8642673	23	22	varied	varied	ADJ
bjos-8642673	23	23	types	type	NOUN
bjos-8642673	23	24	of	of	ADP
bjos-8642673	23	25	habitat	habitat	NOUN
bjos-8642673	23	26	for	for	ADP
bjos-8642673	23	27	colonization	colonization	NOUN
bjos-8642673	23	28	.	.	PUNCT
bjos-8642673	24	1	the	the	DET
bjos-8642673	24	2	composition	composition	NOUN
bjos-8642673	24	3	of	of	ADP
bjos-8642673	24	4	the	the	DET
bjos-8642673	24	5	oral	oral	ADJ
bjos-8642673	24	6	bacterial	bacterial	ADJ
bjos-8642673	24	7	flora	flora	NOUN
bjos-8642673	24	8	in	in	ADP
bjos-8642673	24	9	disease	disease	NOUN
bjos-8642673	24	10	and	and	CCONJ
bjos-8642673	24	11	in	in	ADP
bjos-8642673	24	12	health	health	NOUN
bjos-8642673	24	13	may	may	AUX
bjos-8642673	24	14	not	not	PART
bjos-8642673	24	15	be	be	AUX
bjos-8642673	24	16	different	different	ADJ
bjos-8642673	24	17	and	and	CCONJ
bjos-8642673	24	18	any	any	DET
bjos-8642673	24	19	adverse	adverse	ADJ
bjos-8642673	24	20	changes	change	NOUN
bjos-8642673	24	21	resulting	result	VERB
bjos-8642673	24	22	from	from	ADP
bjos-8642673	24	23	immunosuppression	immunosuppression	NOUN
bjos-8642673	24	24	predispose	predispose	ADJ
bjos-8642673	24	25	to	to	ADP
bjos-8642673	24	26	infections9	infections9	NOUN
bjos-8642673	24	27	.	.	PUNCT
bjos-8642673	25	1	conditions	condition	NOUN
bjos-8642673	25	2	at	at	ADP
bjos-8642673	25	3	the	the	DET
bjos-8642673	25	4	sites	site	NOUN
bjos-8642673	25	5	and	and	CCONJ
bjos-8642673	25	6	compositions	composition	NOUN
bjos-8642673	25	7	of	of	ADP
bjos-8642673	25	8	oral	oral	ADJ
bjos-8642673	25	9	microorganisms	microorganism	NOUN
bjos-8642673	25	10	vary	vary	VERB
bjos-8642673	25	11	with	with	ADP
bjos-8642673	25	12	respect	respect	NOUN
bjos-8642673	25	13	to	to	ADP
bjos-8642673	25	14	oxygen	oxygen	NOUN
bjos-8642673	25	15	level	level	NOUN
bjos-8642673	25	16	,	,	PUNCT
bjos-8642673	25	17	braz	braz	PROPN
bjos-8642673	25	18	j	j	PROPN
bjos-8642673	25	19	oral	oral	PROPN
bjos-8642673	25	20	sci	sci	PROPN
bjos-8642673	25	21	.	.	PUNCT
bjos-8642673	26	1	july	july	PROPN
bjos-8642673	26	2	/	/	SYM
bjos-8642673	26	3	september	september	PROPN
bjos-8642673	26	4	2008	2008	NUM
bjos-8642673	26	5	vol	vol	NOUN
bjos-8642673	26	6	.	.	NOUN
bjos-8642673	27	1	7	7	NUM
bjos-8642673	27	2	number	number	NOUN
bjos-8642673	27	3	26	26	NUM
bjos-8642673	27	4	1592	1592	NUM
bjos-8642673	27	5	oral	oral	ADJ
bjos-8642673	27	6	lesions	lesion	NOUN
bjos-8642673	27	7	number	number	NOUN
bjos-8642673	27	8	(	(	PUNCT
bjos-8642673	27	9	%	%	INTJ
bjos-8642673	27	10	)	)	PUNCT
bjos-8642673	27	11	positive	positive	ADJ
bjos-8642673	27	12	a.	a.	NOUN
bjos-8642673	27	13	pseudomembranous	pseudomembranous	ADJ
bjos-8642673	27	14	candidiasis	candidiasis	NOUN
bjos-8642673	27	15	(	(	PUNCT
bjos-8642673	27	16	pc	pc	NOUN
bjos-8642673	27	17	)	)	PUNCT
bjos-8642673	27	18	211	211	NUM
bjos-8642673	27	19	(	(	PUNCT
bjos-8642673	27	20	34.9	34.9	NUM
bjos-8642673	27	21	)	)	PUNCT
bjos-8642673	27	22	b.	b.	NOUN
bjos-8642673	27	23	erythematous	erythematous	ADJ
bjos-8642673	27	24	candidiasis	candidiasis	NOUN
bjos-8642673	27	25	(	(	PUNCT
bjos-8642673	27	26	ec	ec	PROPN
bjos-8642673	27	27	)	)	PUNCT
bjos-8642673	27	28	80	80	NUM
bjos-8642673	27	29	(	(	PUNCT
bjos-8642673	27	30	13.2	13.2	NUM
bjos-8642673	27	31	)	)	PUNCT
bjos-8642673	27	32	c.	c.	PROPN
bjos-8642673	27	33	angular	angular	ADJ
bjos-8642673	27	34	chelitis	chelitis	PROPN
bjos-8642673	27	35	alone	alone	ADV
bjos-8642673	27	36	(	(	PUNCT
bjos-8642673	27	37	ac	ac	PROPN
bjos-8642673	27	38	)	)	PUNCT
bjos-8642673	27	39	19	19	NUM
bjos-8642673	27	40	(	(	PUNCT
bjos-8642673	27	41	3.1	3.1	NUM
bjos-8642673	27	42	)	)	PUNCT
bjos-8642673	27	43	d.	d.	PROPN
bjos-8642673	27	44	pc	pc	PROPN
bjos-8642673	27	45	and	and	CCONJ
bjos-8642673	27	46	ec	ec	PROPN
bjos-8642673	27	47	143	143	NUM
bjos-8642673	27	48	(	(	PUNCT
bjos-8642673	27	49	23.6	23.6	NUM
bjos-8642673	27	50	)	)	PUNCT
bjos-8642673	27	51	e.	e.	PROPN
bjos-8642673	27	52	pc	pc	PROPN
bjos-8642673	28	1	and	and	CCONJ
bjos-8642673	28	2	ac	ac	PROPN
bjos-8642673	28	3	76	76	NUM
bjos-8642673	28	4	(	(	PUNCT
bjos-8642673	28	5	12.6	12.6	NUM
bjos-8642673	28	6	)	)	PUNCT
bjos-8642673	28	7	f.	f.	PROPN
bjos-8642673	28	8	ec	ec	PROPN
bjos-8642673	28	9	and	and	CCONJ
bjos-8642673	28	10	ac	ac	PROPN
bjos-8642673	28	11	19	19	NUM
bjos-8642673	28	12	(	(	PUNCT
bjos-8642673	28	13	3.1	3.1	NUM
bjos-8642673	28	14	)	)	PUNCT
bjos-8642673	28	15	g.	g.	PROPN
bjos-8642673	28	16	kaposi	kaposi	PROPN
bjos-8642673	28	17	sarcoma	sarcoma	PROPN
bjos-8642673	28	18	(	(	PUNCT
bjos-8642673	28	19	ks	ks	NOUN
bjos-8642673	28	20	)	)	SYM
bjos-8642673	28	21	28	28	NUM
bjos-8642673	28	22	(	(	PUNCT
bjos-8642673	28	23	4.6	4.6	NUM
bjos-8642673	28	24	)	)	PUNCT
bjos-8642673	28	25	h.	h.	NOUN
bjos-8642673	28	26	recurrent	recurrent	ADJ
bjos-8642673	28	27	aphthous	aphthous	ADJ
bjos-8642673	28	28	ulceration	ulceration	NOUN
bjos-8642673	28	29	(	(	PUNCT
bjos-8642673	28	30	rau	rau	PROPN
bjos-8642673	28	31	)	)	PUNCT
bjos-8642673	28	32	15	15	NUM
bjos-8642673	28	33	(	(	PUNCT
bjos-8642673	28	34	2.5	2.5	NUM
bjos-8642673	28	35	)	)	PUNCT
bjos-8642673	28	36	i.	i.	NOUN
bjos-8642673	28	37	acute	acute	PROPN
bjos-8642673	28	38	necrotizing	necrotize	VERB
bjos-8642673	28	39	ulcerative	ulcerative	ADJ
bjos-8642673	28	40	gingivitis	gingivitis	NOUN
bjos-8642673	28	41	(	(	PUNCT
bjos-8642673	28	42	anug	anug	PROPN
bjos-8642673	28	43	)	)	PUNCT
bjos-8642673	28	44	7	7	NUM
bjos-8642673	28	45	(	(	PUNCT
bjos-8642673	28	46	1.2	1.2	NUM
bjos-8642673	28	47	)	)	PUNCT
bjos-8642673	28	48	j.	j.	PROPN
bjos-8642673	28	49	linear	linear	PROPN
bjos-8642673	28	50	gingival	gingival	NOUN
bjos-8642673	28	51	erythematous	erythematous	ADJ
bjos-8642673	28	52	banding	banding	NOUN
bjos-8642673	28	53	(	(	PUNCT
bjos-8642673	28	54	lgeb	lgeb	PROPN
bjos-8642673	28	55	)	)	PUNCT
bjos-8642673	28	56	6	6	NUM
bjos-8642673	28	57	(	(	PUNCT
bjos-8642673	28	58	1.0	1.0	NUM
bjos-8642673	28	59	)	)	PUNCT
bjos-8642673	28	60	k.	k.	NOUN
bjos-8642673	29	1	necrotizing	necrotize	VERB
bjos-8642673	29	2	ulcerative	ulcerative	ADJ
bjos-8642673	29	3	gingivitis	gingivitis	NOUN
bjos-8642673	29	4	(	(	PUNCT
bjos-8642673	29	5	nug	nug	NOUN
bjos-8642673	29	6	)	)	PUNCT
bjos-8642673	29	7	1	1	NUM
bjos-8642673	29	8	(	(	PUNCT
bjos-8642673	29	9	0.2	0.2	NUM
bjos-8642673	29	10	)	)	PUNCT
bjos-8642673	29	11	l.	l.	PROPN
bjos-8642673	29	12	intra	intra	ADJ
bjos-8642673	29	13	-	-	ADJ
bjos-8642673	29	14	oral	oral	ADJ
bjos-8642673	29	15	pigmentation	pigmentation	NOUN
bjos-8642673	29	16	103	103	NUM
bjos-8642673	29	17	(	(	PUNCT
bjos-8642673	29	18	17.0	17.0	NUM
bjos-8642673	29	19	)	)	PUNCT
bjos-8642673	29	20	m.	m.	NOUN
bjos-8642673	29	21	xerostomia	xerostomia	NOUN
bjos-8642673	30	1	206	206	NUM
bjos-8642673	30	2	(	(	PUNCT
bjos-8642673	30	3	34.0	34.0	NUM
bjos-8642673	30	4	)	)	PUNCT
bjos-8642673	30	5	table	table	NOUN
bjos-8642673	30	6	1	1	NUM
bjos-8642673	30	7	distribution	distribution	NOUN
bjos-8642673	30	8	of	of	ADP
bjos-8642673	30	9	oral	oral	ADJ
bjos-8642673	30	10	lesions	lesion	NOUN
bjos-8642673	30	11	identified	identify	VERB
bjos-8642673	30	12	among	among	ADP
bjos-8642673	30	13	the	the	DET
bjos-8642673	30	14	hiv	hiv	PROPN
bjos-8642673	30	15	infected	infect	VERB
bjos-8642673	30	16	and	and	CCONJ
bjos-8642673	30	17	aids	aids	PROPN
bjos-8642673	30	18	taso	taso	PROPN
bjos-8642673	30	19	clients	client	NOUN
bjos-8642673	30	20	surveyed	survey	VERB
bjos-8642673	30	21	using	use	VERB
bjos-8642673	30	22	pearson	pearson	PROPN
bjos-8642673	30	23	’s	’s	PART
bjos-8642673	30	24	chi	chi	PROPN
bjos-8642673	30	25	square	square	PROPN
bjos-8642673	30	26	test	test	NOUN
bjos-8642673	30	27	(	(	PUNCT
bjos-8642673	30	28	á=0.05	á=0.05	NOUN
bjos-8642673	30	29	)	)	PUNCT
bjos-8642673	30	30	,	,	PUNCT
bjos-8642673	30	31	there	there	PRON
bjos-8642673	30	32	was	be	VERB
bjos-8642673	30	33	a	a	DET
bjos-8642673	30	34	statistical	statistical	ADJ
bjos-8642673	30	35	significant	significant	ADJ
bjos-8642673	30	36	difference	difference	NOUN
bjos-8642673	30	37	(	(	PUNCT
bjos-8642673	30	38	p<0.05	p<0.05	NOUN
bjos-8642673	30	39	)	)	PUNCT
bjos-8642673	30	40	when	when	SCONJ
bjos-8642673	30	41	the	the	DET
bjos-8642673	30	42	relationship	relationship	NOUN
bjos-8642673	30	43	between	between	ADP
bjos-8642673	30	44	prevalence	prevalence	NOUN
bjos-8642673	30	45	of	of	ADP
bjos-8642673	30	46	oral	oral	ADJ
bjos-8642673	30	47	lesions	lesion	NOUN
bjos-8642673	30	48	of	of	ADP
bjos-8642673	30	49	the	the	DET
bjos-8642673	30	50	studied	study	VERB
bjos-8642673	30	51	population	population	NOUN
bjos-8642673	30	52	was	be	AUX
bjos-8642673	30	53	compared	compare	VERB
bjos-8642673	30	54	availability	availability	NOUN
bjos-8642673	30	55	of	of	ADP
bjos-8642673	30	56	nutrients	nutrient	NOUN
bjos-8642673	30	57	and	and	CCONJ
bjos-8642673	30	58	exposure	exposure	NOUN
bjos-8642673	30	59	to	to	ADP
bjos-8642673	30	60	salivary	salivary	ADJ
bjos-8642673	30	61	secretions	secretion	NOUN
bjos-8642673	30	62	,	,	PUNCT
bjos-8642673	30	63	immunosuppression	immunosuppression	NOUN
bjos-8642673	30	64	,	,	PUNCT
bjos-8642673	30	65	and	and	CCONJ
bjos-8642673	30	66	oral	oral	ADJ
bjos-8642673	30	67	hygiene10	hygiene10	NOUN
bjos-8642673	30	68	.	.	PUNCT
bjos-8642673	31	1	despite	despite	SCONJ
bjos-8642673	31	2	many	many	ADJ
bjos-8642673	31	3	african	african	ADJ
bjos-8642673	31	4	reports	report	NOUN
bjos-8642673	31	5	on	on	ADP
bjos-8642673	31	6	oral	oral	ADJ
bjos-8642673	31	7	lesions	lesion	NOUN
bjos-8642673	31	8	associated	associate	VERB
bjos-8642673	31	9	with	with	ADP
bjos-8642673	31	10	hiv	hiv	PROPN
bjos-8642673	31	11	/	/	SYM
bjos-8642673	31	12	aids	aids	PROPN
bjos-8642673	31	13	,	,	PUNCT
bjos-8642673	31	14	similar	similar	ADJ
bjos-8642673	31	15	reports	report	NOUN
bjos-8642673	31	16	from	from	ADP
bjos-8642673	31	17	uganda	uganda	PROPN
bjos-8642673	31	18	are	be	AUX
bjos-8642673	31	19	highly	highly	ADV
bjos-8642673	31	20	limited1011	limited1011	NOUN
bjos-8642673	31	21	.	.	PUNCT
bjos-8642673	32	1	in	in	ADP
bjos-8642673	32	2	this	this	DET
bjos-8642673	32	3	study	study	NOUN
bjos-8642673	32	4	,	,	PUNCT
bjos-8642673	32	5	we	we	PRON
bjos-8642673	32	6	appraised	appraise	VERB
bjos-8642673	32	7	the	the	DET
bjos-8642673	32	8	current	current	ADJ
bjos-8642673	32	9	status	status	NOUN
bjos-8642673	32	10	of	of	ADP
bjos-8642673	32	11	oral	oral	ADJ
bjos-8642673	32	12	lesions	lesion	NOUN
bjos-8642673	32	13	among	among	ADP
bjos-8642673	32	14	hiv	hiv	PROPN
bjos-8642673	32	15	patients	patient	NOUN
bjos-8642673	32	16	presenting	present	VERB
bjos-8642673	32	17	to	to	ADP
bjos-8642673	32	18	“	"	PUNCT
bjos-8642673	32	19	the	the	DET
bjos-8642673	32	20	aids	aids	PROPN
bjos-8642673	32	21	support	support	VERB
bjos-8642673	32	22	organization-(taso	organization-(taso	NOUN
bjos-8642673	32	23	)	)	PUNCT
bjos-8642673	32	24	”	"	PUNCT
bjos-8642673	32	25	centers	center	NOUN
bjos-8642673	32	26	in	in	ADP
bjos-8642673	32	27	south	south	PROPN
bjos-8642673	32	28	-	-	PUNCT
bjos-8642673	32	29	west	west	PROPN
bjos-8642673	32	30	uganda	uganda	PROPN
bjos-8642673	32	31	.	.	PUNCT
bjos-8642673	33	1	the	the	DET
bjos-8642673	33	2	ultimate	ultimate	ADJ
bjos-8642673	33	3	goal	goal	NOUN
bjos-8642673	33	4	of	of	ADP
bjos-8642673	33	5	this	this	DET
bjos-8642673	33	6	study	study	NOUN
bjos-8642673	33	7	is	be	AUX
bjos-8642673	33	8	to	to	PART
bjos-8642673	33	9	obtain	obtain	VERB
bjos-8642673	33	10	a	a	DET
bjos-8642673	33	11	regional	regional	ADJ
bjos-8642673	33	12	surveillance	surveillance	NOUN
bjos-8642673	33	13	data	datum	NOUN
bjos-8642673	33	14	on	on	ADP
bjos-8642673	33	15	oral	oral	ADJ
bjos-8642673	33	16	lesions	lesion	NOUN
bjos-8642673	33	17	among	among	ADP
bjos-8642673	33	18	hiv	hiv	PROPN
bjos-8642673	33	19	patients	patient	NOUN
bjos-8642673	33	20	so	so	SCONJ
bjos-8642673	33	21	as	as	SCONJ
bjos-8642673	33	22	to	to	PART
bjos-8642673	33	23	determine	determine	VERB
bjos-8642673	33	24	the	the	DET
bjos-8642673	33	25	role	role	NOUN
bjos-8642673	33	26	of	of	ADP
bjos-8642673	33	27	oral	oral	ADJ
bjos-8642673	33	28	lesion	lesion	NOUN
bjos-8642673	33	29	surveillance	surveillance	NOUN
bjos-8642673	33	30	in	in	ADP
bjos-8642673	33	31	hiv	hiv	PROPN
bjos-8642673	33	32	prevention	prevention	NOUN
bjos-8642673	33	33	programs	program	NOUN
bjos-8642673	33	34	.	.	PUNCT
bjos-8642673	34	1	this	this	PRON
bjos-8642673	34	2	is	be	AUX
bjos-8642673	34	3	expected	expect	VERB
bjos-8642673	34	4	to	to	PART
bjos-8642673	34	5	improve	improve	VERB
bjos-8642673	34	6	our	our	PRON
bjos-8642673	34	7	existing	exist	VERB
bjos-8642673	34	8	diagnostic	diagnostic	ADJ
bjos-8642673	34	9	and	and	CCONJ
bjos-8642673	34	10	management	management	NOUN
bjos-8642673	34	11	protocols	protocol	NOUN
bjos-8642673	34	12	of	of	ADP
bjos-8642673	34	13	oral	oral	ADJ
bjos-8642673	34	14	lesions	lesion	NOUN
bjos-8642673	34	15	among	among	ADP
bjos-8642673	34	16	people	people	NOUN
bjos-8642673	34	17	living	live	VERB
bjos-8642673	34	18	with	with	ADP
bjos-8642673	34	19	hiv	hiv	PROPN
bjos-8642673	34	20	in	in	ADP
bjos-8642673	34	21	this	this	DET
bjos-8642673	34	22	region	region	NOUN
bjos-8642673	34	23	.	.	PUNCT
bjos-8642673	35	1	materials	material	NOUN
bjos-8642673	35	2	and	and	CCONJ
bjos-8642673	35	3	methods	method	NOUN
bjos-8642673	35	4	sample	sample	NOUN
bjos-8642673	35	5	area	area	NOUN
bjos-8642673	35	6	,	,	PUNCT
bjos-8642673	35	7	size	size	NOUN
bjos-8642673	35	8	and	and	CCONJ
bjos-8642673	35	9	inclusion	inclusion	NOUN
bjos-8642673	35	10	criteria	criterion	NOUN
bjos-8642673	35	11	three	three	NUM
bjos-8642673	35	12	main	main	ADJ
bjos-8642673	35	13	centers	center	NOUN
bjos-8642673	35	14	of	of	ADP
bjos-8642673	35	15	the	the	DET
bjos-8642673	35	16	aids	aids	PROPN
bjos-8642673	35	17	support	support	NOUN
bjos-8642673	35	18	organization	organization	NOUN
bjos-8642673	35	19	“	"	PUNCT
bjos-8642673	35	20	taso	taso	PROPN
bjos-8642673	35	21	”	"	PUNCT
bjos-8642673	35	22	,	,	PUNCT
bjos-8642673	35	23	located	locate	VERB
bjos-8642673	35	24	in	in	ADP
bjos-8642673	35	25	three	three	NUM
bjos-8642673	35	26	districts	district	NOUN
bjos-8642673	35	27	(	(	PUNCT
bjos-8642673	35	28	masaka	masaka	PROPN
bjos-8642673	35	29	,	,	PUNCT
bjos-8642673	35	30	rukunguri	rukunguri	NOUN
bjos-8642673	35	31	and	and	CCONJ
bjos-8642673	35	32	mbarara	mbarara	NOUN
bjos-8642673	35	33	)	)	PUNCT
bjos-8642673	35	34	,	,	PUNCT
bjos-8642673	35	35	and	and	CCONJ
bjos-8642673	35	36	five	five	NUM
bjos-8642673	35	37	outreach	outreach	NOUN
bjos-8642673	35	38	taso	taso	NOUN
bjos-8642673	35	39	centers	center	NOUN
bjos-8642673	35	40	(	(	PUNCT
bjos-8642673	35	41	katungu	katungu	PROPN
bjos-8642673	35	42	,	,	PUNCT
bjos-8642673	35	43	motoma	motoma	ADJ
bjos-8642673	35	44	,	,	PUNCT
bjos-8642673	35	45	kigarama	kigarama	PROPN
bjos-8642673	35	46	,	,	PUNCT
bjos-8642673	35	47	ibwanda	ibwanda	NOUN
bjos-8642673	35	48	and	and	CCONJ
bjos-8642673	35	49	nyihanga	nyihanga	PROPN
bjos-8642673	35	50	)	)	PUNCT
bjos-8642673	35	51	,	,	PUNCT
bjos-8642673	35	52	located	locate	VERB
bjos-8642673	35	53	in	in	ADP
bjos-8642673	35	54	two	two	NUM
bjos-8642673	35	55	districts	district	NOUN
bjos-8642673	35	56	(	(	PUNCT
bjos-8642673	35	57	bushenyi	bushenyi	ADJ
bjos-8642673	35	58	and	and	CCONJ
bjos-8642673	35	59	mbarara	mbarara	NOUN
bjos-8642673	35	60	)	)	PUNCT
bjos-8642673	35	61	all	all	PRON
bjos-8642673	35	62	in	in	ADP
bjos-8642673	35	63	south	south	ADJ
bjos-8642673	35	64	western	western	ADJ
bjos-8642673	35	65	uganda	uganda	PROPN
bjos-8642673	35	66	were	be	AUX
bjos-8642673	35	67	used	use	VERB
bjos-8642673	35	68	for	for	ADP
bjos-8642673	35	69	this	this	DET
bjos-8642673	35	70	investigation	investigation	NOUN
bjos-8642673	35	71	.	.	PUNCT
bjos-8642673	36	1	the	the	DET
bjos-8642673	36	2	inclusion	inclusion	NOUN
bjos-8642673	36	3	criterion	criterion	NOUN
bjos-8642673	36	4	for	for	ADP
bjos-8642673	36	5	taso	taso	NOUN
bjos-8642673	36	6	centers	center	NOUN
bjos-8642673	36	7	was	be	AUX
bjos-8642673	36	8	based	base	VERB
bjos-8642673	36	9	on	on	ADP
bjos-8642673	36	10	center	center	ADJ
bjos-8642673	36	11	participation	participation	NOUN
bjos-8642673	36	12	in	in	ADP
bjos-8642673	36	13	a	a	DET
bjos-8642673	36	14	previews	preview	NOUN
bjos-8642673	36	15	study12	study12	NOUN
bjos-8642673	36	16	in	in	ADP
bjos-8642673	36	17	a	a	DET
bjos-8642673	36	18	similar	similar	ADJ
bjos-8642673	36	19	cohort	cohort	NOUN
bjos-8642673	36	20	which	which	PRON
bjos-8642673	36	21	revealed	reveal	VERB
bjos-8642673	36	22	different	different	ADJ
bjos-8642673	36	23	kinds	kind	NOUN
bjos-8642673	36	24	of	of	ADP
bjos-8642673	36	25	oral	oral	ADJ
bjos-8642673	36	26	manifestations	manifestation	NOUN
bjos-8642673	36	27	of	of	ADP
bjos-8642673	36	28	hiv	hiv	PROPN
bjos-8642673	36	29	/	/	SYM
bjos-8642673	36	30	aids	aids	PROPN
bjos-8642673	36	31	infection	infection	NOUN
bjos-8642673	36	32	.	.	PUNCT
bjos-8642673	37	1	the	the	DET
bjos-8642673	37	2	conditions	condition	NOUN
bjos-8642673	37	3	for	for	ADP
bjos-8642673	37	4	which	which	PRON
bjos-8642673	37	5	patients	patient	NOUN
bjos-8642673	37	6	were	be	AUX
bjos-8642673	37	7	included	include	VERB
bjos-8642673	37	8	in	in	ADP
bjos-8642673	37	9	this	this	DET
bjos-8642673	37	10	study	study	NOUN
bjos-8642673	37	11	were	be	AUX
bjos-8642673	37	12	that	that	SCONJ
bjos-8642673	37	13	patients	patient	NOUN
bjos-8642673	37	14	:	:	PUNCT
bjos-8642673	37	15	must	must	AUX
bjos-8642673	37	16	have	have	AUX
bjos-8642673	37	17	tested	test	VERB
bjos-8642673	37	18	positive	positive	ADJ
bjos-8642673	37	19	to	to	ADP
bjos-8642673	37	20	hiv	hiv	PROPN
bjos-8642673	37	21	using	use	VERB
bjos-8642673	37	22	an	an	DET
bjos-8642673	37	23	enzyme	enzyme	NOUN
bjos-8642673	37	24	linked	link	VERB
bjos-8642673	37	25	immunosobent	immunosobent	NOUN
bjos-8642673	37	26	assay	assay	NOUN
bjos-8642673	37	27	(	(	PUNCT
bjos-8642673	37	28	elisa	elisa	NOUN
bjos-8642673	37	29	)	)	PUNCT
bjos-8642673	37	30	and	and	CCONJ
bjos-8642673	37	31	any	any	DET
bjos-8642673	37	32	other	other	ADJ
bjos-8642673	37	33	immuno	immuno	ADJ
bjos-8642673	37	34	-	-	PUNCT
bjos-8642673	37	35	serological	serological	ADJ
bjos-8642673	37	36	method	method	NOUN
bjos-8642673	37	37	;	;	PUNCT
bjos-8642673	37	38	must	must	AUX
bjos-8642673	37	39	have	have	AUX
bjos-8642673	37	40	had	have	VERB
bjos-8642673	37	41	his	his	PRON
bjos-8642673	37	42	/	/	SYM
bjos-8642673	37	43	her	her	PRON
bjos-8642673	37	44	hiv	hiv	PROPN
bjos-8642673	37	45	/	/	SYM
bjos-8642673	37	46	aids	aids	PROPN
bjos-8642673	37	47	clinical	clinical	ADJ
bjos-8642673	37	48	staging	staging	NOUN
bjos-8642673	37	49	done	do	VERB
bjos-8642673	37	50	not	not	PART
bjos-8642673	37	51	earlier	early	ADJ
bjos-8642673	37	52	than	than	ADP
bjos-8642673	37	53	one	one	NUM
bjos-8642673	37	54	month	month	NOUN
bjos-8642673	37	55	prior	prior	ADV
bjos-8642673	37	56	to	to	ADP
bjos-8642673	37	57	time	time	NOUN
bjos-8642673	37	58	of	of	ADP
bjos-8642673	37	59	sample	sample	NOUN
bjos-8642673	37	60	collection	collection	NOUN
bjos-8642673	37	61	;	;	PUNCT
bjos-8642673	37	62	must	must	AUX
bjos-8642673	37	63	be	be	AUX
bjos-8642673	37	64	a	a	DET
bjos-8642673	37	65	current	current	ADJ
bjos-8642673	37	66	taso	taso	NOUN
bjos-8642673	37	67	client	client	NOUN
bjos-8642673	37	68	above	above	ADP
bjos-8642673	37	69	18	18	NUM
bjos-8642673	37	70	years	year	NOUN
bjos-8642673	37	71	of	of	ADP
bjos-8642673	37	72	age	age	NOUN
bjos-8642673	37	73	although	although	SCONJ
bjos-8642673	37	74	826	826	NUM
bjos-8642673	37	75	patients	patient	NOUN
bjos-8642673	37	76	have	have	AUX
bjos-8642673	37	77	consented	consent	VERB
bjos-8642673	37	78	to	to	PART
bjos-8642673	37	79	participate	participate	VERB
bjos-8642673	37	80	in	in	ADP
bjos-8642673	37	81	this	this	DET
bjos-8642673	37	82	study	study	NOUN
bjos-8642673	37	83	,	,	PUNCT
bjos-8642673	37	84	605	605	NUM
bjos-8642673	37	85	were	be	AUX
bjos-8642673	37	86	qualified	qualified	ADJ
bjos-8642673	37	87	.	.	PUNCT
bjos-8642673	38	1	this	this	PRON
bjos-8642673	38	2	was	be	AUX
bjos-8642673	38	3	guided	guide	VERB
bjos-8642673	38	4	by	by	ADP
bjos-8642673	38	5	the	the	DET
bjos-8642673	38	6	upper	upper	ADJ
bjos-8642673	38	7	limit	limit	NOUN
bjos-8642673	38	8	required	require	VERB
bjos-8642673	38	9	to	to	PART
bjos-8642673	38	10	give	give	VERB
bjos-8642673	38	11	95	95	NUM
bjos-8642673	38	12	%	%	NOUN
bjos-8642673	38	13	level	level	NOUN
bjos-8642673	38	14	of	of	ADP
bjos-8642673	38	15	confidence	confidence	NOUN
bjos-8642673	38	16	at	at	ADP
bjos-8642673	38	17	an	an	DET
bjos-8642673	38	18	expected	expect	VERB
bjos-8642673	38	19	prevalence	prevalence	NOUN
bjos-8642673	38	20	of	of	ADP
bjos-8642673	38	21	about	about	ADP
bjos-8642673	38	22	55%12	55%12	NUM
bjos-8642673	38	23	using	use	VERB
bjos-8642673	38	24	the	the	DET
bjos-8642673	38	25	precise	precise	ADJ
bjos-8642673	38	26	prevalence	prevalence	NOUN
bjos-8642673	38	27	formula	formula	NOUN
bjos-8642673	38	28	:	:	PUNCT
bjos-8642673	38	29	sample	sample	NOUN
bjos-8642673	38	30	size	size	NOUN
bjos-8642673	38	31	(	(	PUNCT
bjos-8642673	38	32	n	n	CCONJ
bjos-8642673	38	33	)	)	PUNCT
bjos-8642673	38	34	=	=	SYM
bjos-8642673	38	35	z2p	z2p	NOUN
bjos-8642673	38	36	(	(	PUNCT
bjos-8642673	38	37	100	100	NUM
bjos-8642673	38	38	-	-	PUNCT
bjos-8642673	38	39	p)/d2	p)/d2	ADJ
bjos-8642673	38	40	(	(	PUNCT
bjos-8642673	38	41	epi	epi	NOUN
bjos-8642673	38	42	-	-	NOUN
bjos-8642673	38	43	info	info	NOUN
bjos-8642673	38	44	version	version	NOUN
bjos-8642673	38	45	3.2	3.2	NUM
bjos-8642673	38	46	data	data	NOUN
bjos-8642673	38	47	-	-	PUNCT
bjos-8642673	38	48	base	base	NOUN
bjos-8642673	38	49	;	;	PUNCT
bjos-8642673	38	50	1995	1995	NUM
bjos-8642673	38	51	)	)	PUNCT
bjos-8642673	38	52	,	,	PUNCT
bjos-8642673	38	53	where	where	SCONJ
bjos-8642673	38	54	z	z	NOUN
bjos-8642673	38	55	is	be	AUX
bjos-8642673	38	56	a	a	DET
bjos-8642673	38	57	constant	constant	ADJ
bjos-8642673	38	58	given	give	VERB
bjos-8642673	38	59	as	as	ADP
bjos-8642673	38	60	(	(	PUNCT
bjos-8642673	38	61	1.96	1.96	NUM
bjos-8642673	38	62	)	)	PUNCT
bjos-8642673	38	63	,	,	PUNCT
bjos-8642673	38	64	p	p	NOUN
bjos-8642673	38	65	is	be	AUX
bjos-8642673	38	66	expected	expect	VERB
bjos-8642673	38	67	prevalence	prevalence	NOUN
bjos-8642673	38	68	(	(	PUNCT
bjos-8642673	38	69	55	55	NUM
bjos-8642673	38	70	%	%	NOUN
bjos-8642673	38	71	)	)	PUNCT
bjos-8642673	38	72	,	,	PUNCT
bjos-8642673	38	73	and	and	CCONJ
bjos-8642673	38	74	d	d	NOUN
bjos-8642673	38	75	is	be	AUX
bjos-8642673	38	76	acceptable	acceptable	ADJ
bjos-8642673	38	77	error	error	NOUN
bjos-8642673	38	78	(	(	PUNCT
bjos-8642673	38	79	5	5	NUM
bjos-8642673	38	80	%	%	NOUN
bjos-8642673	38	81	)	)	PUNCT
bjos-8642673	38	82	.	.	PUNCT
bjos-8642673	39	1	informed	informed	ADJ
bjos-8642673	39	2	consent	consent	NOUN
bjos-8642673	39	3	was	be	AUX
bjos-8642673	39	4	sought	seek	VERB
bjos-8642673	39	5	and	and	CCONJ
bjos-8642673	39	6	obtained	obtain	VERB
bjos-8642673	39	7	from	from	ADP
bjos-8642673	39	8	the	the	DET
bjos-8642673	39	9	following	following	NOUN
bjos-8642673	39	10	:	:	PUNCT
bjos-8642673	39	11	uganda	uganda	PROPN
bjos-8642673	39	12	national	national	PROPN
bjos-8642673	39	13	council	council	PROPN
bjos-8642673	39	14	of	of	ADP
bjos-8642673	39	15	science	science	NOUN
bjos-8642673	39	16	and	and	CCONJ
bjos-8642673	39	17	technology	technology	NOUN
bjos-8642673	39	18	,	,	PUNCT
bjos-8642673	39	19	kampala	kampala	PROPN
bjos-8642673	39	20	international	international	PROPN
bjos-8642673	39	21	university	university	PROPN
bjos-8642673	39	22	research	research	NOUN
bjos-8642673	39	23	and	and	CCONJ
bjos-8642673	39	24	ethics	ethic	NOUN
bjos-8642673	39	25	committee	committee	NOUN
bjos-8642673	39	26	,	,	PUNCT
bjos-8642673	39	27	the	the	DET
bjos-8642673	39	28	aids	aids	PROPN
bjos-8642673	39	29	support	support	NOUN
bjos-8642673	39	30	organizations	organization	NOUN
bjos-8642673	39	31	(	(	PUNCT
bjos-8642673	39	32	taso	taso	PROPN
bjos-8642673	39	33	)	)	PUNCT
bjos-8642673	39	34	at	at	ADP
bjos-8642673	39	35	both	both	CCONJ
bjos-8642673	39	36	local	local	ADJ
bjos-8642673	39	37	and	and	CCONJ
bjos-8642673	39	38	national	national	ADJ
bjos-8642673	39	39	level	level	NOUN
bjos-8642673	39	40	and	and	CCONJ
bjos-8642673	39	41	taso	taso	NOUN
bjos-8642673	39	42	clients	client	NOUN
bjos-8642673	39	43	(	(	PUNCT
bjos-8642673	39	44	patients	patient	NOUN
bjos-8642673	39	45	)	)	PUNCT
bjos-8642673	39	46	through	through	ADP
bjos-8642673	39	47	their	their	PRON
bjos-8642673	39	48	informed	informed	ADJ
bjos-8642673	39	49	consent	consent	NOUN
bjos-8642673	39	50	.	.	PUNCT
bjos-8642673	40	1	mouth	mouth	NOUN
bjos-8642673	40	2	examination	examination	NOUN
bjos-8642673	40	3	and	and	CCONJ
bjos-8642673	40	4	sample	sample	NOUN
bjos-8642673	40	5	collection	collection	NOUN
bjos-8642673	40	6	the	the	DET
bjos-8642673	40	7	diagnostic	diagnostic	ADJ
bjos-8642673	40	8	criterion	criterion	NOUN
bjos-8642673	40	9	for	for	ADP
bjos-8642673	40	10	the	the	DET
bjos-8642673	40	11	oral	oral	ADJ
bjos-8642673	40	12	lesion	lesion	NOUN
bjos-8642673	40	13	was	be	AUX
bjos-8642673	40	14	according	accord	VERB
bjos-8642673	40	15	to	to	ADP
bjos-8642673	40	16	world	world	PROPN
bjos-8642673	40	17	health	health	NOUN
bjos-8642673	40	18	organization	organization	NOUN
bjos-8642673	40	19	’s	’s	PART
bjos-8642673	40	20	established	establish	VERB
bjos-8642673	40	21	clinical	clinical	ADJ
bjos-8642673	40	22	criteria	criterion	NOUN
bjos-8642673	40	23	for	for	ADP
bjos-8642673	40	24	hiv	hiv	PROPN
bjos-8642673	40	25	-	-	PUNCT
bjos-8642673	40	26	associated	associate	VERB
bjos-8642673	40	27	oral	oral	ADJ
bjos-8642673	40	28	lesions13	lesions13	NOUN
bjos-8642673	40	29	.	.	PUNCT
bjos-8642673	41	1	the	the	DET
bjos-8642673	41	2	mouth	mouth	NOUN
bjos-8642673	41	3	examination	examination	NOUN
bjos-8642673	41	4	of	of	ADP
bjos-8642673	41	5	the	the	DET
bjos-8642673	41	6	taso	taso	NOUN
bjos-8642673	41	7	clients	client	NOUN
bjos-8642673	41	8	was	be	AUX
bjos-8642673	41	9	done	do	VERB
bjos-8642673	41	10	by	by	ADP
bjos-8642673	41	11	a	a	DET
bjos-8642673	41	12	previously	previously	ADV
bjos-8642673	41	13	trained	train	VERB
bjos-8642673	41	14	and	and	CCONJ
bjos-8642673	41	15	calibrated11	calibrated11	NOUN
bjos-8642673	41	16	oral	oral	ADJ
bjos-8642673	41	17	clinicians	clinician	NOUN
bjos-8642673	41	18	.	.	PUNCT
bjos-8642673	42	1	the	the	DET
bjos-8642673	42	2	three	three	NUM
bjos-8642673	42	3	oral	oral	ADJ
bjos-8642673	42	4	clinicians	clinician	NOUN
bjos-8642673	42	5	included	include	VERB
bjos-8642673	42	6	a	a	DET
bjos-8642673	42	7	dental	dental	ADJ
bjos-8642673	42	8	surgeon	surgeon	NOUN
bjos-8642673	42	9	,	,	PUNCT
bjos-8642673	42	10	a	a	DET
bjos-8642673	42	11	clinical	clinical	ADJ
bjos-8642673	42	12	microbiologist	microbiologist	NOUN
bjos-8642673	42	13	and	and	CCONJ
bjos-8642673	42	14	a	a	DET
bjos-8642673	42	15	public	public	ADJ
bjos-8642673	42	16	dental	dental	ADJ
bjos-8642673	42	17	health	health	NOUN
bjos-8642673	42	18	officer	officer	NOUN
bjos-8642673	42	19	.	.	PUNCT
bjos-8642673	43	1	prior	prior	ADV
bjos-8642673	43	2	to	to	ADP
bjos-8642673	43	3	field	field	NOUN
bjos-8642673	43	4	survey	survey	NOUN
bjos-8642673	43	5	,	,	PUNCT
bjos-8642673	43	6	the	the	DET
bjos-8642673	43	7	three	three	NUM
bjos-8642673	43	8	oral	oral	ADJ
bjos-8642673	43	9	clinicians	clinician	NOUN
bjos-8642673	43	10	were	be	AUX
bjos-8642673	43	11	standardized	standardize	VERB
bjos-8642673	43	12	for	for	ADP
bjos-8642673	43	13	consistencies	consistency	NOUN
bjos-8642673	43	14	in	in	ADP
bjos-8642673	43	15	examination	examination	NOUN
bjos-8642673	43	16	of	of	ADP
bjos-8642673	43	17	oral	oral	ADJ
bjos-8642673	43	18	lesions	lesion	NOUN
bjos-8642673	43	19	to	to	PART
bjos-8642673	43	20	minimize	minimize	VERB
bjos-8642673	43	21	inter	inter	ADJ
bjos-8642673	43	22	examiners	examiner	NOUN
bjos-8642673	43	23	variability	variability	NOUN
bjos-8642673	43	24	using	use	VERB
bjos-8642673	43	25	guidelines	guideline	NOUN
bjos-8642673	43	26	reported	report	VERB
bjos-8642673	43	27	by	by	ADP
bjos-8642673	43	28	muwazi	muwazi	PROPN
bjos-8642673	43	29	et	et	NOUN
bjos-8642673	43	30	al11	al11	PROPN
bjos-8642673	43	31	.	.	PUNCT
bjos-8642673	44	1	briefly	briefly	NOUN
bjos-8642673	44	2	,	,	PUNCT
bjos-8642673	44	3	a	a	DET
bjos-8642673	44	4	gold	gold	NOUN
bjos-8642673	44	5	standard	standard	NOUN
bjos-8642673	44	6	(	(	PUNCT
bjos-8642673	44	7	benchmark	benchmark	NOUN
bjos-8642673	44	8	)	)	PUNCT
bjos-8642673	44	9	examiner	examiner	NOUN
bjos-8642673	44	10	showed	show	VERB
bjos-8642673	44	11	the	the	DET
bjos-8642673	44	12	examiners	examiner	NOUN
bjos-8642673	44	13	some	some	DET
bjos-8642673	44	14	photographic	photographic	ADJ
bjos-8642673	44	15	slides	slide	NOUN
bjos-8642673	44	16	with	with	ADP
bjos-8642673	44	17	clinical	clinical	ADJ
bjos-8642673	44	18	examples	example	NOUN
bjos-8642673	44	19	of	of	ADP
bjos-8642673	44	20	classical	classical	ADJ
bjos-8642673	44	21	oral	oral	ADJ
bjos-8642673	44	22	lesions	lesion	NOUN
bjos-8642673	44	23	expected	expect	VERB
bjos-8642673	44	24	to	to	PART
bjos-8642673	44	25	be	be	AUX
bjos-8642673	44	26	seen	see	VERB
bjos-8642673	44	27	during	during	ADP
bjos-8642673	44	28	the	the	DET
bjos-8642673	44	29	survey	survey	NOUN
bjos-8642673	44	30	.	.	PUNCT
bjos-8642673	45	1	this	this	PRON
bjos-8642673	45	2	was	be	AUX
bjos-8642673	45	3	done	do	VERB
bjos-8642673	45	4	to	to	PART
bjos-8642673	45	5	determine	determine	VERB
bjos-8642673	45	6	the	the	DET
bjos-8642673	45	7	examiners	examiner	NOUN
bjos-8642673	45	8	’	’	PART
bjos-8642673	45	9	ability	ability	NOUN
bjos-8642673	45	10	to	to	PART
bjos-8642673	45	11	uniformly	uniformly	ADV
bjos-8642673	45	12	identify	identify	VERB
bjos-8642673	45	13	oral	oral	ADJ
bjos-8642673	45	14	lesions	lesion	NOUN
bjos-8642673	45	15	with	with	ADP
bjos-8642673	45	16	minimum	minimum	ADJ
bjos-8642673	45	17	inconsistency	inconsistency	NOUN
bjos-8642673	45	18	.	.	PUNCT
bjos-8642673	46	1	the	the	DET
bjos-8642673	46	2	clients	client	NOUN
bjos-8642673	46	3	were	be	AUX
bjos-8642673	46	4	examined	examine	VERB
bjos-8642673	46	5	in	in	ADP
bjos-8642673	46	6	a	a	DET
bjos-8642673	46	7	room	room	NOUN
bjos-8642673	46	8	with	with	ADP
bjos-8642673	46	9	a	a	DET
bjos-8642673	46	10	natural	natural	ADJ
bjos-8642673	46	11	light	light	NOUN
bjos-8642673	46	12	while	while	SCONJ
bjos-8642673	46	13	seated	seat	VERB
bjos-8642673	46	14	on	on	ADP
bjos-8642673	46	15	an	an	DET
bjos-8642673	46	16	office	office	NOUN
bjos-8642673	46	17	chair	chair	NOUN
bjos-8642673	46	18	and	and	CCONJ
bjos-8642673	46	19	facing	face	VERB
bjos-8642673	46	20	the	the	DET
bjos-8642673	46	21	window	window	NOUN
bjos-8642673	46	22	.	.	PUNCT
bjos-8642673	47	1	the	the	DET
bjos-8642673	47	2	mouth	mouth	NOUN
bjos-8642673	47	3	was	be	AUX
bjos-8642673	47	4	examined	examine	VERB
bjos-8642673	47	5	using	use	VERB
bjos-8642673	47	6	natural	natural	ADJ
bjos-8642673	47	7	light	light	NOUN
bjos-8642673	47	8	and	and	CCONJ
bjos-8642673	47	9	a	a	DET
bjos-8642673	47	10	mouth	mouth	NOUN
bjos-8642673	47	11	mirror	mirror	NOUN
bjos-8642673	47	12	.	.	PUNCT
bjos-8642673	48	1	a	a	DET
bjos-8642673	48	2	disposable	disposable	ADJ
bjos-8642673	48	3	wooden	wooden	ADJ
bjos-8642673	48	4	tongue	tongue	NOUN
bjos-8642673	48	5	depressor	depressor	NOUN
bjos-8642673	48	6	was	be	AUX
bjos-8642673	48	7	used	use	VERB
bjos-8642673	48	8	to	to	PART
bjos-8642673	48	9	retract	retract	VERB
bjos-8642673	48	10	the	the	DET
bjos-8642673	48	11	cheeks	cheek	NOUN
bjos-8642673	48	12	.	.	PUNCT
bjos-8642673	49	1	some	some	DET
bjos-8642673	49	2	clinical	clinical	ADJ
bjos-8642673	49	3	photographs	photograph	NOUN
bjos-8642673	49	4	of	of	ADP
bjos-8642673	49	5	classical	classical	ADJ
bjos-8642673	49	6	examples	example	NOUN
bjos-8642673	49	7	of	of	ADP
bjos-8642673	49	8	the	the	DET
bjos-8642673	49	9	lesions	lesion	NOUN
bjos-8642673	49	10	were	be	AUX
bjos-8642673	49	11	taken	take	VERB
bjos-8642673	49	12	using	use	VERB
bjos-8642673	49	13	digital	digital	ADJ
bjos-8642673	49	14	camera	camera	NOUN
bjos-8642673	49	15	.	.	PUNCT
bjos-8642673	50	1	resu	resu	PROPN
bjos-8642673	50	2	l	l	PROPN
bjos-8642673	50	3	t	t	PROPN
bjos-8642673	50	4	s	s	VERB
bjos-8642673	50	5	the	the	DET
bjos-8642673	50	6	overall	overall	ADJ
bjos-8642673	50	7	prevalence	prevalence	NOUN
bjos-8642673	50	8	of	of	ADP
bjos-8642673	50	9	individuals	individual	NOUN
bjos-8642673	50	10	with	with	ADP
bjos-8642673	50	11	oral	oral	ADJ
bjos-8642673	50	12	lesions	lesion	NOUN
bjos-8642673	50	13	was	be	AUX
bjos-8642673	50	14	73.2	73.2	NUM
bjos-8642673	50	15	%	%	NOUN
bjos-8642673	50	16	,	,	PUNCT
bjos-8642673	50	17	occurring	occur	VERB
bjos-8642673	50	18	both	both	PRON
bjos-8642673	50	19	as	as	ADV
bjos-8642673	50	20	single	single	ADJ
bjos-8642673	50	21	and	and	CCONJ
bjos-8642673	50	22	double	double	ADJ
bjos-8642673	50	23	manifestations	manifestation	NOUN
bjos-8642673	50	24	,	,	PUNCT
bjos-8642673	50	25	as	as	SCONJ
bjos-8642673	50	26	showed	show	VERB
bjos-8642673	50	27	in	in	ADP
bjos-8642673	50	28	table	table	NOUN
bjos-8642673	50	29	1	1	NUM
bjos-8642673	50	30	.	.	PUNCT
bjos-8642673	50	31	pseudomembranous	pseudomembranous	ADJ
bjos-8642673	50	32	candidiasis	candidiasis	NOUN
bjos-8642673	50	33	(	(	PUNCT
bjos-8642673	50	34	pc	pc	NOUN
bjos-8642673	50	35	)	)	PUNCT
bjos-8642673	50	36	showed	show	VERB
bjos-8642673	50	37	the	the	DET
bjos-8642673	50	38	highest	high	ADJ
bjos-8642673	50	39	overall	overall	ADJ
bjos-8642673	50	40	prevalence	prevalence	NOUN
bjos-8642673	50	41	of	of	ADP
bjos-8642673	50	42	71.1	71.1	NUM
bjos-8642673	50	43	%	%	NOUN
bjos-8642673	50	44	(	(	PUNCT
bjos-8642673	50	45	34.9	34.9	NUM
bjos-8642673	50	46	%	%	NOUN
bjos-8642673	50	47	single	single	ADJ
bjos-8642673	50	48	and	and	CCONJ
bjos-8642673	50	49	36.2	36.2	NUM
bjos-8642673	50	50	%	%	NOUN
bjos-8642673	50	51	mixed	mixed	ADJ
bjos-8642673	50	52	oral	oral	ADJ
bjos-8642673	50	53	manifestations	manifestation	NOUN
bjos-8642673	50	54	)	)	PUNCT
bjos-8642673	50	55	,	,	PUNCT
bjos-8642673	50	56	followed	follow	VERB
bjos-8642673	50	57	by	by	ADP
bjos-8642673	50	58	39.9	39.9	NUM
bjos-8642673	50	59	%	%	NOUN
bjos-8642673	50	60	prevalence	prevalence	NOUN
bjos-8642673	50	61	of	of	ADP
bjos-8642673	50	62	erythematous	erythematous	ADJ
bjos-8642673	50	63	candidiasis	candidiasis	NOUN
bjos-8642673	50	64	(	(	PUNCT
bjos-8642673	50	65	ec	ec	PROPN
bjos-8642673	50	66	)	)	PUNCT
bjos-8642673	50	67	,	,	PUNCT
bjos-8642673	50	68	(	(	PUNCT
bjos-8642673	50	69	13.2	13.2	NUM
bjos-8642673	50	70	%	%	NOUN
bjos-8642673	50	71	single	single	ADJ
bjos-8642673	50	72	and	and	CCONJ
bjos-8642673	50	73	26.7	26.7	NUM
bjos-8642673	50	74	%	%	NOUN
bjos-8642673	50	75	mixed	mixed	ADJ
bjos-8642673	50	76	oral	oral	ADJ
bjos-8642673	50	77	manifestations	manifestation	NOUN
bjos-8642673	50	78	)	)	PUNCT
bjos-8642673	50	79	;	;	PUNCT
bjos-8642673	50	80	18.8	18.8	NUM
bjos-8642673	50	81	%	%	NOUN
bjos-8642673	50	82	prevalence	prevalence	NOUN
bjos-8642673	50	83	of	of	ADP
bjos-8642673	50	84	angular	angular	ADJ
bjos-8642673	50	85	chelitis	chelitis	PROPN
bjos-8642673	50	86	(	(	PUNCT
bjos-8642673	50	87	ac	ac	PROPN
bjos-8642673	50	88	)	)	PUNCT
bjos-8642673	50	89	(	(	PUNCT
bjos-8642673	50	90	3.1	3.1	NUM
bjos-8642673	50	91	%	%	NOUN
bjos-8642673	50	92	was	be	AUX
bjos-8642673	50	93	single	single	ADJ
bjos-8642673	50	94	and	and	CCONJ
bjos-8642673	50	95	15.7	15.7	NUM
bjos-8642673	50	96	%	%	NOUN
bjos-8642673	50	97	was	be	AUX
bjos-8642673	50	98	mixed	mixed	ADJ
bjos-8642673	50	99	oral	oral	ADJ
bjos-8642673	50	100	manifestations	manifestation	NOUN
bjos-8642673	50	101	)	)	PUNCT
bjos-8642673	50	102	.	.	PUNCT
bjos-8642673	51	1	out	out	ADP
bjos-8642673	51	2	of	of	ADP
bjos-8642673	51	3	605	605	NUM
bjos-8642673	51	4	oral	oral	ADJ
bjos-8642673	51	5	manifestations	manifestation	NOUN
bjos-8642673	51	6	diagnosed	diagnose	VERB
bjos-8642673	51	7	from	from	ADP
bjos-8642673	51	8	single	single	ADJ
bjos-8642673	51	9	and	and	CCONJ
bjos-8642673	51	10	mixed	mixed	ADJ
bjos-8642673	51	11	infections	infection	NOUN
bjos-8642673	51	12	,	,	PUNCT
bjos-8642673	51	13	143	143	NUM
bjos-8642673	51	14	(	(	PUNCT
bjos-8642673	51	15	23.6	23.6	NUM
bjos-8642673	51	16	%	%	NOUN
bjos-8642673	51	17	)	)	PUNCT
bjos-8642673	51	18	were	be	AUX
bjos-8642673	51	19	pc	pc	NOUN
bjos-8642673	51	20	and	and	CCONJ
bjos-8642673	51	21	ec	ec	PROPN
bjos-8642673	51	22	;	;	PUNCT
bjos-8642673	51	23	76	76	NUM
bjos-8642673	51	24	(	(	PUNCT
bjos-8642673	51	25	12.6	12.6	NUM
bjos-8642673	51	26	%	%	NOUN
bjos-8642673	51	27	)	)	PUNCT
bjos-8642673	51	28	were	be	AUX
bjos-8642673	51	29	pc	pc	NOUN
bjos-8642673	51	30	and	and	CCONJ
bjos-8642673	51	31	ac	ac	PROPN
bjos-8642673	51	32	and	and	CCONJ
bjos-8642673	51	33	19	19	NUM
bjos-8642673	51	34	(	(	PUNCT
bjos-8642673	51	35	3.1	3.1	NUM
bjos-8642673	51	36	%	%	NOUN
bjos-8642673	51	37	)	)	PUNCT
bjos-8642673	51	38	were	be	AUX
bjos-8642673	51	39	ec	ec	PROPN
bjos-8642673	51	40	and	and	CCONJ
bjos-8642673	51	41	ac	ac	PROPN
bjos-8642673	51	42	.	.	PUNCT
bjos-8642673	52	1	other	other	ADJ
bjos-8642673	52	2	oral	oral	ADJ
bjos-8642673	52	3	lesions	lesion	NOUN
bjos-8642673	52	4	also	also	ADV
bjos-8642673	52	5	observed	observe	VERB
bjos-8642673	52	6	in	in	ADP
bjos-8642673	52	7	this	this	DET
bjos-8642673	52	8	study	study	NOUN
bjos-8642673	52	9	included	include	VERB
bjos-8642673	52	10	:	:	PUNCT
bjos-8642673	52	11	4.6	4.6	NUM
bjos-8642673	52	12	%	%	NOUN
bjos-8642673	52	13	kaposi	kaposi	PROPN
bjos-8642673	52	14	sarcoma	sarcoma	PROPN
bjos-8642673	52	15	(	(	PUNCT
bjos-8642673	52	16	ks	ks	NOUN
bjos-8642673	52	17	)	)	PUNCT
bjos-8642673	52	18	;	;	PUNCT
bjos-8642673	52	19	2.5	2.5	NUM
bjos-8642673	52	20	%	%	NOUN
bjos-8642673	52	21	recurrent	recurrent	ADJ
bjos-8642673	52	22	aphthous	aphthous	ADJ
bjos-8642673	52	23	ulceration	ulceration	NOUN
bjos-8642673	52	24	(	(	PUNCT
bjos-8642673	52	25	rau	rau	PROPN
bjos-8642673	52	26	)	)	PUNCT
bjos-8642673	52	27	;	;	PUNCT
bjos-8642673	52	28	1.2	1.2	NUM
bjos-8642673	52	29	%	%	NOUN
bjos-8642673	52	30	acute	acute	ADJ
bjos-8642673	52	31	necrotizing	necrotize	VERB
bjos-8642673	52	32	ulcerative	ulcerative	ADJ
bjos-8642673	52	33	gingivitis	gingivitis	NOUN
bjos-8642673	52	34	(	(	PUNCT
bjos-8642673	52	35	anug	anug	PROPN
bjos-8642673	52	36	)	)	PUNCT
bjos-8642673	52	37	;	;	PUNCT
bjos-8642673	52	38	1.0	1.0	NUM
bjos-8642673	52	39	%	%	NOUN
bjos-8642673	52	40	linear	linear	PROPN
bjos-8642673	52	41	gingival	gingival	NOUN
bjos-8642673	52	42	braz	braz	PROPN
bjos-8642673	52	43	j	j	PROPN
bjos-8642673	52	44	oral	oral	PROPN
bjos-8642673	52	45	sci	sci	PROPN
bjos-8642673	52	46	.	.	PUNCT
bjos-8642673	53	1	7(26):1591	7(26):1591	NUM
bjos-8642673	53	2	-	-	SYM
bjos-8642673	53	3	1595	1595	NUM
bjos-8642673	53	4	appraisal	appraisal	NOUN
bjos-8642673	53	5	of	of	ADP
bjos-8642673	53	6	oral	oral	ADJ
bjos-8642673	53	7	lesions	lesion	NOUN
bjos-8642673	53	8	status	status	NOUN
bjos-8642673	53	9	of	of	ADP
bjos-8642673	53	10	hiv	hiv	PROPN
bjos-8642673	53	11	/	/	SYM
bjos-8642673	53	12	aids	aids	PROPN
bjos-8642673	53	13	patients	patient	NOUN
bjos-8642673	53	14	in	in	ADP
bjos-8642673	53	15	south	south	ADJ
bjos-8642673	53	16	western	western	ADJ
bjos-8642673	53	17	uganda	uganda	PROPN
bjos-8642673	53	18	1593	1593	NUM
bjos-8642673	53	19	erythematous	erythematous	ADJ
bjos-8642673	53	20	banding	banding	NOUN
bjos-8642673	53	21	(	(	PUNCT
bjos-8642673	53	22	lgeb	lgeb	PROPN
bjos-8642673	53	23	)	)	PUNCT
bjos-8642673	53	24	;	;	PUNCT
bjos-8642673	53	25	and	and	CCONJ
bjos-8642673	53	26	0.2	0.2	NUM
bjos-8642673	53	27	%	%	NOUN
bjos-8642673	53	28	necrotizing	necrotize	VERB
bjos-8642673	53	29	ulcerative	ulcerative	ADJ
bjos-8642673	53	30	gingivitis	gingivitis	NOUN
bjos-8642673	53	31	(	(	PUNCT
bjos-8642673	53	32	nug	nug	NOUN
bjos-8642673	53	33	)	)	PUNCT
bjos-8642673	53	34	.	.	PUNCT
bjos-8642673	54	1	intra	intra	ADJ
bjos-8642673	54	2	-	-	ADJ
bjos-8642673	54	3	oral	oral	ADJ
bjos-8642673	54	4	pigmentation	pigmentation	NOUN
bjos-8642673	54	5	was	be	AUX
bjos-8642673	54	6	103	103	NUM
bjos-8642673	54	7	(	(	PUNCT
bjos-8642673	54	8	17.0	17.0	NUM
bjos-8642673	54	9	%	%	NOUN
bjos-8642673	54	10	)	)	PUNCT
bjos-8642673	54	11	prevalent	prevalent	NOUN
bjos-8642673	54	12	among	among	ADP
bjos-8642673	54	13	the	the	DET
bjos-8642673	54	14	studied	studied	ADJ
bjos-8642673	54	15	population	population	NOUN
bjos-8642673	54	16	.	.	PUNCT
bjos-8642673	55	1	using	use	VERB
bjos-8642673	55	2	pearson	pearson	PROPN
bjos-8642673	55	3	’s	’s	PART
bjos-8642673	55	4	chi	chi	PROPN
bjos-8642673	55	5	square	square	PROPN
bjos-8642673	55	6	test	test	NOUN
bjos-8642673	55	7	of	of	ADP
bjos-8642673	55	8	independence	independence	NOUN
bjos-8642673	55	9	(	(	PUNCT
bjos-8642673	55	10	x2	x2	PROPN
bjos-8642673	55	11	;	;	PUNCT
bjos-8642673	55	12	á=0.05	á=0.05	NOUN
bjos-8642673	55	13	,	,	PUNCT
bjos-8642673	55	14	0.01	0.01	NUM
bjos-8642673	55	15	)	)	PUNCT
bjos-8642673	55	16	,	,	PUNCT
bjos-8642673	55	17	there	there	PRON
bjos-8642673	55	18	was	be	VERB
bjos-8642673	55	19	a	a	DET
bjos-8642673	55	20	statistical	statistical	ADJ
bjos-8642673	55	21	significant	significant	ADJ
bjos-8642673	55	22	difference	difference	NOUN
bjos-8642673	55	23	(	(	PUNCT
bjos-8642673	55	24	p<0.05	p<0.05	NOUN
bjos-8642673	55	25	;	;	PUNCT
bjos-8642673	55	26	0.01	0.01	NUM
bjos-8642673	55	27	)	)	PUNCT
bjos-8642673	55	28	when	when	SCONJ
bjos-8642673	55	29	the	the	DET
bjos-8642673	55	30	relationship	relationship	NOUN
bjos-8642673	55	31	between	between	ADP
bjos-8642673	55	32	prevalences	prevalence	NOUN
bjos-8642673	55	33	of	of	ADP
bjos-8642673	55	34	oral	oral	ADJ
bjos-8642673	55	35	lesions	lesion	NOUN
bjos-8642673	55	36	of	of	ADP
bjos-8642673	55	37	the	the	DET
bjos-8642673	55	38	studied	studied	ADJ
bjos-8642673	55	39	population	population	NOUN
bjos-8642673	55	40	were	be	AUX
bjos-8642673	55	41	compared	compare	VERB
bjos-8642673	55	42	.	.	PUNCT
bjos-8642673	56	1	out	out	ADP
bjos-8642673	56	2	of	of	ADP
bjos-8642673	56	3	the	the	DET
bjos-8642673	56	4	605	605	NUM
bjos-8642673	56	5	patients	patient	NOUN
bjos-8642673	56	6	diagnosed	diagnose	VERB
bjos-8642673	56	7	with	with	ADP
bjos-8642673	56	8	oral	oral	ADJ
bjos-8642673	56	9	lesions	lesion	NOUN
bjos-8642673	56	10	,	,	PUNCT
bjos-8642673	56	11	the	the	DET
bjos-8642673	56	12	result	result	NOUN
bjos-8642673	56	13	of	of	ADP
bjos-8642673	56	14	pre	pre	NOUN
bjos-8642673	56	15	-	-	NOUN
bjos-8642673	56	16	exposure	exposure	NOUN
bjos-8642673	56	17	of	of	ADP
bjos-8642673	56	18	patients	patient	NOUN
bjos-8642673	56	19	to	to	ADP
bjos-8642673	56	20	antimicrobial	antimicrobial	ADJ
bjos-8642673	56	21	agents	agent	NOUN
bjos-8642673	56	22	was	be	AUX
bjos-8642673	56	23	as	as	SCONJ
bjos-8642673	56	24	follows	follow	VERB
bjos-8642673	56	25	:	:	PUNCT
bjos-8642673	56	26	clotrimazole	clotrimazole	NOUN
bjos-8642673	56	27	44	44	NUM
bjos-8642673	56	28	(	(	PUNCT
bjos-8642673	56	29	7.3	7.3	NUM
bjos-8642673	56	30	%	%	NOUN
bjos-8642673	56	31	)	)	PUNCT
bjos-8642673	56	32	;	;	PUNCT
bjos-8642673	56	33	fluconazole	fluconazole	NOUN
bjos-8642673	56	34	27	27	NUM
bjos-8642673	56	35	(	(	PUNCT
bjos-8642673	56	36	4.5	4.5	NUM
bjos-8642673	56	37	%	%	NOUN
bjos-8642673	56	38	)	)	PUNCT
bjos-8642673	56	39	;	;	PUNCT
bjos-8642673	56	40	ketoconazole	ketoconazole	NOUN
bjos-8642673	56	41	62	62	NUM
bjos-8642673	56	42	(	(	PUNCT
bjos-8642673	56	43	10.2	10.2	NUM
bjos-8642673	56	44	%	%	NOUN
bjos-8642673	56	45	)	)	PUNCT
bjos-8642673	56	46	;	;	PUNCT
bjos-8642673	56	47	nystatine	nystatine	NOUN
bjos-8642673	56	48	68	68	NUM
bjos-8642673	56	49	(	(	PUNCT
bjos-8642673	56	50	11.2	11.2	NUM
bjos-8642673	56	51	%	%	NOUN
bjos-8642673	56	52	)	)	PUNCT
bjos-8642673	56	53	;	;	PUNCT
bjos-8642673	56	54	anti	anti	ADJ
bjos-8642673	56	55	-	-	ADJ
bjos-8642673	56	56	retroviral	retroviral	ADJ
bjos-8642673	56	57	agent	agent	NOUN
bjos-8642673	56	58	(	(	PUNCT
bjos-8642673	56	59	unspecified	unspecified	ADJ
bjos-8642673	56	60	)	)	PUNCT
bjos-8642673	56	61	48	48	NUM
bjos-8642673	56	62	(	(	PUNCT
bjos-8642673	56	63	7.9	7.9	NUM
bjos-8642673	56	64	%	%	NOUN
bjos-8642673	56	65	)	)	PUNCT
bjos-8642673	56	66	and	and	CCONJ
bjos-8642673	56	67	patients	patient	NOUN
bjos-8642673	56	68	not	not	PART
bjos-8642673	56	69	exposed	expose	VERB
bjos-8642673	56	70	to	to	ADP
bjos-8642673	56	71	anti	anti	ADJ
bjos-8642673	56	72	-	-	ADJ
bjos-8642673	56	73	fungal	fungal	ADJ
bjos-8642673	56	74	/	/	SYM
bjos-8642673	56	75	viral	viral	ADJ
bjos-8642673	56	76	agents	agent	NOUN
bjos-8642673	56	77	356	356	NUM
bjos-8642673	56	78	(	(	PUNCT
bjos-8642673	56	79	58.8	58.8	NUM
bjos-8642673	56	80	%	%	NOUN
bjos-8642673	56	81	)	)	PUNCT
bjos-8642673	56	82	.	.	PUNCT
bjos-8642673	57	1	there	there	PRON
bjos-8642673	57	2	was	be	VERB
bjos-8642673	57	3	a	a	DET
bjos-8642673	57	4	significant	significant	ADJ
bjos-8642673	57	5	statistical	statistical	ADJ
bjos-8642673	57	6	difference	difference	NOUN
bjos-8642673	57	7	(	(	PUNCT
bjos-8642673	57	8	p<0.01	p<0.01	PROPN
bjos-8642673	57	9	)	)	PUNCT
bjos-8642673	57	10	when	when	SCONJ
bjos-8642673	57	11	chi	chi	PROPN
bjos-8642673	57	12	square	square	PROPN
bjos-8642673	57	13	(	(	PUNCT
bjos-8642673	57	14	x2	x2	PROPN
bjos-8642673	57	15	;	;	PUNCT
bjos-8642673	57	16	á=0.01	á=0.01	NUM
bjos-8642673	57	17	)	)	PUNCT
bjos-8642673	57	18	was	be	AUX
bjos-8642673	57	19	used	use	VERB
bjos-8642673	57	20	to	to	PART
bjos-8642673	57	21	test	test	VERB
bjos-8642673	57	22	for	for	ADP
bjos-8642673	57	23	independence	independence	NOUN
bjos-8642673	57	24	of	of	ADP
bjos-8642673	57	25	the	the	DET
bjos-8642673	57	26	different	different	ADJ
bjos-8642673	57	27	antimicrobial	antimicrobial	ADJ
bjos-8642673	57	28	agents	agent	NOUN
bjos-8642673	57	29	used	use	VERB
bjos-8642673	57	30	.	.	PUNCT
bjos-8642673	58	1	discu	discu	PROPN
bjos-8642673	58	2	s	s	PART
bjos-8642673	59	1	s	s	X
bjos-8642673	59	2	i	i	PRON
bjos-8642673	59	3	on	on	ADP
bjos-8642673	59	4	in	in	ADP
bjos-8642673	59	5	resource	resource	NOUN
bjos-8642673	59	6	poor	poor	ADJ
bjos-8642673	59	7	countries	country	NOUN
bjos-8642673	59	8	,	,	PUNCT
bjos-8642673	59	9	sporadic	sporadic	ADJ
bjos-8642673	59	10	prevalence	prevalence	NOUN
bjos-8642673	59	11	reports	report	VERB
bjos-8642673	59	12	with	with	ADP
bjos-8642673	59	13	no	no	DET
bjos-8642673	59	14	longitudinal	longitudinal	ADJ
bjos-8642673	59	15	cohort	cohort	NOUN
bjos-8642673	59	16	studies	study	NOUN
bjos-8642673	59	17	have	have	AUX
bjos-8642673	59	18	made	make	VERB
bjos-8642673	59	19	oral	oral	ADJ
bjos-8642673	59	20	lesions	lesion	NOUN
bjos-8642673	59	21	an	an	DET
bjos-8642673	59	22	increasing	increase	VERB
bjos-8642673	59	23	concern	concern	NOUN
bjos-8642673	59	24	,	,	PUNCT
bjos-8642673	59	25	mainly	mainly	ADV
bjos-8642673	59	26	in	in	ADP
bjos-8642673	59	27	immunocompromised	immunocompromise	VERB
bjos-8642673	59	28	patients14	patients14	NOUN
bjos-8642673	59	29	.	.	PUNCT
bjos-8642673	60	1	the	the	DET
bjos-8642673	60	2	observed	observed	ADJ
bjos-8642673	60	3	73.2	73.2	NUM
bjos-8642673	60	4	%	%	NOUN
bjos-8642673	60	5	prevalence	prevalence	NOUN
bjos-8642673	60	6	of	of	ADP
bjos-8642673	60	7	oral	oral	ADJ
bjos-8642673	60	8	lesions	lesion	NOUN
bjos-8642673	60	9	among	among	ADP
bjos-8642673	60	10	the	the	DET
bjos-8642673	60	11	consenting	consent	VERB
bjos-8642673	60	12	population	population	NOUN
bjos-8642673	60	13	of	of	ADP
bjos-8642673	60	14	hiv	hiv	PROPN
bjos-8642673	60	15	infected	infected	ADJ
bjos-8642673	60	16	and	and	CCONJ
bjos-8642673	60	17	aids	aids	PROPN
bjos-8642673	60	18	taso	taso	NOUN
bjos-8642673	60	19	patients	patient	NOUN
bjos-8642673	60	20	,	,	PUNCT
bjos-8642673	60	21	is	be	AUX
bjos-8642673	60	22	in	in	ADP
bjos-8642673	60	23	line	line	NOUN
bjos-8642673	60	24	with	with	ADP
bjos-8642673	60	25	the	the	DET
bjos-8642673	60	26	30	30	NUM
bjos-8642673	60	27	-	-	SYM
bjos-8642673	60	28	80	80	NUM
bjos-8642673	60	29	%	%	NOUN
bjos-8642673	60	30	oral	oral	ADJ
bjos-8642673	60	31	lesions	lesion	NOUN
bjos-8642673	60	32	among	among	ADP
bjos-8642673	60	33	hiv	hiv	PROPN
bjos-8642673	60	34	/	/	SYM
bjos-8642673	60	35	aids	aids	PROPN
bjos-8642673	60	36	patients	patient	NOUN
bjos-8642673	60	37	in	in	ADP
bjos-8642673	60	38	developing	develop	VERB
bjos-8642673	60	39	countries	country	NOUN
bjos-8642673	60	40	,	,	PUNCT
bjos-8642673	60	41	reported	report	VERB
bjos-8642673	60	42	by	by	ADP
bjos-8642673	60	43	arendiof	arendiof	NOUN
bjos-8642673	60	44	et	et	PROPN
bjos-8642673	60	45	al.5	al.5	PROPN
bjos-8642673	60	46	and	and	CCONJ
bjos-8642673	60	47	patton	patton	PROPN
bjos-8642673	60	48	et	et	PROPN
bjos-8642673	60	49	al.15	al.15	PROPN
bjos-8642673	60	50	,	,	PUNCT
bjos-8642673	60	51	as	as	ADV
bjos-8642673	60	52	well	well	ADV
bjos-8642673	60	53	as	as	ADP
bjos-8642673	60	54	with	with	ADP
bjos-8642673	60	55	a	a	DET
bjos-8642673	60	56	survey	survey	NOUN
bjos-8642673	60	57	conducted	conduct	VERB
bjos-8642673	60	58	on	on	ADP
bjos-8642673	60	59	a	a	DET
bjos-8642673	60	60	subset	subset	NOUN
bjos-8642673	60	61	of	of	ADP
bjos-8642673	60	62	taso	taso	NOUN
bjos-8642673	60	63	clients	client	NOUN
bjos-8642673	60	64	in	in	ADP
bjos-8642673	60	65	the	the	DET
bjos-8642673	60	66	same	same	ADJ
bjos-8642673	60	67	region	region	NOUN
bjos-8642673	60	68	in	in	ADP
bjos-8642673	60	69	the	the	DET
bjos-8642673	60	70	year	year	NOUN
bjos-8642673	60	71	200512	200512	NUM
bjos-8642673	60	72	.	.	PUNCT
bjos-8642673	61	1	moreover	moreover	ADV
bjos-8642673	61	2	,	,	PUNCT
bjos-8642673	61	3	tirwomwe	tirwomwe	PROPN
bjos-8642673	61	4	et	et	NOUN
bjos-8642673	61	5	al.12	al.12	NOUN
bjos-8642673	61	6	found	find	VERB
bjos-8642673	61	7	similar	similar	ADJ
bjos-8642673	61	8	prevalence	prevalence	NOUN
bjos-8642673	61	9	of	of	ADP
bjos-8642673	61	10	oral	oral	ADJ
bjos-8642673	61	11	lesions	lesion	NOUN
bjos-8642673	61	12	,	,	PUNCT
bjos-8642673	61	13	meaning	mean	VERB
bjos-8642673	61	14	that	that	SCONJ
bjos-8642673	61	15	hiv/	hiv/	NOUN
bjos-8642673	61	16	aids	aid	NOUN
bjos-8642673	61	17	patients	patient	NOUN
bjos-8642673	61	18	benefiting	benefit	VERB
bjos-8642673	61	19	from	from	ADP
bjos-8642673	61	20	taso	taso	NOUN
bjos-8642673	61	21	services	service	NOUN
bjos-8642673	61	22	need	need	VERB
bjos-8642673	61	23	essential	essential	ADJ
bjos-8642673	61	24	oral	oral	ADJ
bjos-8642673	61	25	health	health	NOUN
bjos-8642673	61	26	care	care	NOUN
bjos-8642673	61	27	.	.	PUNCT
bjos-8642673	62	1	in	in	ADP
bjos-8642673	62	2	this	this	DET
bjos-8642673	62	3	region	region	NOUN
bjos-8642673	62	4	more	more	ADJ
bjos-8642673	62	5	effort	effort	NOUN
bjos-8642673	62	6	is	be	AUX
bjos-8642673	62	7	therefore	therefore	ADV
bjos-8642673	62	8	required	require	VERB
bjos-8642673	62	9	to	to	PART
bjos-8642673	62	10	reduce	reduce	VERB
bjos-8642673	62	11	the	the	DET
bjos-8642673	62	12	current	current	ADJ
bjos-8642673	62	13	prevalence	prevalence	NOUN
bjos-8642673	62	14	of	of	ADP
bjos-8642673	62	15	oral	oral	ADJ
bjos-8642673	62	16	lesions	lesion	NOUN
bjos-8642673	62	17	among	among	ADP
bjos-8642673	62	18	taso	taso	NOUN
bjos-8642673	62	19	patients	patient	NOUN
bjos-8642673	62	20	and	and	CCONJ
bjos-8642673	62	21	other	other	ADJ
bjos-8642673	62	22	hiv	hiv	PROPN
bjos-8642673	62	23	patients	patient	NOUN
bjos-8642673	62	24	to	to	ADP
bjos-8642673	62	25	the	the	DET
bjos-8642673	62	26	barest	bare	ADJ
bjos-8642673	62	27	minimum	minimum	NOUN
bjos-8642673	62	28	.	.	PUNCT
bjos-8642673	63	1	on	on	ADP
bjos-8642673	63	2	the	the	DET
bjos-8642673	63	3	other	other	ADJ
bjos-8642673	63	4	hand	hand	NOUN
bjos-8642673	63	5	,	,	PUNCT
bjos-8642673	63	6	the	the	DET
bjos-8642673	63	7	found	find	VERB
bjos-8642673	63	8	prevalence	prevalence	NOUN
bjos-8642673	63	9	in	in	ADP
bjos-8642673	63	10	the	the	DET
bjos-8642673	63	11	present	present	ADJ
bjos-8642673	63	12	study	study	NOUN
bjos-8642673	63	13	was	be	AUX
bjos-8642673	63	14	different	different	ADJ
bjos-8642673	63	15	from	from	ADP
bjos-8642673	63	16	a	a	DET
bjos-8642673	63	17	former	former	ADJ
bjos-8642673	63	18	survey	survey	NOUN
bjos-8642673	63	19	in	in	ADP
bjos-8642673	63	20	a	a	DET
bjos-8642673	63	21	rural	rural	ADJ
bjos-8642673	63	22	uganda	uganda	PROPN
bjos-8642673	63	23	community	community	NOUN
bjos-8642673	63	24	,	,	PUNCT
bjos-8642673	63	25	which	which	PRON
bjos-8642673	63	26	showed	show	VERB
bjos-8642673	63	27	42	42	NUM
bjos-8642673	63	28	%	%	NOUN
bjos-8642673	63	29	manifestation	manifestation	NOUN
bjos-8642673	63	30	of	of	ADP
bjos-8642673	63	31	oral	oral	ADJ
bjos-8642673	63	32	lesions16	lesions16	NOUN
bjos-8642673	63	33	,	,	PUNCT
bjos-8642673	63	34	probably	probably	ADV
bjos-8642673	63	35	due	due	ADP
bjos-8642673	63	36	to	to	ADP
bjos-8642673	63	37	the	the	DET
bjos-8642673	63	38	inclusion	inclusion	NOUN
bjos-8642673	63	39	of	of	ADP
bjos-8642673	63	40	non	non	ADJ
bjos-8642673	63	41	hiv/	hiv/	PROPN
bjos-8642673	63	42	aids	aids	PROPN
bjos-8642673	63	43	individuals	individual	NOUN
bjos-8642673	63	44	.	.	PUNCT
bjos-8642673	64	1	latiff	latiff	PROPN
bjos-8642673	64	2	et	et	PROPN
bjos-8642673	64	3	al.17	al.17	PROPN
bjos-8642673	64	4	reported	report	VERB
bjos-8642673	64	5	a	a	DET
bjos-8642673	64	6	prevalence	prevalence	NOUN
bjos-8642673	64	7	of	of	ADP
bjos-8642673	64	8	75	75	NUM
bjos-8642673	64	9	%	%	NOUN
bjos-8642673	64	10	in	in	ADP
bjos-8642673	64	11	india	india	PROPN
bjos-8642673	64	12	and	and	CCONJ
bjos-8642673	64	13	a	a	DET
bjos-8642673	64	14	higher	high	ADJ
bjos-8642673	64	15	prevalence	prevalence	NOUN
bjos-8642673	64	16	,	,	PUNCT
bjos-8642673	64	17	90	90	NUM
bjos-8642673	64	18	%	%	NOUN
bjos-8642673	64	19	,	,	PUNCT
bjos-8642673	64	20	was	be	AUX
bjos-8642673	64	21	found	find	VERB
bjos-8642673	64	22	by	by	ADP
bjos-8642673	64	23	fidel18	fidel18	NOUN
bjos-8642673	64	24	in	in	ADP
bjos-8642673	64	25	the	the	DET
bjos-8642673	64	26	wester18	wester18	NOUN
bjos-8642673	64	27	.	.	PUNCT
bjos-8642673	65	1	lower	low	ADJ
bjos-8642673	65	2	result	result	NOUN
bjos-8642673	65	3	should	should	AUX
bjos-8642673	65	4	have	have	AUX
bjos-8642673	65	5	been	be	AUX
bjos-8642673	65	6	expected	expect	VERB
bjos-8642673	65	7	from	from	ADP
bjos-8642673	65	8	india	india	PROPN
bjos-8642673	65	9	and	and	CCONJ
bjos-8642673	65	10	the	the	DET
bjos-8642673	65	11	western	western	ADJ
bjos-8642673	65	12	because	because	SCONJ
bjos-8642673	65	13	of	of	ADP
bjos-8642673	65	14	expected	expect	VERB
bjos-8642673	65	15	increased	increase	VERB
bjos-8642673	65	16	support	support	NOUN
bjos-8642673	65	17	from	from	ADP
bjos-8642673	65	18	government	government	NOUN
bjos-8642673	65	19	and	and	CCONJ
bjos-8642673	65	20	donor	donor	NOUN
bjos-8642673	65	21	agencies	agency	NOUN
bjos-8642673	65	22	and	and	CCONJ
bjos-8642673	65	23	better	well	ADJ
bjos-8642673	65	24	strategies	strategy	NOUN
bjos-8642673	65	25	for	for	ADP
bjos-8642673	65	26	management	management	NOUN
bjos-8642673	65	27	and	and	CCONJ
bjos-8642673	65	28	control	control	NOUN
bjos-8642673	65	29	of	of	ADP
bjos-8642673	65	30	this	this	DET
bjos-8642673	65	31	infection	infection	NOUN
bjos-8642673	65	32	.	.	PUNCT
bjos-8642673	66	1	umedevi	umedevi	ADJ
bjos-8642673	66	2	et	et	NOUN
bjos-8642673	66	3	al.19	al.19	PROPN
bjos-8642673	66	4	in	in	ADP
bjos-8642673	66	5	johannesburg	johannesburg	PROPN
bjos-8642673	66	6	,	,	PUNCT
bjos-8642673	66	7	south	south	PROPN
bjos-8642673	66	8	africa	africa	PROPN
bjos-8642673	66	9	,	,	PUNCT
bjos-8642673	66	10	found	find	VERB
bjos-8642673	66	11	significant	significant	ADJ
bjos-8642673	66	12	differences	difference	NOUN
bjos-8642673	66	13	in	in	ADP
bjos-8642673	66	14	the	the	DET
bjos-8642673	66	15	occurrence	occurrence	NOUN
bjos-8642673	66	16	of	of	ADP
bjos-8642673	66	17	oral	oral	ADJ
bjos-8642673	66	18	lesions	lesion	NOUN
bjos-8642673	66	19	between	between	ADP
bjos-8642673	66	20	hiv	hiv	PROPN
bjos-8642673	66	21	-	-	PUNCT
bjos-8642673	66	22	positive	positive	ADJ
bjos-8642673	66	23	and	and	CCONJ
bjos-8642673	66	24	-negative	-negative	ADJ
bjos-8642673	66	25	women	woman	NOUN
bjos-8642673	66	26	,	,	PUNCT
bjos-8642673	66	27	thus	thus	ADV
bjos-8642673	66	28	highlights	highlight	VERB
bjos-8642673	66	29	the	the	DET
bjos-8642673	66	30	usefulness	usefulness	NOUN
bjos-8642673	66	31	of	of	ADP
bjos-8642673	66	32	oral	oral	ADJ
bjos-8642673	66	33	lesions	lesion	NOUN
bjos-8642673	66	34	in	in	ADP
bjos-8642673	66	35	the	the	DET
bjos-8642673	66	36	detection	detection	NOUN
bjos-8642673	66	37	of	of	ADP
bjos-8642673	66	38	early	early	ADJ
bjos-8642673	66	39	and	and	CCONJ
bjos-8642673	66	40	unknown	unknown	ADJ
bjos-8642673	66	41	hiv	hiv	PROPN
bjos-8642673	66	42	infections	infection	NOUN
bjos-8642673	66	43	.	.	PUNCT
bjos-8642673	67	1	the	the	DET
bjos-8642673	67	2	wide	wide	ADJ
bjos-8642673	67	3	range	range	NOUN
bjos-8642673	67	4	of	of	ADP
bjos-8642673	67	5	oral	oral	ADJ
bjos-8642673	67	6	manifestation	manifestation	NOUN
bjos-8642673	67	7	(	(	PUNCT
bjos-8642673	67	8	table	table	NOUN
bjos-8642673	67	9	1	1	NUM
bjos-8642673	67	10	)	)	PUNCT
bjos-8642673	67	11	,	,	PUNCT
bjos-8642673	67	12	from	from	ADP
bjos-8642673	67	13	0.1	0.1	NUM
bjos-8642673	67	14	%	%	NOUN
bjos-8642673	67	15	(	(	PUNCT
bjos-8642673	67	16	nug	nug	NOUN
bjos-8642673	67	17	)	)	PUNCT
bjos-8642673	67	18	to	to	ADP
bjos-8642673	67	19	71.1	71.1	NUM
bjos-8642673	67	20	%	%	NOUN
bjos-8642673	67	21	(	(	PUNCT
bjos-8642673	67	22	pc	pc	NOUN
bjos-8642673	67	23	)	)	PUNCT
bjos-8642673	67	24	,	,	PUNCT
bjos-8642673	67	25	is	be	AUX
bjos-8642673	67	26	slightly	slightly	ADV
bjos-8642673	67	27	lower	low	ADJ
bjos-8642673	67	28	than	than	ADP
bjos-8642673	67	29	reports	report	NOUN
bjos-8642673	67	30	in	in	ADP
bjos-8642673	67	31	south	south	ADJ
bjos-8642673	67	32	africa7	africa7	PROPN
bjos-8642673	67	33	and	and	CCONJ
bjos-8642673	67	34	the	the	DET
bjos-8642673	67	35	united	united	PROPN
bjos-8642673	67	36	states20	states20	PROPN
bjos-8642673	67	37	(	(	PUNCT
bjos-8642673	67	38	1.5	1.5	NUM
bjos-8642673	67	39	%	%	NOUN
bjos-8642673	67	40	to	to	ADP
bjos-8642673	67	41	94	94	NUM
bjos-8642673	67	42	%	%	NOUN
bjos-8642673	67	43	)	)	PUNCT
bjos-8642673	67	44	.	.	PUNCT
bjos-8642673	68	1	slightly	slightly	ADV
bjos-8642673	68	2	lower	low	ADJ
bjos-8642673	68	3	range	range	NOUN
bjos-8642673	68	4	of	of	ADP
bjos-8642673	68	5	oral	oral	ADJ
bjos-8642673	68	6	manifestation	manifestation	NOUN
bjos-8642673	68	7	observed	observe	VERB
bjos-8642673	68	8	in	in	ADP
bjos-8642673	68	9	uganda	uganda	PROPN
bjos-8642673	68	10	taso	taso	PROPN
bjos-8642673	68	11	hiv	hiv	PROPN
bjos-8642673	68	12	population	population	NOUN
bjos-8642673	68	13	points	point	VERB
bjos-8642673	68	14	to	to	ADP
bjos-8642673	68	15	a	a	DET
bjos-8642673	68	16	positive	positive	ADJ
bjos-8642673	68	17	impact	impact	NOUN
bjos-8642673	68	18	of	of	ADP
bjos-8642673	68	19	taso	taso	NOUN
bjos-8642673	68	20	services	service	NOUN
bjos-8642673	68	21	to	to	ADP
bjos-8642673	68	22	the	the	DET
bjos-8642673	68	23	people	people	NOUN
bjos-8642673	68	24	living	live	VERB
bjos-8642673	68	25	with	with	ADP
bjos-8642673	68	26	hiv	hiv	PROPN
bjos-8642673	68	27	in	in	ADP
bjos-8642673	68	28	uganda	uganda	PROPN
bjos-8642673	68	29	.	.	PUNCT
bjos-8642673	69	1	hodgson	hodgson	PROPN
bjos-8642673	69	2	et	et	PROPN
bjos-8642673	69	3	al.8	al.8	PROPN
bjos-8642673	69	4	had	have	AUX
bjos-8642673	69	5	considered	consider	VERB
bjos-8642673	69	6	that	that	SCONJ
bjos-8642673	69	7	the	the	DET
bjos-8642673	69	8	wide	wide	ADJ
bjos-8642673	69	9	range	range	NOUN
bjos-8642673	69	10	found	find	VERB
bjos-8642673	69	11	in	in	ADP
bjos-8642673	69	12	african	african	ADJ
bjos-8642673	69	13	studies	study	NOUN
bjos-8642673	69	14	could	could	AUX
bjos-8642673	69	15	be	be	AUX
bjos-8642673	69	16	due	due	ADJ
bjos-8642673	69	17	to	to	ADP
bjos-8642673	69	18	the	the	DET
bjos-8642673	69	19	improper	improper	ADJ
bjos-8642673	69	20	calibration	calibration	NOUN
bjos-8642673	69	21	in	in	ADP
bjos-8642673	69	22	methodologies	methodology	NOUN
bjos-8642673	69	23	.	.	PUNCT
bjos-8642673	70	1	lack	lack	NOUN
bjos-8642673	70	2	of	of	ADP
bjos-8642673	70	3	adequate	adequate	ADJ
bjos-8642673	70	4	resources	resource	NOUN
bjos-8642673	70	5	to	to	PART
bjos-8642673	70	6	warrant	warrant	VERB
bjos-8642673	70	7	in	in	ADP
bjos-8642673	70	8	-	-	PUNCT
bjos-8642673	70	9	depth	depth	ADJ
bjos-8642673	70	10	qualitative	qualitative	ADJ
bjos-8642673	70	11	laboratory	laboratory	NOUN
bjos-8642673	70	12	study	study	NOUN
bjos-8642673	70	13	so	so	SCONJ
bjos-8642673	70	14	as	as	SCONJ
bjos-8642673	70	15	to	to	PART
bjos-8642673	70	16	confidently	confidently	ADV
bjos-8642673	70	17	and	and	CCONJ
bjos-8642673	70	18	more	more	ADV
bjos-8642673	70	19	accurately	accurately	ADV
bjos-8642673	70	20	formation	formation	NOUN
bjos-8642673	70	21	of	of	ADP
bjos-8642673	70	22	lesion	lesion	NOUN
bjos-8642673	70	23	groups	group	NOUN
bjos-8642673	70	24	,	,	PUNCT
bjos-8642673	70	25	as	as	SCONJ
bjos-8642673	70	26	recommended	recommend	VERB
bjos-8642673	70	27	by	by	ADP
bjos-8642673	70	28	e	e	PROPN
bjos-8642673	70	29	-	-	PROPN
bjos-8642673	70	30	c	c	NOUN
bjos-8642673	70	31	clearinghouse17	clearinghouse17	NOUN
bjos-8642673	70	32	,	,	PUNCT
bjos-8642673	70	33	may	may	AUX
bjos-8642673	70	34	be	be	AUX
bjos-8642673	70	35	a	a	DET
bjos-8642673	70	36	contributing	contribute	VERB
bjos-8642673	70	37	factor	factor	NOUN
bjos-8642673	70	38	for	for	ADP
bjos-8642673	70	39	the	the	DET
bjos-8642673	70	40	wide	wide	ADJ
bjos-8642673	70	41	range	range	NOUN
bjos-8642673	70	42	in	in	ADP
bjos-8642673	70	43	prevalence	prevalence	NOUN
bjos-8642673	70	44	of	of	ADP
bjos-8642673	70	45	different	different	ADJ
bjos-8642673	70	46	oral	oral	ADJ
bjos-8642673	70	47	lesions	lesion	NOUN
bjos-8642673	70	48	found	find	VERB
bjos-8642673	70	49	in	in	ADP
bjos-8642673	70	50	african	african	ADJ
bjos-8642673	70	51	studies	study	NOUN
bjos-8642673	70	52	.	.	PUNCT
bjos-8642673	71	1	meanwhile	meanwhile	ADV
bjos-8642673	71	2	,	,	PUNCT
bjos-8642673	71	3	it	it	PRON
bjos-8642673	71	4	is	be	AUX
bjos-8642673	71	5	interesting	interesting	ADJ
bjos-8642673	71	6	to	to	PART
bjos-8642673	71	7	note	note	VERB
bjos-8642673	71	8	that	that	SCONJ
bjos-8642673	71	9	the	the	DET
bjos-8642673	71	10	17.0	17.0	NUM
bjos-8642673	71	11	%	%	NOUN
bjos-8642673	71	12	prevalence	prevalence	NOUN
bjos-8642673	71	13	of	of	ADP
bjos-8642673	71	14	unique	unique	ADJ
bjos-8642673	71	15	iop	iop	NOUN
bjos-8642673	71	16	found	find	VERB
bjos-8642673	71	17	in	in	ADP
bjos-8642673	71	18	this	this	DET
bjos-8642673	71	19	study	study	NOUN
bjos-8642673	71	20	is	be	AUX
bjos-8642673	71	21	lower	low	ADJ
bjos-8642673	71	22	than	than	ADP
bjos-8642673	71	23	the	the	DET
bjos-8642673	71	24	26.3	26.3	NUM
bjos-8642673	71	25	%	%	NOUN
bjos-8642673	71	26	reported	report	VERB
bjos-8642673	71	27	in	in	ADP
bjos-8642673	71	28	south	south	PROPN
bjos-8642673	71	29	indian	indian	PROPN
bjos-8642673	71	30	hiv	hiv	PROPN
bjos-8642673	71	31	population21	population21	PROPN
bjos-8642673	71	32	.	.	PUNCT
bjos-8642673	72	1	in	in	ADP
bjos-8642673	72	2	documenting	document	VERB
bjos-8642673	72	3	the	the	DET
bjos-8642673	72	4	population	population	NOUN
bjos-8642673	72	5	with	with	ADP
bjos-8642673	72	6	oral	oral	ADJ
bjos-8642673	72	7	pigmentation	pigmentation	NOUN
bjos-8642673	72	8	seen	see	VERB
bjos-8642673	72	9	after	after	ADP
bjos-8642673	72	10	hiv	hiv	PROPN
bjos-8642673	72	11	infection	infection	NOUN
bjos-8642673	72	12	,	,	PUNCT
bjos-8642673	72	13	48	48	NUM
bjos-8642673	72	14	(	(	PUNCT
bjos-8642673	72	15	7.9	7.9	NUM
bjos-8642673	72	16	%	%	NOUN
bjos-8642673	72	17	)	)	PUNCT
bjos-8642673	72	18	patients	patient	NOUN
bjos-8642673	72	19	with	with	ADP
bjos-8642673	72	20	oral	oral	ADJ
bjos-8642673	72	21	lesions	lesion	NOUN
bjos-8642673	72	22	and	and	CCONJ
bjos-8642673	72	23	who	who	PRON
bjos-8642673	72	24	were	be	AUX
bjos-8642673	72	25	taking	take	VERB
bjos-8642673	72	26	unspecified	unspecified	ADJ
bjos-8642673	72	27	antiretroviral	antiretroviral	ADJ
bjos-8642673	72	28	therapy	therapy	NOUN
bjos-8642673	72	29	,	,	PUNCT
bjos-8642673	72	30	including	include	VERB
bjos-8642673	72	31	those	those	PRON
bjos-8642673	72	32	who	who	PRON
bjos-8642673	72	33	possessed	possess	VERB
bjos-8642673	72	34	oral	oral	ADJ
bjos-8642673	72	35	pigmentation	pigmentation	NOUN
bjos-8642673	72	36	from	from	ADP
bjos-8642673	72	37	birth	birth	NOUN
bjos-8642673	72	38	,	,	PUNCT
bjos-8642673	72	39	were	be	AUX
bjos-8642673	72	40	excluded	exclude	VERB
bjos-8642673	72	41	.	.	PUNCT
bjos-8642673	73	1	having	having	AUX
bjos-8642673	73	2	ruled	rule	VERB
bjos-8642673	73	3	out	out	ADP
bjos-8642673	73	4	possible	possible	ADJ
bjos-8642673	73	5	racial	racial	ADJ
bjos-8642673	73	6	melanination	melanination	NOUN
bjos-8642673	73	7	by	by	ADP
bjos-8642673	73	8	hereditary	hereditary	ADJ
bjos-8642673	73	9	and	and	CCONJ
bjos-8642673	73	10	pigmentation	pigmentation	NOUN
bjos-8642673	73	11	due	due	ADJ
bjos-8642673	73	12	to	to	ADP
bjos-8642673	73	13	side	side	ADJ
bjos-8642673	73	14	effect	effect	NOUN
bjos-8642673	73	15	of	of	ADP
bjos-8642673	73	16	antiretroviral	antiretroviral	ADJ
bjos-8642673	73	17	therapy	therapy	NOUN
bjos-8642673	73	18	,	,	PUNCT
bjos-8642673	73	19	the	the	DET
bjos-8642673	73	20	next	next	ADJ
bjos-8642673	73	21	most	most	ADV
bjos-8642673	73	22	probable	probable	ADJ
bjos-8642673	73	23	cause	cause	NOUN
bjos-8642673	73	24	of	of	ADP
bjos-8642673	73	25	oral	oral	ADJ
bjos-8642673	73	26	pigmentation	pigmentation	NOUN
bjos-8642673	73	27	among	among	ADP
bjos-8642673	73	28	the	the	DET
bjos-8642673	73	29	patients	patient	NOUN
bjos-8642673	73	30	studied	study	VERB
bjos-8642673	73	31	could	could	AUX
bjos-8642673	73	32	be	be	AUX
bjos-8642673	73	33	increased	increase	VERB
bjos-8642673	73	34	release	release	NOUN
bjos-8642673	73	35	of	of	ADP
bjos-8642673	73	36	α	α	NOUN
bjos-8642673	73	37	-	-	ADJ
bjos-8642673	73	38	melanocyte	melanocyte	ADJ
bjos-8642673	73	39	stimulating	stimulate	VERB
bjos-8642673	73	40	hormone	hormone	NOUN
bjos-8642673	73	41	(	(	PUNCT
bjos-8642673	73	42	α	α	NOUN
bjos-8642673	73	43	-	-	PUNCT
bjos-8642673	73	44	msh	msh	NOUN
bjos-8642673	73	45	)	)	PUNCT
bjos-8642673	73	46	due	due	ADP
bjos-8642673	73	47	to	to	ADP
bjos-8642673	73	48	deregulated	deregulate	VERB
bjos-8642673	73	49	release	release	NOUN
bjos-8642673	73	50	of	of	ADP
bjos-8642673	73	51	cytokines	cytokine	NOUN
bjos-8642673	73	52	in	in	ADP
bjos-8642673	73	53	hiv	hiv	PROPN
bjos-8642673	73	54	disease	disease	NOUN
bjos-8642673	73	55	and	and	CCONJ
bjos-8642673	73	56	less	less	ADV
bjos-8642673	73	57	likely	likely	ADJ
bjos-8642673	73	58	due	due	ADJ
bjos-8642673	73	59	to	to	ADP
bjos-8642673	73	60	use	use	NOUN
bjos-8642673	73	61	of	of	ADP
bjos-8642673	73	62	antifungals2122	antifungals2122	PROPN
bjos-8642673	73	63	.	.	PUNCT
bjos-8642673	74	1	this	this	DET
bjos-8642673	74	2	observation	observation	NOUN
bjos-8642673	74	3	warrants	warrant	NOUN
bjos-8642673	74	4	further	further	ADJ
bjos-8642673	74	5	investigation	investigation	NOUN
bjos-8642673	74	6	so	so	SCONJ
bjos-8642673	74	7	as	as	SCONJ
bjos-8642673	74	8	to	to	PART
bjos-8642673	74	9	hypothesize	hypothesize	VERB
bjos-8642673	74	10	that	that	SCONJ
bjos-8642673	74	11	hiv	hiv	PROPN
bjos-8642673	74	12	disease	disease	NOUN
bjos-8642673	74	13	is	be	AUX
bjos-8642673	74	14	more	more	ADV
bjos-8642673	74	15	likely	likely	ADJ
bjos-8642673	74	16	to	to	PART
bjos-8642673	74	17	cause	cause	VERB
bjos-8642673	74	18	oral	oral	ADJ
bjos-8642673	74	19	pigmentation	pigmentation	NOUN
bjos-8642673	74	20	in	in	ADP
bjos-8642673	74	21	indians	indians	PROPN
bjos-8642673	74	22	than	than	ADP
bjos-8642673	74	23	in	in	ADP
bjos-8642673	74	24	africans	africans	PROPN
bjos-8642673	74	25	.	.	PUNCT
bjos-8642673	75	1	the	the	DET
bjos-8642673	75	2	observation	observation	NOUN
bjos-8642673	75	3	of	of	ADP
bjos-8642673	75	4	40.9	40.9	NUM
bjos-8642673	75	5	%	%	NOUN
bjos-8642673	75	6	mixed	mixed	ADJ
bjos-8642673	75	7	infection	infection	NOUN
bjos-8642673	75	8	of	of	ADP
bjos-8642673	75	9	pc	pc	NOUN
bjos-8642673	75	10	with	with	ADP
bjos-8642673	75	11	other	other	ADJ
bjos-8642673	75	12	oral	oral	ADJ
bjos-8642673	75	13	lesions	lesion	NOUN
bjos-8642673	75	14	(	(	PUNCT
bjos-8642673	75	15	pc	pc	NOUN
bjos-8642673	75	16	with	with	ADP
bjos-8642673	75	17	ec	ec	PROPN
bjos-8642673	75	18	:	:	PUNCT
bjos-8642673	75	19	29.3	29.3	NUM
bjos-8642673	75	20	%	%	NOUN
bjos-8642673	75	21	and	and	CCONJ
bjos-8642673	75	22	pc	pc	NOUN
bjos-8642673	75	23	with	with	ADP
bjos-8642673	75	24	ac	ac	PROPN
bjos-8642673	75	25	:	:	PUNCT
bjos-8642673	75	26	11.6	11.6	NUM
bjos-8642673	75	27	%	%	NOUN
bjos-8642673	75	28	;	;	PUNCT
bjos-8642673	75	29	table	table	NOUN
bjos-8642673	75	30	1	1	NUM
bjos-8642673	75	31	)	)	PUNCT
bjos-8642673	75	32	gives	give	VERB
bjos-8642673	75	33	this	this	DET
bjos-8642673	75	34	study	study	NOUN
bjos-8642673	75	35	another	another	DET
bjos-8642673	75	36	unique	unique	ADJ
bjos-8642673	75	37	importance	importance	NOUN
bjos-8642673	75	38	because	because	SCONJ
bjos-8642673	75	39	such	such	ADJ
bjos-8642673	75	40	finding	finding	NOUN
bjos-8642673	75	41	is	be	AUX
bjos-8642673	75	42	rare	rare	ADJ
bjos-8642673	75	43	in	in	ADP
bjos-8642673	75	44	many	many	ADJ
bjos-8642673	75	45	african	african	ADJ
bjos-8642673	75	46	studies	study	NOUN
bjos-8642673	75	47	.	.	PUNCT
bjos-8642673	76	1	there	there	PRON
bjos-8642673	76	2	was	be	VERB
bjos-8642673	76	3	a	a	DET
bjos-8642673	76	4	statistical	statistical	ADJ
bjos-8642673	76	5	significant	significant	ADJ
bjos-8642673	76	6	difference	difference	NOUN
bjos-8642673	76	7	(	(	PUNCT
bjos-8642673	76	8	p<0.05	p<0.05	NOUN
bjos-8642673	76	9	and	and	CCONJ
bjos-8642673	76	10	p<0.01	p<0.01	PROPN
bjos-8642673	76	11	)	)	PUNCT
bjos-8642673	76	12	when	when	SCONJ
bjos-8642673	76	13	the	the	DET
bjos-8642673	76	14	relationship	relationship	NOUN
bjos-8642673	76	15	between	between	ADP
bjos-8642673	76	16	prevalence	prevalence	NOUN
bjos-8642673	76	17	of	of	ADP
bjos-8642673	76	18	different	different	ADJ
bjos-8642673	76	19	oral	oral	ADJ
bjos-8642673	76	20	lesions	lesion	NOUN
bjos-8642673	76	21	identified	identify	VERB
bjos-8642673	76	22	among	among	ADP
bjos-8642673	76	23	the	the	DET
bjos-8642673	76	24	studied	studied	ADJ
bjos-8642673	76	25	population	population	NOUN
bjos-8642673	76	26	were	be	AUX
bjos-8642673	76	27	compared	compare	VERB
bjos-8642673	76	28	.	.	PUNCT
bjos-8642673	77	1	this	this	PRON
bjos-8642673	77	2	implies	imply	VERB
bjos-8642673	77	3	that	that	SCONJ
bjos-8642673	77	4	the	the	DET
bjos-8642673	77	5	interaction	interaction	NOUN
bjos-8642673	77	6	of	of	ADP
bjos-8642673	77	7	different	different	ADJ
bjos-8642673	77	8	oral	oral	ADJ
bjos-8642673	77	9	lesions	lesion	NOUN
bjos-8642673	77	10	noted	note	VERB
bjos-8642673	77	11	in	in	ADP
bjos-8642673	77	12	this	this	DET
bjos-8642673	77	13	study	study	NOUN
bjos-8642673	77	14	was	be	AUX
bjos-8642673	77	15	due	due	ADJ
bjos-8642673	77	16	to	to	ADP
bjos-8642673	77	17	other	other	ADJ
bjos-8642673	77	18	factors	factor	NOUN
bjos-8642673	77	19	(	(	PUNCT
bjos-8642673	77	20	such	such	ADJ
bjos-8642673	77	21	as	as	ADP
bjos-8642673	77	22	change	change	NOUN
bjos-8642673	77	23	in	in	ADP
bjos-8642673	77	24	cd4	cd4	PROPN
bjos-8642673	77	25	level	level	NOUN
bjos-8642673	77	26	and	and	CCONJ
bjos-8642673	77	27	viral	viral	ADJ
bjos-8642673	77	28	load	load	NOUN
bjos-8642673	77	29	)	)	PUNCT
bjos-8642673	77	30	and	and	CCONJ
bjos-8642673	77	31	not	not	PART
bjos-8642673	77	32	by	by	ADP
bjos-8642673	77	33	chance	chance	NOUN
bjos-8642673	77	34	alone	alone	ADV
bjos-8642673	77	35	.	.	PUNCT
bjos-8642673	78	1	therefore	therefore	ADV
bjos-8642673	78	2	,	,	PUNCT
bjos-8642673	78	3	in	in	ADP
bjos-8642673	78	4	addition	addition	NOUN
bjos-8642673	78	5	to	to	ADP
bjos-8642673	78	6	the	the	DET
bjos-8642673	78	7	reported	report	VERB
bjos-8642673	78	8	possible	possible	ADJ
bjos-8642673	78	9	correlation	correlation	NOUN
bjos-8642673	78	10	of	of	ADP
bjos-8642673	78	11	single	single	ADJ
bjos-8642673	78	12	or	or	CCONJ
bjos-8642673	78	13	grouped	group	VERB
bjos-8642673	78	14	oral	oral	ADJ
bjos-8642673	78	15	lesions	lesion	NOUN
bjos-8642673	78	16	to	to	ADP
bjos-8642673	78	17	cd4	cd4	PROPN
bjos-8642673	78	18	cell	cell	NOUN
bjos-8642673	78	19	levels23	levels23	PROPN
bjos-8642673	78	20	,	,	PUNCT
bjos-8642673	78	21	we	we	PRON
bjos-8642673	78	22	hereby	hereby	ADV
bjos-8642673	78	23	suggest	suggest	VERB
bjos-8642673	78	24	that	that	SCONJ
bjos-8642673	78	25	cd4	cd4	PROPN
bjos-8642673	78	26	cell	cell	NOUN
bjos-8642673	78	27	levels	level	NOUN
bjos-8642673	78	28	could	could	AUX
bjos-8642673	78	29	also	also	ADV
bjos-8642673	78	30	be	be	AUX
bjos-8642673	78	31	correlated	correlate	VERB
bjos-8642673	78	32	with	with	ADP
bjos-8642673	78	33	the	the	DET
bjos-8642673	78	34	levels	level	NOUN
bjos-8642673	78	35	of	of	ADP
bjos-8642673	78	36	mixed	mixed	ADJ
bjos-8642673	78	37	manifestations	manifestation	NOUN
bjos-8642673	78	38	of	of	ADP
bjos-8642673	78	39	oral	oral	ADJ
bjos-8642673	78	40	lesions	lesion	NOUN
bjos-8642673	78	41	in	in	ADP
bjos-8642673	78	42	severely	severely	ADV
bjos-8642673	78	43	immunosuppressed	immunosuppressed	ADJ
bjos-8642673	78	44	patients	patient	NOUN
bjos-8642673	78	45	.	.	PUNCT
bjos-8642673	79	1	thus	thus	ADV
bjos-8642673	79	2	the	the	DET
bjos-8642673	79	3	level	level	NOUN
bjos-8642673	79	4	of	of	ADP
bjos-8642673	79	5	mixed	mixed	ADJ
bjos-8642673	79	6	oral	oral	ADJ
bjos-8642673	79	7	infection	infection	NOUN
bjos-8642673	79	8	may	may	AUX
bjos-8642673	79	9	herald	herald	PROPN
bjos-8642673	79	10	emergence	emergence	NOUN
bjos-8642673	79	11	and	and	CCONJ
bjos-8642673	79	12	progression	progression	NOUN
bjos-8642673	79	13	of	of	ADP
bjos-8642673	79	14	hiv	hiv	PROPN
bjos-8642673	79	15	disease	disease	NOUN
bjos-8642673	79	16	.	.	PUNCT
bjos-8642673	80	1	despite	despite	SCONJ
bjos-8642673	80	2	the	the	DET
bjos-8642673	80	3	fact	fact	NOUN
bjos-8642673	80	4	that	that	SCONJ
bjos-8642673	80	5	the	the	DET
bjos-8642673	80	6	critical	critical	ADJ
bjos-8642673	80	7	immunological	immunological	ADJ
bjos-8642673	80	8	defects	defect	NOUN
bjos-8642673	80	9	,	,	PUNCT
bjos-8642673	80	10	which	which	PRON
bjos-8642673	80	11	are	be	AUX
bjos-8642673	80	12	responsible	responsible	ADJ
bjos-8642673	80	13	for	for	ADP
bjos-8642673	80	14	the	the	DET
bjos-8642673	80	15	onset	onset	NOUN
bjos-8642673	80	16	and	and	CCONJ
bjos-8642673	80	17	maintenance	maintenance	NOUN
bjos-8642673	80	18	of	of	ADP
bjos-8642673	80	19	mucosal	mucosal	ADJ
bjos-8642673	80	20	candidiasis	candidiasis	NOUN
bjos-8642673	80	21	in	in	ADP
bjos-8642673	80	22	patients	patient	NOUN
bjos-8642673	80	23	with	with	ADP
bjos-8642673	80	24	hiv	hiv	PROPN
bjos-8642673	80	25	infection	infection	NOUN
bjos-8642673	80	26	,	,	PUNCT
bjos-8642673	80	27	has	have	AUX
bjos-8642673	80	28	not	not	PART
bjos-8642673	80	29	been	be	AUX
bjos-8642673	80	30	elucidated	elucidate	VERB
bjos-8642673	80	31	,	,	PUNCT
bjos-8642673	80	32	the	the	DET
bjos-8642673	80	33	devastating	devastating	ADJ
bjos-8642673	80	34	impact	impact	NOUN
bjos-8642673	80	35	of	of	ADP
bjos-8642673	80	36	hiv	hiv	PROPN
bjos-8642673	80	37	infection	infection	NOUN
bjos-8642673	80	38	on	on	ADP
bjos-8642673	80	39	mucosal	mucosal	ADJ
bjos-8642673	80	40	langerhans	langerhan	NOUN
bjos-8642673	80	41	’	'	PUNCT
bjos-8642673	80	42	cell	cell	NOUN
bjos-8642673	80	43	and	and	CCONJ
bjos-8642673	80	44	cd4	cd4	PROPN
bjos-8642673	80	45	+	+	NOUN
bjos-8642673	80	46	cell	cell	NOUN
bjos-8642673	80	47	populations	population	NOUN
bjos-8642673	80	48	may	may	AUX
bjos-8642673	80	49	most	most	ADV
bjos-8642673	80	50	probably	probably	ADV
bjos-8642673	80	51	be	be	AUX
bjos-8642673	80	52	central	central	ADJ
bjos-8642673	80	53	to	to	ADP
bjos-8642673	80	54	the	the	DET
bjos-8642673	80	55	pathogenesis	pathogenesis	NOUN
bjos-8642673	80	56	of	of	ADP
bjos-8642673	80	57	mucosal	mucosal	ADJ
bjos-8642673	80	58	candidiasis	candidiasis	NOUN
bjos-8642673	80	59	in	in	ADP
bjos-8642673	80	60	hiv	hiv	PROPN
bjos-8642673	80	61	-	-	PUNCT
bjos-8642673	80	62	infected	infect	VERB
bjos-8642673	80	63	patients24	patients24	NOUN
bjos-8642673	80	64	.	.	PUNCT
bjos-8642673	81	1	however	however	ADV
bjos-8642673	81	2	,	,	PUNCT
bjos-8642673	81	3	these	these	DET
bjos-8642673	81	4	defects	defect	NOUN
bjos-8642673	81	5	may	may	AUX
bjos-8642673	81	6	be	be	AUX
bjos-8642673	81	7	partly	partly	ADV
bjos-8642673	81	8	compensated	compensate	VERB
bjos-8642673	81	9	by	by	ADP
bjos-8642673	81	10	preserved	preserve	VERB
bjos-8642673	81	11	host	host	NOUN
bjos-8642673	81	12	defense	defense	NOUN
bjos-8642673	81	13	mechanisms	mechanism	NOUN
bjos-8642673	81	14	(	(	PUNCT
bjos-8642673	81	15	calprotectin	calprotectin	NOUN
bjos-8642673	81	16	,	,	PUNCT
bjos-8642673	81	17	keratinocytes	keratinocyte	NOUN
bjos-8642673	81	18	,	,	PUNCT
bjos-8642673	81	19	cd8	cd8	PROPN
bjos-8642673	81	20	+	+	PROPN
bjos-8642673	81	21	t	t	NOUN
bjos-8642673	81	22	cells	cell	NOUN
bjos-8642673	81	23	,	,	PUNCT
bjos-8642673	81	24	and	and	CCONJ
bjos-8642673	81	25	phagocytes	phagocyte	NOUN
bjos-8642673	81	26	)	)	PUNCT
bjos-8642673	81	27	,	,	PUNCT
bjos-8642673	81	28	which	which	PRON
bjos-8642673	81	29	individually	individually	ADV
bjos-8642673	81	30	or	or	CCONJ
bjos-8642673	81	31	together	together	ADV
bjos-8642673	81	32	,	,	PUNCT
bjos-8642673	81	33	may	may	AUX
bjos-8642673	81	34	limit	limit	VERB
bjos-8642673	81	35	candida	candida	NOUN
bjos-8642673	81	36	albicans	albican	NOUN
bjos-8642673	81	37	proliferation	proliferation	NOUN
bjos-8642673	81	38	to	to	ADP
bjos-8642673	81	39	the	the	DET
bjos-8642673	81	40	superficial	superficial	ADJ
bjos-8642673	81	41	mucosa25	mucosa25	NOUN
bjos-8642673	81	42	.	.	PUNCT
bjos-8642673	82	1	a	a	DET
bjos-8642673	82	2	close	close	ADJ
bjos-8642673	82	3	comparison	comparison	NOUN
bjos-8642673	82	4	with	with	ADP
bjos-8642673	82	5	a	a	DET
bjos-8642673	82	6	tirwomwe	tirwomwe	NOUN
bjos-8642673	82	7	et	et	NOUN
bjos-8642673	82	8	al.12	al.12	NOUN
bjos-8642673	82	9	study	study	NOUN
bjos-8642673	82	10	reveals	reveal	VERB
bjos-8642673	82	11	minor	minor	ADJ
bjos-8642673	82	12	improvement	improvement	NOUN
bjos-8642673	82	13	in	in	ADP
bjos-8642673	82	14	some	some	DET
bjos-8642673	82	15	lesions	lesion	NOUN
bjos-8642673	82	16	and	and	CCONJ
bjos-8642673	82	17	worsening	worsen	VERB
bjos-8642673	82	18	condition	condition	NOUN
bjos-8642673	82	19	in	in	ADP
bjos-8642673	82	20	other	other	ADJ
bjos-8642673	82	21	ones	one	NOUN
bjos-8642673	82	22	.	.	PUNCT
bjos-8642673	83	1	oral	oral	ADJ
bjos-8642673	83	2	hairy	hairy	ADJ
bjos-8642673	83	3	leukoplakia	leukoplakia	NOUN
bjos-8642673	83	4	which	which	PRON
bjos-8642673	83	5	was	be	AUX
bjos-8642673	83	6	braz	braz	PROPN
bjos-8642673	83	7	j	j	PROPN
bjos-8642673	83	8	oral	oral	PROPN
bjos-8642673	83	9	sci	sci	PROPN
bjos-8642673	83	10	.	.	PUNCT
bjos-8642673	84	1	7(26):1591	7(26):1591	NUM
bjos-8642673	84	2	-	-	SYM
bjos-8642673	84	3	1595	1595	NUM
bjos-8642673	84	4	appraisal	appraisal	NOUN
bjos-8642673	84	5	of	of	ADP
bjos-8642673	84	6	oral	oral	ADJ
bjos-8642673	84	7	lesions	lesion	NOUN
bjos-8642673	84	8	status	status	NOUN
bjos-8642673	84	9	of	of	ADP
bjos-8642673	84	10	hiv	hiv	PROPN
bjos-8642673	84	11	/	/	SYM
bjos-8642673	84	12	aids	aids	PROPN
bjos-8642673	84	13	patients	patient	NOUN
bjos-8642673	84	14	in	in	ADP
bjos-8642673	84	15	south	south	ADJ
bjos-8642673	84	16	western	western	ADJ
bjos-8642673	84	17	uganda	uganda	PROPN
bjos-8642673	84	18	1594	1594	NUM
bjos-8642673	84	19	0.3%12	0.3%12	NUM
bjos-8642673	84	20	was	be	AUX
bjos-8642673	84	21	not	not	PART
bjos-8642673	84	22	seen	see	VERB
bjos-8642673	84	23	in	in	ADP
bjos-8642673	84	24	the	the	DET
bjos-8642673	84	25	present	present	ADJ
bjos-8642673	84	26	study	study	NOUN
bjos-8642673	84	27	.	.	PUNCT
bjos-8642673	85	1	lgeb	lgeb	PROPN
bjos-8642673	85	2	was	be	AUX
bjos-8642673	85	3	reduced	reduce	VERB
bjos-8642673	85	4	by	by	ADP
bjos-8642673	85	5	6.8	6.8	NUM
bjos-8642673	85	6	%	%	NOUN
bjos-8642673	85	7	(	(	PUNCT
bjos-8642673	85	8	7.8	7.8	NUM
bjos-8642673	85	9	%	%	NOUN
bjos-8642673	85	10	:	:	PUNCT
bjos-8642673	85	11	1.0	1.0	NUM
bjos-8642673	85	12	%	%	NOUN
bjos-8642673	85	13	)	)	PUNCT
bjos-8642673	85	14	,	,	PUNCT
bjos-8642673	85	15	while	while	SCONJ
bjos-8642673	85	16	kaposi	kaposi	PROPN
bjos-8642673	85	17	sarcoma	sarcoma	NOUN
bjos-8642673	85	18	was	be	AUX
bjos-8642673	85	19	reduced	reduce	VERB
bjos-8642673	85	20	by	by	ADP
bjos-8642673	85	21	0.2	0.2	NUM
bjos-8642673	85	22	%	%	NOUN
bjos-8642673	85	23	(	(	PUNCT
bjos-8642673	85	24	4.8	4.8	NUM
bjos-8642673	85	25	%	%	NOUN
bjos-8642673	85	26	:	:	PUNCT
bjos-8642673	85	27	4.6	4.6	NUM
bjos-8642673	85	28	%	%	NOUN
bjos-8642673	85	29	)	)	PUNCT
bjos-8642673	85	30	in	in	ADP
bjos-8642673	85	31	the	the	DET
bjos-8642673	85	32	present	present	ADJ
bjos-8642673	85	33	study	study	NOUN
bjos-8642673	85	34	.	.	PUNCT
bjos-8642673	86	1	the	the	DET
bjos-8642673	86	2	slight	slight	ADJ
bjos-8642673	86	3	reduction	reduction	NOUN
bjos-8642673	86	4	in	in	ADP
bjos-8642673	86	5	the	the	DET
bjos-8642673	86	6	relative	relative	ADJ
bjos-8642673	86	7	prevalence	prevalence	NOUN
bjos-8642673	86	8	of	of	ADP
bjos-8642673	86	9	oral	oral	ADJ
bjos-8642673	86	10	lesions	lesion	NOUN
bjos-8642673	86	11	,	,	PUNCT
bjos-8642673	86	12	two	two	NUM
bjos-8642673	86	13	years	year	NOUN
bjos-8642673	86	14	after	after	SCONJ
bjos-8642673	86	15	the	the	DET
bjos-8642673	86	16	lesions	lesion	NOUN
bjos-8642673	86	17	were	be	AUX
bjos-8642673	86	18	identified	identify	VERB
bjos-8642673	86	19	and	and	CCONJ
bjos-8642673	86	20	recommendations	recommendation	NOUN
bjos-8642673	86	21	made	make	VERB
bjos-8642673	86	22	on	on	ADP
bjos-8642673	86	23	the	the	DET
bjos-8642673	86	24	need	need	NOUN
bjos-8642673	86	25	to	to	PART
bjos-8642673	86	26	follow	follow	VERB
bjos-8642673	86	27	improved	improved	ADJ
bjos-8642673	86	28	management	management	NOUN
bjos-8642673	86	29	protocols	protocol	NOUN
bjos-8642673	86	30	,	,	PUNCT
bjos-8642673	86	31	shows	show	VERB
bjos-8642673	86	32	that	that	SCONJ
bjos-8642673	86	33	the	the	DET
bjos-8642673	86	34	goal	goal	NOUN
bjos-8642673	86	35	of	of	ADP
bjos-8642673	86	36	improvement	improvement	NOUN
bjos-8642673	86	37	of	of	ADP
bjos-8642673	86	38	oral	oral	ADJ
bjos-8642673	86	39	health	health	NOUN
bjos-8642673	86	40	condition	condition	NOUN
bjos-8642673	86	41	among	among	ADP
bjos-8642673	86	42	people	people	NOUN
bjos-8642673	86	43	living	live	VERB
bjos-8642673	86	44	with	with	ADP
bjos-8642673	86	45	hiv	hiv	PROPN
bjos-8642673	86	46	in	in	ADP
bjos-8642673	86	47	uganda	uganda	PROPN
bjos-8642673	86	48	may	may	AUX
bjos-8642673	86	49	be	be	AUX
bjos-8642673	86	50	achievable	achievable	ADJ
bjos-8642673	86	51	.	.	PUNCT
bjos-8642673	87	1	therefore	therefore	ADV
bjos-8642673	87	2	,	,	PUNCT
bjos-8642673	87	3	more	more	ADJ
bjos-8642673	87	4	efforts	effort	NOUN
bjos-8642673	87	5	should	should	AUX
bjos-8642673	87	6	be	be	AUX
bjos-8642673	87	7	made	make	VERB
bjos-8642673	87	8	to	to	PART
bjos-8642673	87	9	increase	increase	VERB
bjos-8642673	87	10	the	the	DET
bjos-8642673	87	11	reduction	reduction	NOUN
bjos-8642673	87	12	rate	rate	NOUN
bjos-8642673	87	13	of	of	ADP
bjos-8642673	87	14	these	these	DET
bjos-8642673	87	15	oral	oral	ADJ
bjos-8642673	87	16	lesions	lesion	NOUN
bjos-8642673	87	17	observed	observe	VERB
bjos-8642673	87	18	among	among	ADP
bjos-8642673	87	19	the	the	DET
bjos-8642673	87	20	people	people	NOUN
bjos-8642673	87	21	with	with	ADP
bjos-8642673	87	22	hiv	hiv	PROPN
bjos-8642673	87	23	in	in	ADP
bjos-8642673	87	24	uganda	uganda	PROPN
bjos-8642673	87	25	.	.	PUNCT
bjos-8642673	88	1	on	on	ADP
bjos-8642673	88	2	the	the	DET
bjos-8642673	88	3	other	other	ADJ
bjos-8642673	88	4	hand	hand	NOUN
bjos-8642673	88	5	,	,	PUNCT
bjos-8642673	88	6	the	the	DET
bjos-8642673	88	7	incidence	incidence	NOUN
bjos-8642673	88	8	of	of	ADP
bjos-8642673	88	9	pc	pc	NOUN
bjos-8642673	88	10	among	among	ADP
bjos-8642673	88	11	hiv	hiv	PROPN
bjos-8642673	88	12	patients	patient	NOUN
bjos-8642673	88	13	diagnosed	diagnose	VERB
bjos-8642673	88	14	with	with	ADP
bjos-8642673	88	15	oral	oral	ADJ
bjos-8642673	88	16	lesions	lesion	NOUN
bjos-8642673	88	17	increased	increase	VERB
bjos-8642673	88	18	by	by	ADP
bjos-8642673	88	19	30.7	30.7	NUM
bjos-8642673	88	20	%	%	NOUN
bjos-8642673	88	21	(	(	PUNCT
bjos-8642673	88	22	40.8	40.8	NUM
bjos-8642673	88	23	%	%	NOUN
bjos-8642673	88	24	:	:	PUNCT
bjos-8642673	88	25	71.1	71.1	NUM
bjos-8642673	88	26	%	%	NOUN
bjos-8642673	88	27	)	)	PUNCT
bjos-8642673	88	28	,	,	PUNCT
bjos-8642673	88	29	angular	angular	ADJ
bjos-8642673	88	30	chelitis	chelitis	NOUN
bjos-8642673	88	31	increased	increase	VERB
bjos-8642673	88	32	by	by	ADP
bjos-8642673	88	33	1.2	1.2	NUM
bjos-8642673	88	34	%	%	NOUN
bjos-8642673	88	35	(	(	PUNCT
bjos-8642673	88	36	17.6	17.6	NUM
bjos-8642673	88	37	%	%	NOUN
bjos-8642673	88	38	:	:	PUNCT
bjos-8642673	88	39	18.8	18.8	NUM
bjos-8642673	88	40	%	%	NOUN
bjos-8642673	88	41	)	)	PUNCT
bjos-8642673	88	42	,	,	PUNCT
bjos-8642673	88	43	ec	ec	PROPN
bjos-8642673	88	44	increased	increase	VERB
bjos-8642673	88	45	by	by	ADP
bjos-8642673	88	46	1.0	1.0	NUM
bjos-8642673	88	47	%	%	NOUN
bjos-8642673	88	48	(	(	PUNCT
bjos-8642673	88	49	38.9	38.9	NUM
bjos-8642673	88	50	%	%	NOUN
bjos-8642673	88	51	:	:	PUNCT
bjos-8642673	88	52	39.9	39.9	NUM
bjos-8642673	88	53	)	)	PUNCT
bjos-8642673	88	54	and	and	CCONJ
bjos-8642673	88	55	nug	nug	PROPN
bjos-8642673	88	56	was	be	AUX
bjos-8642673	88	57	increased	increase	VERB
bjos-8642673	88	58	by	by	ADP
bjos-8642673	88	59	0.9	0.9	NUM
bjos-8642673	88	60	%	%	NOUN
bjos-8642673	88	61	(	(	PUNCT
bjos-8642673	88	62	0.3	0.3	NUM
bjos-8642673	88	63	%	%	NOUN
bjos-8642673	88	64	:	:	PUNCT
bjos-8642673	88	65	1.2	1.2	NUM
bjos-8642673	88	66	%	%	NOUN
bjos-8642673	88	67	)	)	PUNCT
bjos-8642673	88	68	respectively	respectively	ADV
bjos-8642673	88	69	.	.	PUNCT
bjos-8642673	89	1	information	information	NOUN
bjos-8642673	89	2	obtained	obtain	VERB
bjos-8642673	89	3	from	from	ADP
bjos-8642673	89	4	this	this	DET
bjos-8642673	89	5	study	study	NOUN
bjos-8642673	89	6	(	(	PUNCT
bjos-8642673	89	7	table	table	NOUN
bjos-8642673	89	8	1	1	NUM
bjos-8642673	89	9	)	)	PUNCT
bjos-8642673	89	10	shows	show	VERB
bjos-8642673	89	11	that	that	SCONJ
bjos-8642673	89	12	from	from	ADP
bjos-8642673	89	13	71.1	71.1	NUM
bjos-8642673	89	14	%	%	NOUN
bjos-8642673	89	15	individuals	individual	NOUN
bjos-8642673	89	16	with	with	ADP
bjos-8642673	89	17	pc	pc	NOUN
bjos-8642673	89	18	,	,	PUNCT
bjos-8642673	89	19	58.8	58.8	NUM
bjos-8642673	89	20	%	%	NOUN
bjos-8642673	89	21	were	be	AUX
bjos-8642673	89	22	not	not	PART
bjos-8642673	89	23	taking	take	VERB
bjos-8642673	89	24	any	any	DET
bjos-8642673	89	25	antifungal	antifungal	ADJ
bjos-8642673	89	26	and	and	CCONJ
bjos-8642673	89	27	antiviral	antiviral	ADJ
bjos-8642673	89	28	therapy	therapy	NOUN
bjos-8642673	89	29	,	,	PUNCT
bjos-8642673	89	30	whereas	whereas	SCONJ
bjos-8642673	89	31	11.2	11.2	NUM
bjos-8642673	89	32	%	%	NOUN
bjos-8642673	89	33	were	be	AUX
bjos-8642673	89	34	taking	take	VERB
bjos-8642673	89	35	nystatine	nystatine	NOUN
bjos-8642673	89	36	at	at	ADP
bjos-8642673	89	37	the	the	DET
bjos-8642673	89	38	time	time	NOUN
bjos-8642673	89	39	of	of	ADP
bjos-8642673	89	40	this	this	DET
bjos-8642673	89	41	investigation	investigation	NOUN
bjos-8642673	89	42	.	.	PUNCT
bjos-8642673	90	1	furthermore	furthermore	ADV
bjos-8642673	90	2	,	,	PUNCT
bjos-8642673	90	3	from	from	ADP
bjos-8642673	90	4	the	the	DET
bjos-8642673	90	5	39.9	39.9	NUM
bjos-8642673	90	6	%	%	NOUN
bjos-8642673	90	7	individuals	individual	NOUN
bjos-8642673	90	8	with	with	ADP
bjos-8642673	90	9	ec	ec	PROPN
bjos-8642673	90	10	,	,	PUNCT
bjos-8642673	90	11	about	about	ADV
bjos-8642673	90	12	35	35	NUM
bjos-8642673	90	13	%	%	NOUN
bjos-8642673	90	14	were	be	AUX
bjos-8642673	90	15	not	not	PART
bjos-8642673	90	16	taking	take	VERB
bjos-8642673	90	17	any	any	DET
bjos-8642673	90	18	antifungal	antifungal	ADJ
bjos-8642673	90	19	and	and	CCONJ
bjos-8642673	90	20	antiviral	antiviral	ADJ
bjos-8642673	90	21	therapy	therapy	NOUN
bjos-8642673	90	22	while	while	SCONJ
bjos-8642673	90	23	4.9	4.9	NUM
bjos-8642673	90	24	%	%	NOUN
bjos-8642673	90	25	were	be	AUX
bjos-8642673	90	26	on	on	ADP
bjos-8642673	90	27	azoles	azole	NOUN
bjos-8642673	90	28	.	.	PUNCT
bjos-8642673	91	1	finally	finally	ADV
bjos-8642673	91	2	,	,	PUNCT
bjos-8642673	91	3	from	from	ADP
bjos-8642673	91	4	18.8	18.8	NUM
bjos-8642673	91	5	%	%	NOUN
bjos-8642673	91	6	patients	patient	NOUN
bjos-8642673	91	7	with	with	ADP
bjos-8642673	91	8	ac	ac	PROPN
bjos-8642673	91	9	,	,	PUNCT
bjos-8642673	91	10	7.9	7.9	NUM
bjos-8642673	91	11	%	%	NOUN
bjos-8642673	91	12	were	be	AUX
bjos-8642673	91	13	on	on	ADP
bjos-8642673	91	14	unspecified	unspecified	ADJ
bjos-8642673	91	15	anti	anti	ADJ
bjos-8642673	91	16	-	-	ADJ
bjos-8642673	91	17	retroviral	retroviral	ADJ
bjos-8642673	91	18	therapy	therapy	NOUN
bjos-8642673	91	19	and	and	CCONJ
bjos-8642673	91	20	10.9	10.9	NUM
bjos-8642673	91	21	%	%	NOUN
bjos-8642673	91	22	were	be	AUX
bjos-8642673	91	23	on	on	ADP
bjos-8642673	91	24	azoles	azole	NOUN
bjos-8642673	91	25	antifungals	antifungal	NOUN
bjos-8642673	91	26	.	.	PUNCT
bjos-8642673	92	1	therefore	therefore	ADV
bjos-8642673	92	2	,	,	PUNCT
bjos-8642673	92	3	observed	observed	ADJ
bjos-8642673	92	4	increase	increase	NOUN
bjos-8642673	92	5	in	in	ADP
bjos-8642673	92	6	the	the	DET
bjos-8642673	92	7	relative	relative	ADJ
bjos-8642673	92	8	prevalence	prevalence	NOUN
bjos-8642673	92	9	of	of	ADP
bjos-8642673	92	10	candidiasis	candidiasis	NOUN
bjos-8642673	92	11	in	in	ADP
bjos-8642673	92	12	this	this	DET
bjos-8642673	92	13	study	study	NOUN
bjos-8642673	92	14	may	may	AUX
bjos-8642673	92	15	be	be	AUX
bjos-8642673	92	16	due	due	ADJ
bjos-8642673	92	17	to	to	ADP
bjos-8642673	92	18	antifungal	antifungal	ADJ
bjos-8642673	92	19	resistance	resistance	NOUN
bjos-8642673	92	20	and	and	CCONJ
bjos-8642673	92	21	inadequate	inadequate	ADJ
bjos-8642673	92	22	treatment	treatment	NOUN
bjos-8642673	92	23	.	.	PUNCT
bjos-8642673	93	1	proper	proper	ADJ
bjos-8642673	93	2	oral	oral	ADJ
bjos-8642673	93	3	care	care	NOUN
bjos-8642673	93	4	of	of	ADP
bjos-8642673	93	5	patients	patient	NOUN
bjos-8642673	93	6	especially	especially	ADV
bjos-8642673	93	7	in	in	ADP
bjos-8642673	93	8	remote	remote	ADJ
bjos-8642673	93	9	villages	village	NOUN
bjos-8642673	93	10	where	where	SCONJ
bjos-8642673	93	11	taso	taso	NOUN
bjos-8642673	93	12	render	render	VERB
bjos-8642673	93	13	their	their	PRON
bjos-8642673	93	14	services	service	NOUN
bjos-8642673	93	15	once	once	ADV
bjos-8642673	93	16	in	in	ADP
bjos-8642673	93	17	a	a	DET
bjos-8642673	93	18	month	month	NOUN
bjos-8642673	93	19	or	or	CCONJ
bjos-8642673	93	20	two	two	NUM
bjos-8642673	93	21	were	be	AUX
bjos-8642673	93	22	clearly	clearly	ADV
bjos-8642673	93	23	lacking	lacking	ADJ
bjos-8642673	93	24	.	.	PUNCT
bjos-8642673	94	1	this	this	PRON
bjos-8642673	94	2	is	be	AUX
bjos-8642673	94	3	because	because	SCONJ
bjos-8642673	94	4	taso	taso	NOUN
bjos-8642673	94	5	services	service	NOUN
bjos-8642673	94	6	do	do	AUX
bjos-8642673	94	7	not	not	PART
bjos-8642673	94	8	include	include	VERB
bjos-8642673	94	9	routine	routine	ADJ
bjos-8642673	94	10	oral	oral	ADJ
bjos-8642673	94	11	inspection	inspection	NOUN
bjos-8642673	94	12	and	and	CCONJ
bjos-8642673	94	13	care	care	NOUN
bjos-8642673	94	14	of	of	ADP
bjos-8642673	94	15	their	their	PRON
bjos-8642673	94	16	hiv	hiv	PROPN
bjos-8642673	94	17	/	/	SYM
bjos-8642673	94	18	aids	aids	PROPN
bjos-8642673	94	19	patients	patient	NOUN
bjos-8642673	94	20	.	.	PUNCT
bjos-8642673	95	1	inclusion	inclusion	NOUN
bjos-8642673	95	2	of	of	ADP
bjos-8642673	95	3	trained	train	VERB
bjos-8642673	95	4	dental	dental	ADJ
bjos-8642673	95	5	officers	officer	NOUN
bjos-8642673	95	6	among	among	ADP
bjos-8642673	95	7	taso	taso	PROPN
bjos-8642673	95	8	healthcare	healthcare	NOUN
bjos-8642673	95	9	team	team	NOUN
bjos-8642673	95	10	is	be	AUX
bjos-8642673	95	11	hereby	hereby	ADV
bjos-8642673	95	12	recommended	recommend	VERB
bjos-8642673	95	13	.	.	PUNCT
bjos-8642673	96	1	this	this	DET
bjos-8642673	96	2	recommendation	recommendation	NOUN
bjos-8642673	96	3	is	be	AUX
bjos-8642673	96	4	paramount	paramount	ADJ
bjos-8642673	96	5	to	to	ADP
bjos-8642673	96	6	the	the	DET
bjos-8642673	96	7	overall	overall	ADJ
bjos-8642673	96	8	effort	effort	NOUN
bjos-8642673	96	9	in	in	ADP
bjos-8642673	96	10	reduction	reduction	NOUN
bjos-8642673	96	11	of	of	ADP
bjos-8642673	96	12	oral	oral	ADJ
bjos-8642673	96	13	infection	infection	NOUN
bjos-8642673	96	14	among	among	ADP
bjos-8642673	96	15	people	people	NOUN
bjos-8642673	96	16	living	live	VERB
bjos-8642673	96	17	with	with	ADP
bjos-8642673	96	18	hiv	hiv	PROPN
bjos-8642673	96	19	in	in	ADP
bjos-8642673	96	20	uganda	uganda	PROPN
bjos-8642673	96	21	and	and	CCONJ
bjos-8642673	96	22	other	other	ADJ
bjos-8642673	96	23	developing	develop	VERB
bjos-8642673	96	24	resource	resource	NOUN
bjos-8642673	96	25	poor	poor	ADJ
bjos-8642673	96	26	countries	country	NOUN
bjos-8642673	96	27	.	.	PUNCT
bjos-8642673	97	1	in	in	ADP
bjos-8642673	97	2	conclusion	conclusion	NOUN
bjos-8642673	97	3	,	,	PUNCT
bjos-8642673	97	4	oral	oral	ADJ
bjos-8642673	97	5	infections	infection	NOUN
bjos-8642673	97	6	are	be	AUX
bjos-8642673	97	7	still	still	ADV
bjos-8642673	97	8	highly	highly	ADV
bjos-8642673	97	9	prevalent	prevalent	ADJ
bjos-8642673	97	10	among	among	ADP
bjos-8642673	97	11	hiv	hiv	PROPN
bjos-8642673	97	12	/	/	SYM
bjos-8642673	97	13	aids	aids	PROPN
bjos-8642673	97	14	patients	patient	NOUN
bjos-8642673	97	15	in	in	ADP
bjos-8642673	97	16	south	south	ADJ
bjos-8642673	97	17	western	western	ADJ
bjos-8642673	97	18	uganda	uganda	PROPN
bjos-8642673	97	19	.	.	PUNCT
bjos-8642673	98	1	inadequate	inadequate	ADJ
bjos-8642673	98	2	provision	provision	NOUN
bjos-8642673	98	3	of	of	ADP
bjos-8642673	98	4	antimicrobial	antimicrobial	ADJ
bjos-8642673	98	5	agents	agent	NOUN
bjos-8642673	98	6	and	and	CCONJ
bjos-8642673	98	7	absence	absence	NOUN
bjos-8642673	98	8	of	of	ADP
bjos-8642673	98	9	oral	oral	ADJ
bjos-8642673	98	10	and	and	CCONJ
bjos-8642673	98	11	dental	dental	ADJ
bjos-8642673	98	12	care	care	NOUN
bjos-8642673	98	13	were	be	AUX
bjos-8642673	98	14	suggested	suggest	VERB
bjos-8642673	98	15	to	to	PART
bjos-8642673	98	16	have	have	AUX
bjos-8642673	98	17	contributed	contribute	VERB
bjos-8642673	98	18	to	to	PART
bjos-8642673	98	19	upsurge	upsurge	VERB
bjos-8642673	98	20	of	of	ADP
bjos-8642673	98	21	oral	oral	ADJ
bjos-8642673	98	22	infections	infection	NOUN
bjos-8642673	98	23	among	among	ADP
bjos-8642673	98	24	taso	taso	NOUN
bjos-8642673	98	25	patients	patient	NOUN
bjos-8642673	98	26	in	in	ADP
bjos-8642673	98	27	this	this	DET
bjos-8642673	98	28	region	region	NOUN
bjos-8642673	98	29	.	.	PUNCT
bjos-8642673	99	1	increasing	increase	VERB
bjos-8642673	99	2	prevalence	prevalence	NOUN
bjos-8642673	99	3	of	of	ADP
bjos-8642673	99	4	oral	oral	ADJ
bjos-8642673	99	5	candidiasis	candidiasis	NOUN
bjos-8642673	99	6	among	among	ADP
bjos-8642673	99	7	hiv/	hiv/	NOUN
bjos-8642673	99	8	aids	aid	NOUN
bjos-8642673	99	9	patients	patient	NOUN
bjos-8642673	99	10	stresses	stress	VERB
bjos-8642673	99	11	the	the	DET
bjos-8642673	99	12	fact	fact	NOUN
bjos-8642673	99	13	that	that	SCONJ
bjos-8642673	99	14	hiv	hiv	PROPN
bjos-8642673	99	15	/	/	SYM
bjos-8642673	99	16	aids	aids	PROPN
bjos-8642673	99	17	is	be	AUX
bjos-8642673	99	18	still	still	ADV
bjos-8642673	99	19	a	a	DET
bjos-8642673	99	20	terminal	terminal	ADJ
bjos-8642673	99	21	disease	disease	NOUN
bjos-8642673	99	22	especially	especially	ADV
bjos-8642673	99	23	among	among	ADP
bjos-8642673	99	24	people	people	NOUN
bjos-8642673	99	25	living	live	VERB
bjos-8642673	99	26	in	in	ADP
bjos-8642673	99	27	resource	resource	NOUN
bjos-8642673	99	28	poor	poor	ADJ
bjos-8642673	99	29	countries	country	NOUN
bjos-8642673	99	30	.	.	PUNCT
bjos-8642673	100	1	provision	provision	NOUN
bjos-8642673	100	2	of	of	ADP
bjos-8642673	100	3	adequate	adequate	ADJ
bjos-8642673	100	4	resources	resource	NOUN
bjos-8642673	100	5	and	and	CCONJ
bjos-8642673	100	6	qualified	qualified	ADJ
bjos-8642673	100	7	personnel	personnel	NOUN
bjos-8642673	100	8	to	to	PART
bjos-8642673	100	9	warrant	warrant	VERB
bjos-8642673	100	10	in	in	ADP
bjos-8642673	100	11	-	-	PUNCT
bjos-8642673	100	12	depth	depth	NOUN
bjos-8642673	100	13	clinical	clinical	ADJ
bjos-8642673	100	14	and	and	CCONJ
bjos-8642673	100	15	qualitative	qualitative	ADJ
bjos-8642673	100	16	laboratory	laboratory	NOUN
bjos-8642673	100	17	study	study	NOUN
bjos-8642673	100	18	is	be	AUX
bjos-8642673	100	19	supreme	supreme	ADJ
bjos-8642673	100	20	to	to	ADP
bjos-8642673	100	21	achieving	achieve	VERB
bjos-8642673	100	22	the	the	DET
bjos-8642673	100	23	goal	goal	NOUN
bjos-8642673	100	24	of	of	ADP
bjos-8642673	100	25	overall	overall	ADJ
bjos-8642673	100	26	improvement	improvement	NOUN
bjos-8642673	100	27	of	of	ADP
bjos-8642673	100	28	oral	oral	ADJ
bjos-8642673	100	29	health	health	NOUN
bjos-8642673	100	30	condition	condition	NOUN
bjos-8642673	100	31	of	of	ADP
bjos-8642673	100	32	these	these	DET
bjos-8642673	100	33	patients	patient	NOUN
bjos-8642673	100	34	.	.	PUNCT
bjos-8642673	101	1	there	there	PRON
bjos-8642673	101	2	is	be	VERB
bjos-8642673	101	3	an	an	DET
bjos-8642673	101	4	urgent	urgent	ADJ
bjos-8642673	101	5	need	need	NOUN
bjos-8642673	101	6	to	to	PART
bjos-8642673	101	7	train	train	VERB
bjos-8642673	101	8	primary	primary	ADJ
bjos-8642673	101	9	health	health	NOUN
bjos-8642673	101	10	care	care	NOUN
bjos-8642673	101	11	workers	worker	NOUN
bjos-8642673	101	12	in	in	ADP
bjos-8642673	101	13	management	management	NOUN
bjos-8642673	101	14	of	of	ADP
bjos-8642673	101	15	oral	oral	ADJ
bjos-8642673	101	16	lesions	lesion	NOUN
bjos-8642673	101	17	associated	associate	VERB
bjos-8642673	101	18	with	with	ADP
bjos-8642673	101	19	hiv	hiv	PROPN
bjos-8642673	101	20	/	/	SYM
bjos-8642673	101	21	aids	aids	PROPN
bjos-8642673	101	22	.	.	PUNCT
bjos-8642673	102	1	more	more	ADJ
bjos-8642673	102	2	studies	study	NOUN
bjos-8642673	102	3	are	be	AUX
bjos-8642673	102	4	needed	need	VERB
bjos-8642673	102	5	to	to	PART
bjos-8642673	102	6	evaluate	evaluate	VERB
bjos-8642673	102	7	oral	oral	ADJ
bjos-8642673	102	8	lesions	lesion	NOUN
bjos-8642673	102	9	and	and	CCONJ
bjos-8642673	102	10	to	to	PART
bjos-8642673	102	11	assist	assist	VERB
bjos-8642673	102	12	health	health	NOUN
bjos-8642673	102	13	care	care	NOUN
bjos-8642673	102	14	providers	provider	NOUN
bjos-8642673	102	15	in	in	ADP
bjos-8642673	102	16	the	the	DET
bjos-8642673	102	17	early	early	ADJ
bjos-8642673	102	18	detection	detection	NOUN
bjos-8642673	102	19	of	of	ADP
bjos-8642673	102	20	hiv	hiv	PROPN
bjos-8642673	102	21	/	/	SYM
bjos-8642673	102	22	aids	aids	PROPN
bjos-8642673	102	23	in	in	ADP
bjos-8642673	102	24	the	the	DET
bjos-8642673	102	25	studied	studied	ADJ
bjos-8642673	102	26	population	population	NOUN
bjos-8642673	102	27	.	.	PUNCT
bjos-8642673	103	1	acknowledgemen	acknowledgemen	PROPN
bjos-8642673	103	2	t	t	PROPN
bjos-8642673	103	3	this	this	DET
bjos-8642673	103	4	study	study	NOUN
bjos-8642673	103	5	was	be	AUX
bjos-8642673	103	6	supported	support	VERB
bjos-8642673	103	7	in	in	ADP
bjos-8642673	103	8	part	part	NOUN
bjos-8642673	103	9	by	by	ADP
bjos-8642673	103	10	kampala	kampala	PROPN
bjos-8642673	103	11	international	international	PROPN
bjos-8642673	103	12	university	university	PROPN
bjos-8642673	103	13	,	,	PUNCT
bjos-8642673	103	14	western	western	ADJ
bjos-8642673	103	15	campus	campus	NOUN
bjos-8642673	103	16	.	.	PUNCT
bjos-8642673	104	1	we	we	PRON
bjos-8642673	104	2	are	be	AUX
bjos-8642673	104	3	grateful	grateful	ADJ
bjos-8642673	104	4	to	to	ADP
bjos-8642673	104	5	management	management	NOUN
bjos-8642673	104	6	and	and	CCONJ
bjos-8642673	104	7	staff	staff	NOUN
bjos-8642673	104	8	of	of	ADP
bjos-8642673	104	9	the	the	DET
bjos-8642673	104	10	aids	aids	PROPN
bjos-8642673	104	11	support	support	NOUN
bjos-8642673	104	12	organization	organization	NOUN
bjos-8642673	104	13	both	both	CCONJ
bjos-8642673	104	14	at	at	ADP
bjos-8642673	104	15	the	the	DET
bjos-8642673	104	16	headquarters	headquarters	NOUN
bjos-8642673	104	17	in	in	ADP
bjos-8642673	104	18	kampala	kampala	PROPN
bjos-8642673	104	19	and	and	CCONJ
bjos-8642673	104	20	in	in	ADP
bjos-8642673	104	21	the	the	DET
bjos-8642673	104	22	three	three	NUM
bjos-8642673	104	23	centers	center	NOUN
bjos-8642673	104	24	located	locate	VERB
bjos-8642673	104	25	in	in	ADP
bjos-8642673	104	26	south	south	ADJ
bjos-8642673	104	27	western	western	ADJ
bjos-8642673	104	28	uganda	uganda	PROPN
bjos-8642673	104	29	for	for	ADP
bjos-8642673	104	30	their	their	PRON
bjos-8642673	104	31	support	support	NOUN
bjos-8642673	104	32	.	.	PUNCT
bjos-8642673	105	1	we	we	PRON
bjos-8642673	105	2	also	also	ADV
bjos-8642673	105	3	thank	thank	VERB
bjos-8642673	105	4	all	all	DET
bjos-8642673	105	5	taso	taso	NOUN
bjos-8642673	105	6	clients	client	NOUN
bjos-8642673	105	7	whose	whose	DET
bjos-8642673	105	8	consent	consent	NOUN
bjos-8642673	105	9	and	and	CCONJ
bjos-8642673	105	10	participation	participation	NOUN
bjos-8642673	105	11	made	make	VERB
bjos-8642673	105	12	this	this	DET
bjos-8642673	105	13	investigation	investigation	NOUN
bjos-8642673	105	14	possible	possible	ADJ
bjos-8642673	105	15	.	.	PUNCT
bjos-8642673	106	1	refe	refe	PROPN
bjos-8642673	106	2	rence	rence	PROPN
bjos-8642673	106	3	s	s	PART
bjos-8642673	106	4	1	1	NUM
bjos-8642673	106	5	.	.	PUNCT
bjos-8642673	107	1	morgan	morgan	PROPN
bjos-8642673	107	2	d	d	PROPN
bjos-8642673	107	3	,	,	PUNCT
bjos-8642673	107	4	whitworth	whitworth	PROPN
bjos-8642673	107	5	j.	j.	PROPN
bjos-8642673	107	6	the	the	DET
bjos-8642673	107	7	natural	natural	ADJ
bjos-8642673	107	8	history	history	NOUN
bjos-8642673	107	9	of	of	ADP
bjos-8642673	107	10	hiv-1	hiv-1	ADJ
bjos-8642673	107	11	infection	infection	NOUN
bjos-8642673	107	12	in	in	ADP
bjos-8642673	107	13	africa	africa	PROPN
bjos-8642673	107	14	.	.	PUNCT
bjos-8642673	108	1	nat	nat	PROPN
bjos-8642673	108	2	med	med	PROPN
bjos-8642673	108	3	.	.	PUNCT
bjos-8642673	108	4	2001	2001	NUM
bjos-8642673	108	5	;	;	PUNCT
bjos-8642673	108	6	7	7	NUM
bjos-8642673	108	7	:	:	SYM
bjos-8642673	108	8	143	143	NUM
bjos-8642673	108	9	-	-	SYM
bjos-8642673	108	10	5	5	NUM
bjos-8642673	108	11	.	.	NOUN
bjos-8642673	108	12	2	2	NUM
bjos-8642673	108	13	.	.	X
bjos-8642673	108	14	dixon	dixon	PROPN
bjos-8642673	108	15	s	s	PROPN
bjos-8642673	108	16	,	,	PUNCT
bjos-8642673	108	17	mcdonald	mcdonald	PROPN
bjos-8642673	108	18	s	s	PROPN
bjos-8642673	108	19	,	,	PUNCT
bjos-8642673	108	20	roberts	roberts	PROPN
bjos-8642673	108	21	j.	j.	PROPN
bjos-8642673	108	22	the	the	DET
bjos-8642673	108	23	impact	impact	NOUN
bjos-8642673	108	24	of	of	ADP
bjos-8642673	108	25	hiv	hiv	PROPN
bjos-8642673	108	26	and	and	CCONJ
bjos-8642673	108	27	aids	aids	PROPN
bjos-8642673	108	28	on	on	ADP
bjos-8642673	108	29	africa	africa	PROPN
bjos-8642673	108	30	’s	’s	PART
bjos-8642673	108	31	economic	economic	PROPN
bjos-8642673	108	32	development	development	NOUN
bjos-8642673	108	33	.	.	PUNCT
bjos-8642673	109	1	bmj	bmj	PROPN
bjos-8642673	109	2	.	.	PUNCT
bjos-8642673	109	3	2002	2002	NUM
bjos-8642673	109	4	;	;	PUNCT
bjos-8642673	109	5	324	324	NUM
bjos-8642673	109	6	:	:	PUNCT
bjos-8642673	109	7	232	232	NUM
bjos-8642673	109	8	-	-	SYM
bjos-8642673	109	9	4	4	NUM
bjos-8642673	109	10	.	.	NOUN
bjos-8642673	110	1	3	3	NUM
bjos-8642673	110	2	.	.	X
bjos-8642673	110	3	farmer	farmer	PROPN
bjos-8642673	110	4	p	p	NOUN
bjos-8642673	110	5	,	,	PUNCT
bjos-8642673	110	6	leandre	leandre	PROPN
bjos-8642673	110	7	f	f	PROPN
bjos-8642673	110	8	,	,	PUNCT
bjos-8642673	110	9	mukherjee	mukherjee	PROPN
bjos-8642673	110	10	js	js	PROPN
bjos-8642673	110	11	.	.	PUNCT
bjos-8642673	111	1	community	community	NOUN
bjos-8642673	111	2	-	-	PUNCT
bjos-8642673	111	3	based	base	VERB
bjos-8642673	111	4	approaches	approach	NOUN
bjos-8642673	111	5	to	to	ADP
bjos-8642673	111	6	hiv	hiv	PROPN
bjos-8642673	111	7	treatment	treatment	NOUN
bjos-8642673	111	8	in	in	ADP
bjos-8642673	111	9	resource	resource	NOUN
bjos-8642673	111	10	-	-	PUNCT
bjos-8642673	111	11	poor	poor	ADJ
bjos-8642673	111	12	settings	setting	NOUN
bjos-8642673	111	13	.	.	PUNCT
bjos-8642673	112	1	lancet	lancet	PROPN
bjos-8642673	112	2	.	.	PUNCT
bjos-8642673	113	1	2001	2001	NUM
bjos-8642673	113	2	;	;	PUNCT
bjos-8642673	113	3	358	358	NUM
bjos-8642673	113	4	:	:	PUNCT
bjos-8642673	113	5	404	404	NUM
bjos-8642673	113	6	-	-	SYM
bjos-8642673	113	7	9	9	NUM
bjos-8642673	113	8	.	.	NOUN
bjos-8642673	113	9	4	4	NUM
bjos-8642673	113	10	.	.	X
bjos-8642673	113	11	grant	grant	NOUN
bjos-8642673	113	12	ad	ad	NOUN
bjos-8642673	113	13	,	,	PUNCT
bjos-8642673	113	14	djomand	djomand	NOUN
bjos-8642673	113	15	g	g	NOUN
bjos-8642673	113	16	,	,	PUNCT
bjos-8642673	113	17	de	de	X
bjos-8642673	113	18	cock	cock	NOUN
bjos-8642673	113	19	km	km	PROPN
bjos-8642673	113	20	.	.	PUNCT
bjos-8642673	113	21	natural	natural	ADJ
bjos-8642673	113	22	history	history	NOUN
bjos-8642673	113	23	and	and	CCONJ
bjos-8642673	113	24	spectrum	spectrum	NOUN
bjos-8642673	113	25	of	of	ADP
bjos-8642673	113	26	disease	disease	NOUN
bjos-8642673	113	27	in	in	ADP
bjos-8642673	113	28	adults	adult	NOUN
bjos-8642673	113	29	with	with	ADP
bjos-8642673	113	30	hiv	hiv	PROPN
bjos-8642673	113	31	/	/	SYM
bjos-8642673	113	32	aids	aids	PROPN
bjos-8642673	113	33	in	in	ADP
bjos-8642673	113	34	africa	africa	PROPN
bjos-8642673	113	35	.	.	PUNCT
bjos-8642673	114	1	aids	aids	PROPN
bjos-8642673	114	2	1997	1997	NUM
bjos-8642673	114	3	;	;	PUNCT
bjos-8642673	114	4	11	11	NUM
bjos-8642673	114	5	:	:	PUNCT
bjos-8642673	114	6	s43–54	s43–54	NOUN
bjos-8642673	114	7	.	.	NOUN
bjos-8642673	114	8	5	5	NUM
bjos-8642673	114	9	.	.	X
bjos-8642673	114	10	arendorf	arendorf	PROPN
bjos-8642673	114	11	tm	tm	PROPN
bjos-8642673	114	12	,	,	PUNCT
bjos-8642673	114	13	bredekamp	bredekamp	PROPN
bjos-8642673	114	14	b	b	NOUN
bjos-8642673	114	15	,	,	PUNCT
bjos-8642673	114	16	cloete	cloete	ADJ
bjos-8642673	114	17	cac	cac	PROPN
bjos-8642673	114	18	,	,	PUNCT
bjos-8642673	114	19	sauer	sauer	PROPN
bjos-8642673	114	20	g.	g.	PROPN
bjos-8642673	114	21	oral	oral	ADJ
bjos-8642673	114	22	manifestations	manifestation	NOUN
bjos-8642673	114	23	of	of	ADP
bjos-8642673	114	24	hiv	hiv	PROPN
bjos-8642673	114	25	infection	infection	NOUN
bjos-8642673	114	26	in	in	ADP
bjos-8642673	114	27	600	600	NUM
bjos-8642673	114	28	south	south	ADJ
bjos-8642673	114	29	african	african	ADJ
bjos-8642673	114	30	patients	patient	NOUN
bjos-8642673	114	31	.	.	PUNCT
bjos-8642673	115	1	j	j	PROPN
bjos-8642673	115	2	oral	oral	ADJ
bjos-8642673	115	3	pathol	pathol	NOUN
bjos-8642673	115	4	med	me	VERB
bjos-8642673	115	5	.	.	PUNCT
bjos-8642673	115	6	1998	1998	NUM
bjos-8642673	115	7	;	;	PUNCT
bjos-8642673	115	8	27	27	NUM
bjos-8642673	115	9	:	:	SYM
bjos-8642673	115	10	176	176	NUM
bjos-8642673	115	11	-	-	SYM
bjos-8642673	115	12	9	9	NUM
bjos-8642673	115	13	.	.	NOUN
bjos-8642673	115	14	6	6	NUM
bjos-8642673	115	15	.	.	X
bjos-8642673	116	1	patton	patton	PROPN
bjos-8642673	116	2	ll	ll	PROPN
bjos-8642673	116	3	,	,	PUNCT
bjos-8642673	116	4	phelan	phelan	PROPN
bjos-8642673	116	5	ja	ja	PROPN
bjos-8642673	116	6	,	,	PUNCT
bjos-8642673	116	7	ramos	ramos	PROPN
bjos-8642673	116	8	-	-	PROPN
bjos-8642673	116	9	gomez	gomez	PROPN
bjos-8642673	116	10	fj	fj	PROPN
bjos-8642673	116	11	,	,	PUNCT
bjos-8642673	116	12	nittayananta	nittayananta	PROPN
bjos-8642673	116	13	w	w	PROPN
bjos-8642673	116	14	,	,	PUNCT
bjos-8642673	116	15	shiboski	shiboski	PROPN
bjos-8642673	116	16	ch	ch	PROPN
bjos-8642673	116	17	,	,	PUNCT
bjos-8642673	116	18	mbuguye	mbuguye	PROPN
bjos-8642673	116	19	tl	tl	PROPN
bjos-8642673	116	20	.	.	PUNCT
bjos-8642673	117	1	prevalence	prevalence	NOUN
bjos-8642673	117	2	and	and	CCONJ
bjos-8642673	117	3	classification	classification	NOUN
bjos-8642673	117	4	of	of	ADP
bjos-8642673	117	5	hivassociated	hivassociated	ADJ
bjos-8642673	117	6	oral	oral	ADJ
bjos-8642673	117	7	lesions	lesion	NOUN
bjos-8642673	117	8	.	.	PUNCT
bjos-8642673	118	1	oral	oral	ADJ
bjos-8642673	118	2	dis	dis	PROPN
bjos-8642673	118	3	.	.	PUNCT
bjos-8642673	119	1	2002	2002	NUM
bjos-8642673	119	2	;	;	PUNCT
bjos-8642673	119	3	82:98	82:98	NUM
bjos-8642673	119	4	-	-	SYM
bjos-8642673	119	5	109	109	NUM
bjos-8642673	119	6	.	.	PUNCT
bjos-8642673	120	1	7	7	X
bjos-8642673	120	2	.	.	X
bjos-8642673	120	3	greenspan	greenspan	PROPN
bjos-8642673	120	4	js	js	PROPN
bjos-8642673	120	5	,	,	PUNCT
bjos-8642673	120	6	greenspan	greenspan	PROPN
bjos-8642673	120	7	d.	d.	PROPN
bjos-8642673	120	8	the	the	DET
bjos-8642673	120	9	epidemiology	epidemiology	NOUN
bjos-8642673	120	10	of	of	ADP
bjos-8642673	120	11	the	the	DET
bjos-8642673	120	12	oral	oral	ADJ
bjos-8642673	120	13	lesions	lesion	NOUN
bjos-8642673	120	14	of	of	ADP
bjos-8642673	120	15	hiv	hiv	PROPN
bjos-8642673	120	16	infection	infection	NOUN
bjos-8642673	120	17	in	in	ADP
bjos-8642673	120	18	the	the	DET
bjos-8642673	120	19	developed	developed	ADJ
bjos-8642673	120	20	world	world	NOUN
bjos-8642673	120	21	.	.	PUNCT
bjos-8642673	121	1	oral	oral	ADJ
bjos-8642673	121	2	dis	dis	PROPN
bjos-8642673	121	3	.	.	PUNCT
bjos-8642673	122	1	2002	2002	NUM
bjos-8642673	122	2	,	,	PUNCT
bjos-8642673	122	3	8	8	NUM
bjos-8642673	122	4	suppl	suppl	NOUN
bjos-8642673	122	5	2	2	NUM
bjos-8642673	122	6	:	:	SYM
bjos-8642673	122	7	34	34	NUM
bjos-8642673	122	8	-	-	SYM
bjos-8642673	122	9	9	9	NUM
bjos-8642673	122	10	.	.	NOUN
bjos-8642673	122	11	8	8	NUM
bjos-8642673	122	12	.	.	PUNCT
bjos-8642673	123	1	hodgson	hodgson	PROPN
bjos-8642673	123	2	ta	ta	PROPN
bjos-8642673	123	3	,	,	PUNCT
bjos-8642673	123	4	naidoo	naidoo	PROPN
bjos-8642673	123	5	s	s	PROPN
bjos-8642673	123	6	,	,	PUNCT
bjos-8642673	123	7	chidzonga	chidzonga	PROPN
bjos-8642673	123	8	m	m	PROPN
bjos-8642673	123	9	,	,	PUNCT
bjos-8642673	123	10	ramos	ramos	PROPN
bjos-8642673	123	11	gomez	gomez	PROPN
bjos-8642673	123	12	f	f	PROPN
bjos-8642673	123	13	,	,	PUNCT
bjos-8642673	123	14	shiboski	shiboski	PROPN
bjos-8642673	123	15	c.	c.	PROPN
bjos-8642673	123	16	identification	identification	NOUN
bjos-8642673	123	17	of	of	ADP
bjos-8642673	123	18	oral	oral	ADJ
bjos-8642673	123	19	health	health	NOUN
bjos-8642673	123	20	care	care	NOUN
bjos-8642673	123	21	needs	need	NOUN
bjos-8642673	123	22	in	in	ADP
bjos-8642673	123	23	children	child	NOUN
bjos-8642673	123	24	and	and	CCONJ
bjos-8642673	123	25	adults	adult	NOUN
bjos-8642673	123	26	,	,	PUNCT
bjos-8642673	123	27	management	management	NOUN
bjos-8642673	123	28	of	of	ADP
bjos-8642673	123	29	oral	oral	ADJ
bjos-8642673	123	30	diseases	disease	NOUN
bjos-8642673	123	31	.	.	PUNCT
bjos-8642673	124	1	proceedings	proceeding	NOUN
bjos-8642673	124	2	of	of	ADP
bjos-8642673	124	3	the	the	DET
bjos-8642673	124	4	5th	5th	ADJ
bjos-8642673	124	5	world	world	NOUN
bjos-8642673	124	6	workshop	workshop	NOUN
bjos-8642673	124	7	on	on	ADP
bjos-8642673	124	8	oral	oral	ADJ
bjos-8642673	124	9	health	health	NOUN
bjos-8642673	124	10	and	and	CCONJ
bjos-8642673	124	11	disease	disease	NOUN
bjos-8642673	124	12	in	in	ADP
bjos-8642673	124	13	aids	aids	PROPN
bjos-8642673	124	14	,	,	PUNCT
bjos-8642673	124	15	july	july	PROPN
bjos-8642673	124	16	6–9	6–9	PROPN
bjos-8642673	124	17	,	,	PUNCT
bjos-8642673	124	18	2004	2004	NUM
bjos-8642673	124	19	,	,	PUNCT
bjos-8642673	124	20	phuket	phuket	NOUN
bjos-8642673	124	21	,	,	PUNCT
bjos-8642673	124	22	thailand	thailand	PROPN
bjos-8642673	124	23	.	.	PUNCT
bjos-8642673	124	24	advances	advance	NOUN
bjos-8642673	124	25	in	in	ADP
bjos-8642673	124	26	dental	dental	ADJ
bjos-8642673	124	27	research	research	NOUN
bjos-8642673	124	28	;	;	PUNCT
bjos-8642673	124	29	2005	2005	NUM
bjos-8642673	124	30	.	.	PUNCT
bjos-8642673	125	1	9	9	X
bjos-8642673	125	2	.	.	X
bjos-8642673	125	3	scully	scully	PROPN
bjos-8642673	125	4	c	c	AUX
bjos-8642673	125	5	,	,	PUNCT
bjos-8642673	125	6	laskaris	laskaris	VERB
bjos-8642673	125	7	g	g	NOUN
bjos-8642673	125	8	,	,	PUNCT
bjos-8642673	125	9	porter	porter	PROPN
bjos-8642673	125	10	sr	sr	PROPN
bjos-8642673	125	11	.	.	PUNCT
bjos-8642673	126	1	oral	oral	ADJ
bjos-8642673	126	2	manifestations	manifestation	NOUN
bjos-8642673	126	3	of	of	ADP
bjos-8642673	126	4	hiv	hiv	PROPN
bjos-8642673	126	5	infection	infection	NOUN
bjos-8642673	126	6	and	and	CCONJ
bjos-8642673	126	7	their	their	PRON
bjos-8642673	126	8	management	management	NOUN
bjos-8642673	126	9	.	.	PUNCT
bjos-8642673	127	1	i	i	PRON
bjos-8642673	127	2	:	:	PUNCT
bjos-8642673	127	3	more	more	ADV
bjos-8642673	127	4	common	common	ADJ
bjos-8642673	127	5	lesions	lesion	NOUN
bjos-8642673	127	6	.	.	PUNCT
bjos-8642673	128	1	oral	oral	ADJ
bjos-8642673	128	2	surg	surg	NOUN
bjos-8642673	128	3	oral	oral	ADJ
bjos-8642673	128	4	med	med	ADJ
bjos-8642673	128	5	oral	oral	ADJ
bjos-8642673	128	6	pathol	pathol	NOUN
bjos-8642673	128	7	1991	1991	NUM
bjos-8642673	128	8	,	,	PUNCT
bjos-8642673	128	9	71	71	NUM
bjos-8642673	128	10	:	:	SYM
bjos-8642673	128	11	158	158	NUM
bjos-8642673	128	12	-	-	SYM
bjos-8642673	128	13	66	66	NUM
bjos-8642673	128	14	.	.	PUNCT
bjos-8642673	129	1	10	10	NUM
bjos-8642673	129	2	.	.	PUNCT
bjos-8642673	130	1	marsh	marsh	PROPN
bjos-8642673	130	2	,	,	PUNCT
bjos-8642673	130	3	pd	pd	PROPN
bjos-8642673	130	4	,	,	PUNCT
bjos-8642673	130	5	martin	martin	PROPN
bjos-8642673	130	6	mv	mv	PROPN
bjos-8642673	130	7	.	.	PROPN
bjos-8642673	130	8	oral	oral	ADJ
bjos-8642673	130	9	microbiology	microbiology	NOUN
bjos-8642673	130	10	.	.	PUNCT
bjos-8642673	131	1	3rd	3rd	ADJ
bjos-8642673	131	2	ed	ed	NOUN
bjos-8642673	131	3	..	..	PUNCT
bjos-8642673	131	4	london	london	PROPN
bjos-8642673	131	5	:	:	PUNCT
bjos-8642673	131	6	charpman	charpman	NOUN
bjos-8642673	131	7	and	and	CCONJ
bjos-8642673	131	8	hall	hall	PROPN
bjos-8642673	131	9	;	;	PUNCT
bjos-8642673	131	10	1992	1992	NUM
bjos-8642673	131	11	.	.	PUNCT
bjos-8642673	132	1	11	11	NUM
bjos-8642673	132	2	.	.	X
bjos-8642673	132	3	11	11	NUM
bjos-8642673	132	4	,	,	PUNCT
bjos-8642673	132	5	muwazi	muwazi	PROPN
bjos-8642673	132	6	lm	lm	PROPN
bjos-8642673	132	7	,	,	PUNCT
bjos-8642673	132	8	rwenyonyi	rwenyonyi	NOUN
bjos-8642673	132	9	cm	cm	PROPN
bjos-8642673	132	10	,	,	PUNCT
bjos-8642673	132	11	tirwomwe	tirwomwe	PROPN
bjos-8642673	132	12	jf	jf	PROPN
bjos-8642673	132	13	,	,	PUNCT
bjos-8642673	132	14	ssali	ssali	VERB
bjos-8642673	132	15	c	c	PROPN
bjos-8642673	132	16	,	,	PUNCT
bjos-8642673	132	17	kasangaki	kasangaki	PROPN
bjos-8642673	132	18	a	a	X
bjos-8642673	132	19	,	,	PUNCT
bjos-8642673	132	20	nkamba	nkamba	VERB
bjos-8642673	132	21	me	i	PRON
bjos-8642673	132	22	et	et	PROPN
bjos-8642673	132	23	al	al	PROPN
bjos-8642673	132	24	.	.	PUNCT
bjos-8642673	133	1	prevalence	prevalence	NOUN
bjos-8642673	133	2	of	of	ADP
bjos-8642673	133	3	oral	oral	ADJ
bjos-8642673	133	4	diseases/	diseases/	NUM
bjos-8642673	133	5	conditions	condition	NOUN
bjos-8642673	133	6	in	in	ADP
bjos-8642673	133	7	uganda	uganda	PROPN
bjos-8642673	133	8	.	.	PUNCT
bjos-8642673	134	1	afr	afr	PROPN
bjos-8642673	134	2	health	health	PROPN
bjos-8642673	134	3	sci	sci	PROPN
bjos-8642673	134	4	.	.	PROPN
bjos-8642673	134	5	2005	2005	NUM
bjos-8642673	134	6	;	;	PUNCT
bjos-8642673	134	7	5	5	NUM
bjos-8642673	134	8	:	:	SYM
bjos-8642673	134	9	227	227	NUM
bjos-8642673	134	10	-	-	SYM
bjos-8642673	134	11	33	33	NUM
bjos-8642673	134	12	.	.	PUNCT
bjos-8642673	135	1	12	12	NUM
bjos-8642673	135	2	.	.	PUNCT
bjos-8642673	136	1	tirwomwe	tirwomwe	PROPN
bjos-8642673	136	2	jf	jf	PROPN
bjos-8642673	136	3	,	,	PUNCT
bjos-8642673	136	4	rwenyonyi	rwenyonyi	PROPN
bjos-8642673	136	5	cm	cm	PROPN
bjos-8642673	136	6	,	,	PUNCT
bjos-8642673	136	7	muwazi	muwazi	PROPN
bjos-8642673	136	8	lm	lm	PROPN
bjos-8642673	136	9	,	,	PUNCT
bjos-8642673	136	10	besigye	besigye	PROPN
bjos-8642673	136	11	b	b	PROPN
bjos-8642673	136	12	,	,	PUNCT
bjos-8642673	136	13	amboli	amboli	PROPN
bjos-8642673	136	14	f.	f.	PROPN
bjos-8642673	136	15	oral	oral	PROPN
bjos-8642673	136	16	manifestation	manifestation	NOUN
bjos-8642673	136	17	of	of	ADP
bjos-8642673	136	18	hiv	hiv	PROPN
bjos-8642673	136	19	/	/	SYM
bjos-8642673	136	20	aids	aids	PROPN
bjos-8642673	136	21	in	in	ADP
bjos-8642673	136	22	clients	client	NOUN
bjos-8642673	136	23	attending	attend	VERB
bjos-8642673	136	24	taso	taso	NOUN
bjos-8642673	136	25	clinics	clinic	NOUN
bjos-8642673	136	26	in	in	ADP
bjos-8642673	136	27	uganda	uganda	PROPN
bjos-8642673	136	28	.	.	PUNCT
bjos-8642673	137	1	clin	clin	PROPN
bjos-8642673	137	2	oral	oral	PROPN
bjos-8642673	137	3	investig	investig	PROPN
bjos-8642673	137	4	.	.	PROPN
bjos-8642673	137	5	2007	2007	NUM
bjos-8642673	137	6	;	;	PUNCT
bjos-8642673	138	1	11	11	NUM
bjos-8642673	138	2	:	:	SYM
bjos-8642673	138	3	289	289	NUM
bjos-8642673	138	4	-	-	SYM
bjos-8642673	138	5	92	92	NUM
bjos-8642673	138	6	.	.	PUNCT
bjos-8642673	138	7	13	13	NUM
bjos-8642673	138	8	.	.	PUNCT
bjos-8642673	139	1	ec	ec	NOUN
bjos-8642673	139	2	-	-	PUNCT
bjos-8642673	139	3	clearinghouse	clearinghouse	NOUN
bjos-8642673	139	4	on	on	ADP
bjos-8642673	139	5	oral	oral	ADJ
bjos-8642673	139	6	problems	problem	NOUN
bjos-8642673	139	7	related	relate	VERB
bjos-8642673	139	8	to	to	ADP
bjos-8642673	139	9	hiv	hiv	PROPN
bjos-8642673	139	10	infection	infection	NOUN
bjos-8642673	139	11	and	and	CCONJ
bjos-8642673	139	12	who	who	PRON
bjos-8642673	139	13	collaborating	collaborate	VERB
bjos-8642673	139	14	centre	centre	NOUN
bjos-8642673	139	15	on	on	ADP
bjos-8642673	139	16	oral	oral	ADJ
bjos-8642673	139	17	manifestations	manifestation	NOUN
bjos-8642673	139	18	of	of	ADP
bjos-8642673	139	19	the	the	DET
bjos-8642673	139	20	human	human	ADJ
bjos-8642673	139	21	immunodeficiency	immunodeficiency	NOUN
bjos-8642673	139	22	virus	virus	NOUN
bjos-8642673	139	23	.	.	PUNCT
bjos-8642673	140	1	classification	classification	NOUN
bjos-8642673	140	2	and	and	CCONJ
bjos-8642673	140	3	diagnostic	diagnostic	ADJ
bjos-8642673	140	4	criteria	criterion	NOUN
bjos-8642673	140	5	for	for	ADP
bjos-8642673	140	6	oral	oral	ADJ
bjos-8642673	140	7	lesions	lesion	NOUN
bjos-8642673	140	8	in	in	ADP
bjos-8642673	140	9	hiv	hiv	PROPN
bjos-8642673	140	10	infection	infection	NOUN
bjos-8642673	140	11	.	.	PUNCT
bjos-8642673	141	1	j	j	PROPN
bjos-8642673	141	2	oral	oral	ADJ
bjos-8642673	141	3	pathol	pathol	NOUN
bjos-8642673	141	4	med	me	VERB
bjos-8642673	141	5	.	.	PUNCT
bjos-8642673	141	6	1993	1993	NUM
bjos-8642673	141	7	,	,	PUNCT
bjos-8642673	141	8	22	22	NUM
bjos-8642673	141	9	:	:	SYM
bjos-8642673	141	10	289	289	NUM
bjos-8642673	141	11	-	-	SYM
bjos-8642673	141	12	291	291	NUM
bjos-8642673	141	13	.	.	PUNCT
bjos-8642673	142	1	14	14	NUM
bjos-8642673	142	2	.	.	PUNCT
bjos-8642673	143	1	hodgson	hodgson	PROPN
bjos-8642673	143	2	ta	ta	PROPN
bjos-8642673	143	3	,	,	PUNCT
bjos-8642673	143	4	rachanis	rachanis	PROPN
bjos-8642673	143	5	cc	cc	PROPN
bjos-8642673	143	6	.	.	PROPN
bjos-8642673	143	7	oral	oral	ADJ
bjos-8642673	143	8	fungal	fungal	ADJ
bjos-8642673	143	9	and	and	CCONJ
bjos-8642673	143	10	bacterial	bacterial	ADJ
bjos-8642673	143	11	infection	infection	NOUN
bjos-8642673	143	12	in	in	ADP
bjos-8642673	143	13	hiv	hiv	PROPN
bjos-8642673	143	14	infected	infect	VERB
bjos-8642673	143	15	individuals	individual	NOUN
bjos-8642673	143	16	,	,	PUNCT
bjos-8642673	143	17	an	an	DET
bjos-8642673	143	18	overview	overview	NOUN
bjos-8642673	143	19	in	in	ADP
bjos-8642673	143	20	africa	africa	PROPN
bjos-8642673	143	21	.	.	PUNCT
bjos-8642673	144	1	oral	oral	ADJ
bjos-8642673	144	2	dis	dis	PROPN
bjos-8642673	144	3	.	.	PUNCT
bjos-8642673	145	1	2002	2002	NUM
bjos-8642673	145	2	,	,	PUNCT
bjos-8642673	145	3	8(suppl	8(suppl	PROPN
bjos-8642673	145	4	2	2	NUM
bjos-8642673	145	5	):	):	PUNCT
bjos-8642673	145	6	80	80	NUM
bjos-8642673	145	7	-	-	SYM
bjos-8642673	145	8	7	7	NUM
bjos-8642673	145	9	.	.	NOUN
bjos-8642673	145	10	15	15	NUM
bjos-8642673	145	11	.	.	PUNCT
bjos-8642673	146	1	patton	patton	PROPN
bjos-8642673	146	2	ll	ll	PROPN
bjos-8642673	146	3	,	,	PUNCT
bjos-8642673	146	4	mckaig	mckaig	ADJ
bjos-8642673	146	5	r	r	NOUN
bjos-8642673	146	6	,	,	PUNCT
bjos-8642673	146	7	straauss	straauss	ADJ
bjos-8642673	146	8	r	r	NOUN
bjos-8642673	146	9	,	,	PUNCT
bjos-8642673	146	10	rogers	rogers	PROPN
bjos-8642673	146	11	d	d	PROPN
bjos-8642673	146	12	,	,	PUNCT
bjos-8642673	146	13	enron	enron	PROPN
bjos-8642673	146	14	jj	jj	PROPN
bjos-8642673	146	15	jr	jr	PROPN
bjos-8642673	146	16	.	.	PUNCT
bjos-8642673	147	1	changing	change	VERB
bjos-8642673	147	2	prevalence	prevalence	NOUN
bjos-8642673	147	3	of	of	ADP
bjos-8642673	147	4	oral	oral	ADJ
bjos-8642673	147	5	manifestations	manifestation	NOUN
bjos-8642673	147	6	of	of	ADP
bjos-8642673	147	7	human	human	ADJ
bjos-8642673	147	8	immunodeficiency	immunodeficiency	NOUN
bjos-8642673	147	9	virus	virus	NOUN
bjos-8642673	147	10	in	in	ADP
bjos-8642673	147	11	the	the	DET
bjos-8642673	147	12	era	era	NOUN
bjos-8642673	147	13	of	of	ADP
bjos-8642673	147	14	protease	protease	NOUN
bjos-8642673	147	15	inhibitor	inhibitor	NOUN
bjos-8642673	147	16	therapy	therapy	NOUN
bjos-8642673	147	17	.	.	PUNCT
bjos-8642673	148	1	oral	oral	ADJ
bjos-8642673	148	2	surg	surg	NOUN
bjos-8642673	148	3	oral	oral	ADJ
bjos-8642673	148	4	med	med	ADJ
bjos-8642673	148	5	oral	oral	ADJ
bjos-8642673	148	6	pathol	pathol	NOUN
bjos-8642673	148	7	oral	oral	ADJ
bjos-8642673	148	8	radiol	radiol	NOUN
bjos-8642673	148	9	endod	endod	PROPN
bjos-8642673	148	10	.	.	PUNCT
bjos-8642673	149	1	2000	2000	NUM
bjos-8642673	149	2	,	,	PUNCT
bjos-8642673	149	3	90:299	90:299	NUM
bjos-8642673	149	4	-	-	SYM
bjos-8642673	149	5	304	304	NUM
bjos-8642673	149	6	.	.	PUNCT
bjos-8642673	150	1	16	16	NUM
bjos-8642673	150	2	.	.	PUNCT
bjos-8642673	151	1	mayanja	mayanja	PROPN
bjos-8642673	151	2	b	b	PROPN
bjos-8642673	151	3	,	,	PUNCT
bjos-8642673	151	4	morgan	morgan	PROPN
bjos-8642673	151	5	d	d	PROPN
bjos-8642673	151	6	,	,	PUNCT
bjos-8642673	151	7	ross	ross	PROPN
bjos-8642673	151	8	a	a	PRON
bjos-8642673	151	9	,	,	PUNCT
bjos-8642673	151	10	whitworth	whitworth	PROPN
bjos-8642673	151	11	j.	j.	PROPN
bjos-8642673	151	12	the	the	DET
bjos-8642673	151	13	burden	burden	NOUN
bjos-8642673	151	14	of	of	ADP
bjos-8642673	151	15	mucocutaneous	mucocutaneous	ADJ
bjos-8642673	151	16	conditions	condition	NOUN
bjos-8642673	151	17	and	and	CCONJ
bjos-8642673	151	18	the	the	DET
bjos-8642673	151	19	association	association	NOUN
bjos-8642673	151	20	with	with	ADP
bjos-8642673	151	21	hiv-1	hiv-1	ADJ
bjos-8642673	151	22	infection	infection	NOUN
bjos-8642673	151	23	in	in	ADP
bjos-8642673	151	24	a	a	DET
bjos-8642673	151	25	rural	rural	ADJ
bjos-8642673	151	26	community	community	NOUN
bjos-8642673	151	27	in	in	ADP
bjos-8642673	151	28	uganda	uganda	PROPN
bjos-8642673	151	29	.	.	PUNCT
bjos-8642673	152	1	trop	trop	PROPN
bjos-8642673	152	2	med	med	PROPN
bjos-8642673	152	3	int	int	PROPN
bjos-8642673	152	4	health	health	PROPN
bjos-8642673	152	5	1999	1999	NUM
bjos-8642673	152	6	,	,	PUNCT
bjos-8642673	152	7	4	4	NUM
bjos-8642673	152	8	:	:	SYM
bjos-8642673	152	9	349	349	NUM
bjos-8642673	152	10	-	-	SYM
bjos-8642673	152	11	34	34	NUM
bjos-8642673	152	12	.	.	PUNCT
bjos-8642673	152	13	17	17	NUM
bjos-8642673	152	14	.	.	PUNCT
bjos-8642673	153	1	lattif	lattif	VERB
bjos-8642673	153	2	aa	aa	PROPN
bjos-8642673	153	3	,	,	PUNCT
bjos-8642673	153	4	banerjee	banerjee	PROPN
bjos-8642673	153	5	u	u	PROPN
bjos-8642673	153	6	,	,	PUNCT
bjos-8642673	153	7	prasad	prasad	PROPN
bjos-8642673	153	8	r	r	PROPN
bjos-8642673	153	9	,	,	PUNCT
bjos-8642673	153	10	biswas	biswas	PROPN
bjos-8642673	153	11	a	a	NOUN
bjos-8642673	153	12	,	,	PUNCT
bjos-8642673	153	13	wig	wig	NOUN
bjos-8642673	153	14	n	n	CCONJ
bjos-8642673	153	15	,	,	PUNCT
bjos-8642673	153	16	sharma	sharma	PROPN
bjos-8642673	153	17	n	n	CCONJ
bjos-8642673	153	18	,	,	PUNCT
bjos-8642673	153	19	haque	haque	PROPN
bjos-8642673	153	20	et	et	PROPN
bjos-8642673	153	21	al	al	PROPN
bjos-8642673	153	22	.	.	PROPN
bjos-8642673	153	23	susceptibility	susceptibility	NOUN
bjos-8642673	153	24	pattern	pattern	NOUN
bjos-8642673	153	25	and	and	CCONJ
bjos-8642673	153	26	molecular	molecular	ADJ
bjos-8642673	153	27	type	type	NOUN
bjos-8642673	153	28	of	of	ADP
bjos-8642673	153	29	braz	braz	PROPN
bjos-8642673	153	30	j	j	PROPN
bjos-8642673	153	31	oral	oral	PROPN
bjos-8642673	153	32	sci	sci	PROPN
bjos-8642673	153	33	.	.	PUNCT
bjos-8642673	154	1	7(26):1591	7(26):1591	NUM
bjos-8642673	154	2	-	-	SYM
bjos-8642673	154	3	1595	1595	NUM
bjos-8642673	154	4	appraisal	appraisal	NOUN
bjos-8642673	154	5	of	of	ADP
bjos-8642673	154	6	oral	oral	ADJ
bjos-8642673	154	7	lesions	lesion	NOUN
bjos-8642673	154	8	status	status	NOUN
bjos-8642673	154	9	of	of	ADP
bjos-8642673	154	10	hiv	hiv	PROPN
bjos-8642673	154	11	/	/	SYM
bjos-8642673	154	12	aids	aids	PROPN
bjos-8642673	154	13	patients	patient	NOUN
bjos-8642673	154	14	in	in	ADP
bjos-8642673	154	15	south	south	ADJ
bjos-8642673	154	16	western	western	ADJ
bjos-8642673	154	17	uganda	uganda	PROPN
bjos-8642673	154	18	1595	1595	NUM
bjos-8642673	154	19	species	species	NOUN
bjos-8642673	154	20	-	-	PUNCT
bjos-8642673	154	21	specific	specific	ADJ
bjos-8642673	154	22	candida	candida	NOUN
bjos-8642673	154	23	in	in	ADP
bjos-8642673	154	24	oropharyngeal	oropharyngeal	ADJ
bjos-8642673	154	25	lesions	lesion	NOUN
bjos-8642673	154	26	of	of	ADP
bjos-8642673	154	27	indian	indian	ADJ
bjos-8642673	154	28	human	human	ADJ
bjos-8642673	154	29	immunodeficiency	immunodeficiency	NOUN
bjos-8642673	154	30	virus	virus	NOUN
bjos-8642673	154	31	-	-	PUNCT
bjos-8642673	154	32	positive	positive	ADJ
bjos-8642673	154	33	patients	patient	NOUN
bjos-8642673	154	34	.	.	PUNCT
bjos-8642673	155	1	j	j	PROPN
bjos-8642673	155	2	clin	clin	PROPN
bjos-8642673	155	3	microbiol	microbiol	PROPN
bjos-8642673	155	4	2004	2004	NUM
bjos-8642673	155	5	,	,	PUNCT
bjos-8642673	155	6	42	42	NUM
bjos-8642673	155	7	:	:	SYM
bjos-8642673	155	8	1260	1260	NUM
bjos-8642673	155	9	-	-	SYM
bjos-8642673	155	10	2	2	NUM
bjos-8642673	155	11	.	.	NOUN
bjos-8642673	155	12	18	18	NUM
bjos-8642673	155	13	.	.	X
bjos-8642673	156	1	fidel	fidel	PROPN
bjos-8642673	156	2	pl	pl	PROPN
bjos-8642673	156	3	jr	jr	PROPN
bjos-8642673	156	4	.	.	PROPN
bjos-8642673	156	5	immunity	immunity	NOUN
bjos-8642673	156	6	to	to	ADP
bjos-8642673	156	7	candida	candida	PROPN
bjos-8642673	156	8	.	.	PUNCT
bjos-8642673	157	1	oral	oral	ADJ
bjos-8642673	157	2	dis	dis	PROPN
bjos-8642673	157	3	.	.	PUNCT
bjos-8642673	158	1	2002	2002	NUM
bjos-8642673	158	2	,	,	PUNCT
bjos-8642673	158	3	8:69	8:69	NUM
bjos-8642673	158	4	-	-	SYM
bjos-8642673	158	5	75	75	NUM
bjos-8642673	158	6	19	19	NUM
bjos-8642673	158	7	.	.	PUNCT
bjos-8642673	158	8	umadevi	umadevi	ADJ
bjos-8642673	158	9	m.	m.	NOUN
bjos-8642673	158	10	,	,	PUNCT
bjos-8642673	158	11	adeyemi	adeyemi	ADV
bjos-8642673	158	12	pm	pm	NOUN
bjos-8642673	158	13	,	,	PUNCT
bjos-8642673	158	14	reichart	reichart	PROPN
bjos-8642673	158	15	pa	pa	PROPN
bjos-8642673	158	16	,	,	PUNCT
bjos-8642673	158	17	robinson	robinson	PROPN
bjos-8642673	158	18	pg	pg	PROPN
bjos-8642673	158	19	.	.	PUNCT
bjos-8642673	159	1	periodontal	periodontal	ADJ
bjos-8642673	159	2	diseases	disease	NOUN
bjos-8642673	159	3	and	and	CCONJ
bjos-8642673	159	4	other	other	ADJ
bjos-8642673	159	5	bacterial	bacterial	ADJ
bjos-8642673	159	6	infections	infection	NOUN
bjos-8642673	159	7	.	.	PUNCT
bjos-8642673	160	1	adv	adv	PROPN
bjos-8642673	160	2	dent	dent	NOUN
bjos-8642673	160	3	res	re	NOUN
bjos-8642673	160	4	.	.	PUNCT
bjos-8642673	161	1	2006	2006	NUM
bjos-8642673	161	2	,	,	PUNCT
bjos-8642673	161	3	19	19	NUM
bjos-8642673	161	4	:	:	SYM
bjos-8642673	161	5	139	139	NUM
bjos-8642673	161	6	-	-	SYM
bjos-8642673	161	7	45	45	NUM
bjos-8642673	161	8	.	.	NOUN
bjos-8642673	161	9	20	20	NUM
bjos-8642673	161	10	.	.	PUNCT
bjos-8642673	162	1	jonsson	jonsson	PROPN
bjos-8642673	162	2	n	n	PROPN
bjos-8642673	162	3	,	,	PUNCT
bjos-8642673	162	4	zimmerman	zimmerman	PROPN
bjos-8642673	162	5	m	m	PROPN
bjos-8642673	162	6	,	,	PUNCT
bjos-8642673	162	7	chidzonga	chidzonga	PROPN
bjos-8642673	162	8	mm	mm	INTJ
bjos-8642673	162	9	.	.	PUNCT
bjos-8642673	163	1	oral	oral	ADJ
bjos-8642673	163	2	manifestations	manifestation	NOUN
bjos-8642673	163	3	in	in	ADP
bjos-8642673	163	4	100	100	NUM
bjos-8642673	163	5	zimbabwean	zimbabwean	PROPN
bjos-8642673	163	6	hiv	hiv	PROPN
bjos-8642673	163	7	/	/	SYM
bjos-8642673	163	8	aids	aids	PROPN
bjos-8642673	163	9	patients	patient	NOUN
bjos-8642673	163	10	referred	refer	VERB
bjos-8642673	163	11	to	to	ADP
bjos-8642673	163	12	a	a	DET
bjos-8642673	163	13	specialist	specialist	ADJ
bjos-8642673	163	14	centre	centre	NOUN
bjos-8642673	163	15	.	.	PUNCT
bjos-8642673	164	1	cent	cent	NOUN
bjos-8642673	164	2	afr	afr	PROPN
bjos-8642673	164	3	j	j	PROPN
bjos-8642673	164	4	med	med	PROPN
bjos-8642673	164	5	1998	1998	NUM
bjos-8642673	164	6	,	,	PUNCT
bjos-8642673	164	7	44	44	NUM
bjos-8642673	164	8	:	:	SYM
bjos-8642673	164	9	31	31	NUM
bjos-8642673	164	10	-	-	SYM
bjos-8642673	164	11	4	4	NUM
bjos-8642673	164	12	.	.	NUM
bjos-8642673	164	13	21	21	NUM
bjos-8642673	164	14	.	.	PUNCT
bjos-8642673	165	1	ec	ec	NOUN
bjos-8642673	165	2	-	-	PUNCT
bjos-8642673	165	3	clearinghouse	clearinghouse	NOUN
bjos-8642673	165	4	on	on	ADP
bjos-8642673	165	5	oral	oral	ADJ
bjos-8642673	165	6	problems	problem	NOUN
bjos-8642673	165	7	related	relate	VERB
bjos-8642673	165	8	to	to	ADP
bjos-8642673	165	9	hiv	hiv	PROPN
bjos-8642673	165	10	infection	infection	NOUN
bjos-8642673	165	11	and	and	CCONJ
bjos-8642673	165	12	who	who	PRON
bjos-8642673	165	13	collaborating	collaborate	VERB
bjos-8642673	165	14	centre	centre	NOUN
bjos-8642673	165	15	on	on	ADP
bjos-8642673	165	16	oral	oral	ADJ
bjos-8642673	165	17	manifestations	manifestation	NOUN
bjos-8642673	165	18	of	of	ADP
bjos-8642673	165	19	the	the	DET
bjos-8642673	165	20	immunodeficiency	immunodeficiency	NOUN
bjos-8642673	165	21	virus	virus	NOUN
bjos-8642673	165	22	.	.	PUNCT
bjos-8642673	166	1	an	an	DET
bjos-8642673	166	2	update	update	NOUN
bjos-8642673	166	3	of	of	ADP
bjos-8642673	166	4	the	the	DET
bjos-8642673	166	5	classification	classification	NOUN
bjos-8642673	166	6	and	and	CCONJ
bjos-8642673	166	7	diagnostic	diagnostic	ADJ
bjos-8642673	166	8	criteria	criterion	NOUN
bjos-8642673	166	9	of	of	ADP
bjos-8642673	166	10	oral	oral	ADJ
bjos-8642673	166	11	lesions	lesion	NOUN
bjos-8642673	166	12	in	in	ADP
bjos-8642673	166	13	hiv	hiv	PROPN
bjos-8642673	166	14	infection	infection	NOUN
bjos-8642673	166	15	.	.	PUNCT
bjos-8642673	167	1	j	j	PROPN
bjos-8642673	167	2	oral	oral	ADJ
bjos-8642673	167	3	pathol	pathol	NOUN
bjos-8642673	167	4	med	me	VERB
bjos-8642673	167	5	1991	1991	NUM
bjos-8642673	167	6	;	;	PUNCT
bjos-8642673	167	7	20:97	20:97	NUM
bjos-8642673	167	8	-	-	SYM
bjos-8642673	167	9	100	100	NUM
bjos-8642673	167	10	.	.	PUNCT
bjos-8642673	168	1	22	22	NUM
bjos-8642673	168	2	.	.	PUNCT
bjos-8642673	169	1	ranganathan	ranganathan	PROPN
bjos-8642673	169	2	k	k	PROPN
bjos-8642673	169	3	,	,	PUNCT
bjos-8642673	169	4	umadevi	umadevi	PROPN
bjos-8642673	169	5	m	m	PROPN
bjos-8642673	169	6	,	,	PUNCT
bjos-8642673	169	7	saraswathi	saraswathi	PROPN
bjos-8642673	169	8	tr	tr	VERB
bjos-8642673	169	9	,	,	PUNCT
bjos-8642673	169	10	n	n	CCONJ
bjos-8642673	169	11	kumarasamy	kumarasamy	PROPN
bjos-8642673	169	12	n	n	CCONJ
bjos-8642673	169	13	,	,	PUNCT
bjos-8642673	169	14	solomon	solomon	PROPN
bjos-8642673	169	15	s	s	PROPN
bjos-8642673	169	16	,	,	PUNCT
bjos-8642673	169	17	johnson	johnson	PROPN
bjos-8642673	169	18	n.	n.	PROPN
bjos-8642673	169	19	oral	oral	ADJ
bjos-8642673	169	20	lesions	lesion	NOUN
bjos-8642673	169	21	and	and	CCONJ
bjos-8642673	169	22	conditions	condition	NOUN
bjos-8642673	169	23	associated	associate	VERB
bjos-8642673	169	24	with	with	ADP
bjos-8642673	169	25	human	human	ADJ
bjos-8642673	169	26	immunodeficiency	immunodeficiency	NOUN
bjos-8642673	169	27	virus	virus	NOUN
bjos-8642673	169	28	infection	infection	NOUN
bjos-8642673	169	29	in	in	ADP
bjos-8642673	169	30	1000	1000	NUM
bjos-8642673	169	31	south	south	ADJ
bjos-8642673	169	32	indian	indian	ADJ
bjos-8642673	169	33	patients	patient	NOUN
bjos-8642673	169	34	.	.	PUNCT
bjos-8642673	170	1	ann	ann	PROPN
bjos-8642673	170	2	acad	acad	PROPN
bjos-8642673	170	3	med	med	PROPN
bjos-8642673	170	4	singapore	singapore	PROPN
bjos-8642673	170	5	;	;	PUNCT
bjos-8642673	170	6	2004	2004	NUM
bjos-8642673	170	7	,	,	PUNCT
bjos-8642673	170	8	33	33	NUM
bjos-8642673	170	9	:	:	PUNCT
bjos-8642673	170	10	37s-42s	37s-42s	NUM
bjos-8642673	170	11	.	.	PUNCT
bjos-8642673	171	1	23	23	NUM
bjos-8642673	171	2	.	.	PUNCT
bjos-8642673	172	1	eisen	eisen	PROPN
bjos-8642673	172	2	d.	d.	PROPN
bjos-8642673	172	3	disorders	disorder	NOUN
bjos-8642673	172	4	of	of	ADP
bjos-8642673	172	5	pigmentation	pigmentation	NOUN
bjos-8642673	172	6	in	in	ADP
bjos-8642673	172	7	the	the	DET
bjos-8642673	172	8	oral	oral	ADJ
bjos-8642673	172	9	cavity	cavity	NOUN
bjos-8642673	172	10	.	.	PUNCT
bjos-8642673	173	1	clin	clin	PROPN
bjos-8642673	173	2	dermatol	dermatol	NOUN
bjos-8642673	173	3	.	.	PUNCT
bjos-8642673	174	1	2000	2000	NUM
bjos-8642673	174	2	,	,	PUNCT
bjos-8642673	174	3	18:579	18:579	NUM
bjos-8642673	174	4	-	-	SYM
bjos-8642673	174	5	87	87	NUM
bjos-8642673	174	6	.	.	PUNCT
bjos-8642673	175	1	24	24	NUM
bjos-8642673	175	2	.	.	PUNCT
bjos-8642673	176	1	begg	begg	PROPN
bjos-8642673	176	2	md	md	PROPN
bjos-8642673	176	3	,	,	PUNCT
bjos-8642673	176	4	lamster	lamster	NOUN
bjos-8642673	176	5	ib	ib	PROPN
bjos-8642673	176	6	,	,	PUNCT
bjos-8642673	176	7	panageas	panageas	PROPN
bjos-8642673	176	8	ks	ks	PROPN
bjos-8642673	176	9	,	,	PUNCT
bjos-8642673	176	10	mitchell	mitchell	PROPN
bjos-8642673	176	11	-	-	PUNCT
bjos-8642673	176	12	lewis	lewis	PROPN
bjos-8642673	176	13	d	d	PROPN
bjos-8642673	176	14	,	,	PUNCT
bjos-8642673	176	15	phelan	phelan	PROPN
bjos-8642673	176	16	ja	ja	PROPN
bjos-8642673	176	17	,	,	PUNCT
bjos-8642673	176	18	grbic	grbic	ADJ
bjos-8642673	176	19	jt	jt	PROPN
bjos-8642673	176	20	.	.	PUNCT
bjos-8642673	177	1	a	a	DET
bjos-8642673	177	2	prospective	prospective	ADJ
bjos-8642673	177	3	study	study	NOUN
bjos-8642673	177	4	of	of	ADP
bjos-8642673	177	5	oral	oral	ADJ
bjos-8642673	177	6	lesions	lesion	NOUN
bjos-8642673	177	7	and	and	CCONJ
bjos-8642673	177	8	their	their	PRON
bjos-8642673	177	9	predictive	predictive	ADJ
bjos-8642673	177	10	value	value	NOUN
bjos-8642673	177	11	for	for	ADP
bjos-8642673	177	12	progression	progression	NOUN
bjos-8642673	177	13	of	of	ADP
bjos-8642673	177	14	hiv	hiv	PROPN
bjos-8642673	177	15	disease	disease	NOUN
bjos-8642673	177	16	.	.	PUNCT
bjos-8642673	178	1	oral	oral	ADJ
bjos-8642673	178	2	dis	dis	PROPN
bjos-8642673	178	3	.	.	PUNCT
bjos-8642673	179	1	1997	1997	NUM
bjos-8642673	179	2	,	,	PUNCT
bjos-8642673	179	3	3:176	3:176	NOUN
bjos-8642673	179	4	-	-	SYM
bjos-8642673	179	5	83	83	NUM
bjos-8642673	179	6	.	.	PUNCT
bjos-8642673	180	1	25	25	NUM
bjos-8642673	180	2	.	.	PUNCT
bjos-8642673	181	1	repentigny	repentigny	NOUN
bjos-8642673	181	2	l	l	PROPN
bjos-8642673	181	3	,	,	PUNCT
bjos-8642673	181	4	daniel	daniel	PROPN
bjos-8642673	181	5	lewandowski	lewandowski	PROPN
bjos-8642673	181	6	d	d	PROPN
bjos-8642673	181	7	,	,	PUNCT
bjos-8642673	181	8	jolicoeur	jolicoeur	PROPN
bjos-8642673	181	9	p.	p.	NOUN
bjos-8642673	181	10	immunopathogenesis	immunopathogenesis	NOUN
bjos-8642673	181	11	of	of	ADP
bjos-8642673	181	12	oropharyngeal	oropharyngeal	ADJ
bjos-8642673	181	13	candidiasis	candidiasis	NOUN
bjos-8642673	181	14	in	in	ADP
bjos-8642673	181	15	human	human	ADJ
bjos-8642673	181	16	immunodeficiency	immunodeficiency	NOUN
bjos-8642673	181	17	virus	virus	NOUN
bjos-8642673	181	18	infection	infection	NOUN
bjos-8642673	181	19	.	.	PUNCT
bjos-8642673	182	1	clin	clin	PROPN
bjos-8642673	182	2	microbiol	microbiol	PROPN
bjos-8642673	182	3	rev	rev	PROPN
bjos-8642673	182	4	.	.	PROPN
bjos-8642673	182	5	2004	2004	NUM
bjos-8642673	182	6	,	,	PUNCT
bjos-8642673	182	7	17	17	NUM
bjos-8642673	182	8	:	:	PUNCT
bjos-8642673	183	1	729–59	729–59	PROPN
bjos-8642673	183	2	.	.	PROPN
bjos-8642673	184	1	braz	braz	PROPN
bjos-8642673	184	2	j	j	PROPN
bjos-8642673	184	3	oral	oral	PROPN
bjos-8642673	184	4	sci	sci	PROPN
bjos-8642673	184	5	.	.	PUNCT
bjos-8642673	185	1	7(26):1591	7(26):1591	NUM
bjos-8642673	185	2	-	-	SYM
bjos-8642673	185	3	1595	1595	NUM
bjos-8642673	185	4	appraisal	appraisal	NOUN
bjos-8642673	185	5	of	of	ADP
bjos-8642673	185	6	oral	oral	ADJ
bjos-8642673	185	7	lesions	lesion	NOUN
bjos-8642673	185	8	status	status	NOUN
bjos-8642673	185	9	of	of	ADP
bjos-8642673	185	10	hiv	hiv	PROPN
bjos-8642673	185	11	/	/	SYM
bjos-8642673	185	12	aids	aids	PROPN
bjos-8642673	185	13	patients	patient	NOUN
bjos-8642673	185	14	in	in	ADP
bjos-8642673	185	15	south	south	ADJ
bjos-8642673	185	16	western	western	ADJ
bjos-8642673	185	17	uganda	uganda	PROPN